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ABBREVIATIONS 
 
AD  Alzheimer’s disease 
ALS  amyotrophic lateral sclerosis 
AMPA  α-3 -amino-hydroxy-5-methyl-4-isoxalolepropionate receptor 
APP  β-amyloid precursor protein 
BDNF  brain-derived neurotrophic factor 
BM  basement membrane 
CAM  cell adhesion molecule 
cDNA  complementary DNA 
CNS  central nervous system 
CSPG  chondroitin sulfate proteoglycan 
CVL  cerebrovascular lesion 
DCC  deleted in colorectal cancer 
DIG  digoxigenin 
DNA  deoxyribonucleic acid 
ECM  extracellular matrix 
ED  embryonic day 
EHS  Engelbreth-Holm-Swarm tumor 
EGF  epidermal growth factor 
ES  embryonic stem cell 
FALS  familial amyotrophic lateral sclerosis 
FGF  fibroblast growth factor 
GFAP  glial fibrillary acidic protein 
GAG  glycosaminoglycans 
HPSG  heparan sulfate proteoglycan 
HC  hippocampus 
5-HT  serotonin, or 5-hydroxytryptamine 
KA  kainic acid 
KDI  tripeptide-containing amino acids, lysine, aspartic acid, and isoleucine  
MAG   myelin-associated glycoprotein  
mRNA  messenger RNA (ribonucleic acid) 
NF  neurofilament 
NCAM  neuronal cell adhesion molecule 
NgCAM  neuronal-glial cell adhesion molecule 
NGF  nerve growth factor  
NMDA  N-methyl-D-aspartate receptor 
NMJ  neuromuscular junction 
OMgp  oligodendrocyte-myelin glycoprotein 
PBS  phosphate-buffered saline 
PCR  polymerase chain reaction 
PD  Parkinson’s disease 
PNS  peripheral nervous system 
PrP  prion protein 
RT  room temperature 
SCI  spinal cord injury 
SOD  superoxide dismutase 
TBI  traumatic brain injury 
TNFα  tumor necrosis factor α 
tPA  tissue plasminogen activator 
VEGF  vascular endothelial growth factor 
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ABSTRACT 
Since the 1980’s, laminin-1 has been linked to regeneration of the central nervous 
system (CNS) and promotion of neuronal migration and axon guidance during CNS 
development. In this thesis, we clarify the role of γ1 laminin and its KDI tripeptide in 
development of human embryonic spinal cord, in regeneration of adult rat spinal cord 
injury (SCI), in kainic acid-induced neuronal death, and in the spinal cord tissue of 
amyotrophic lateral sclerosis (ALS). 
Laminin-1 is a large (~900,000 Dalton) multidomain matrix glycoprotein 
composed of three disulfide-bonded subunits (α1, β1, and  γ1) present in most basement 
membranes of the body. In the CNS, laminin-1 is expressed by both glial cells and 
neurons and plays a key role in development and trauma. During embryonic and early 
postnatal development of the CNS, laminin-1 is produced by young neuroectodermal 
cells, promotes neurite outgrowth and guides neuronal migration. In the adult mammalian 
CNS, laminin-1 is rapidly induced after injury and has been proposed to promote 
regeneration and to protect neurons from apoptosis. The CNS functions of laminin-1 are 
largely confined to its C-terminus, specifically in the α-helical C-terminal domain I of γ1-
laminin. The shortest biologically active domain carrying these activities is the tripeptide 
Lys-Asp-Ile (KDI). 
  In the embryonic spinal cord, netrin-1, a soluble homologue of γ1 laminin, is 
secreted by the specific floor plate cells in the ventral midline. The floor plate cells are of 
notochordal origin and are thought to play a major role in guidance of commissural axons 
across the ventral midline by secreting chemoattractants such as netrins. Our results (I) 
indicate that the floor plate cells synthesize not only netrins but also large quantities of γ1 
laminin that also accumulates as punctate deposits in the ventral midline in close contact 
with the commissural fibers. In addition, α1, β1, and β3 laminins localize as punctate 
deposits in the floor plate region of the human embryonic spinal cord in close association 
with commissural axons (I). These results indicate that several laminins may participate 
in axon guidance during development of the human embryonic spinal cord. We further 
verified the functional role of γ1 laminin and its KDI tripeptide in commissural axon 
guidance by using a 3D culture system of the human embryonic spinal cord (I).  We show 
that the KDI tripeptide of the γ1 laminin serves as a potent soluble guidance cue for 
commissural axons and thereby has its own axon guidance function independent of 
netrins. 
We have previously shown that the KDI tripeptide promotes regeneration of 
human spinal cord neurons probably by overriding both glia- and myelin-derived 
inhibitory signals known to hamper CNS regeneration.  Based on these findings we 
investigated the ability of the KDI tripeptide to promote functional regeneration of spinal 
cord injury (SCI) in adult rats (II). A local infusion of the KDI tripeptide via an osmotic 
mini-pump on totally transected adult rat spinal cord resulted in a dramatic improvement 
in motor function of the injured animals within 14 weeks of observation (II). The animals 
treated with KDI recovered and were able to sustain their body weight, and even walk 
using their hind limbs, whereas the animals receiving placebo remained paralyzed (II). In 
addition, scar and cyst formation at the lesion site was markedly decreased in the KDI-
treated animals as compared to the placebo-treated animals (II). The functional and 
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histological recovery of the adult rats from a complete SCI indicates that the KDI 
treatment may provide a simple, safe, and clinically applicable method to enhance 
regeneration after CNS trauma. 
In order to understand the protective function of the KDI tripeptide, we tested its 
ability to protect adult rat hippocampal neurons against a potent neurotoxic analogue of 
glutamate, kainic acid (KA; III). An unilateral stereotaxic injection of KA (1 µl at 1 µg/ 
µl concentration) with a preceding injection of the KDI tripeptide (1 µl at 100 µg/ml and 
500 µg/ml concentration) reduced tissue destruction induced by kainic acid. An injection 
of KDI tripeptide at 500 µg/ml concentration was enough to largely preserve the structure 
of the hippocampal CA1 area (III). In control experiments in which an equal volume of 
0.9% NaCl preceded the KA injections the brain tissue was badly damaged with a 
massive destruction of the ipsilateral hippocampus and neocortex accompanied by an 
extensive reactive gliosis (III). Injections of either NaCl + NaCl or KDI + NaCl also 
induced gliosis but only on the ipsilateral side and around the actual injection track. 
These results indicate that the KDI tripeptide largely inhibits the excitotoxicity of the 
glutamate analogue KA, and suggest either a direct or an indirect relationship between γ1 
laminin, its KDI tripeptide, and the function of glutamate.  
We have earlier shown that reactive astrocytes in Alzheimer’s disease and 
Down’s syndrome over-express γ1 laminin and its C-terminal neurite outgrowth domain. 
In order to clarify whether the over-expression of γ1 laminin and its KDI tripeptide is a 
common denominator for all degenerative disorders of the CNS, we studied the 
expression of γ1 laminin in amyotrophic lateral sclerosis (ALS; IV). In ALS, both upper 
and lower motor neurons degenerate, and patients usually die within five years after 
diagnosis of respiratory failure. We found that γ1 laminin was over-expressed in reactive 
astrocytes of both gray and white matter of the ALS spinal cord (IV). Specifically, 
astrocytes immunoreactive for γ1 laminin accumulated in the white matter adjacent to the 
lateral ventral roots in an area of the lateral corticospinal tract (IV).  Furthermore, over-
expression of γ1 laminin was more pronounced in the cervical spinal cord than in the 
thoracic spinal cord, with large numbers of enlarged γ1 laminin immunoreactive reactive 
astrocytes also in the posterior columns of the white matter (IV). As the cervical spinal 
cord is the most seriously affected region in the ALS spinal cord, the glial over-
expression of γ1 laminin appears to correlate with the severity of disease.  
In conclusion, we provide evidence of the role of γ1 laminin and its biologically 
active KDI tripeptide in human spinal cord development (I), in regeneration of adult rat 
SCI (II), and in protection of adult rat hippocampal neurons against glutamate 
excitotoxicity (III). Thus, the over-expression of γ1 laminin in reactive astrocytes of the 
ALS spinal cord (IV) is likely to be a protective measure intended to aid neuronal 
survival. Even if the exact mechanisms of action of γ1 laminin and its KDI tripeptide are 
yet to be elucidated, the view of KDI as a protector in ALS is strongly supported by the 
fact that the KDI tripeptide can counteract the two major denominators playing a role in 
neuronal death in ALS including the function of glutamate, and oxidative stress.  In 
addition, the KDI tripeptide also reduces neuronal overload of calcium by its own 
laminin-like growth factor type mechanisms.  Thus, the true potency of γ1 laminin and its 
KDI tripeptide in protecting viability of CNS neurons and in promoting their axon growth 
is likely to depend on these multiple survival-promoting functions. 
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REVIEW OF THE LITERATURE 
1. LAMININS 
1.1. Laminins in General 
Laminins form a growing family of secretory extracellular matrix glycoproteins 
with diverse functions and cellular distributions. The prototype of laminin, presently 
known as laminin-1 or laminin-111, was purified 1979 from an Engelbreth-Holm-Swarm 
(EHS) tumor, grown either subcutaneously or intramuscularly in mice (Timpl et al., 
1979), and independently from a mouse embryonic carcinoma cell line (Chung et al., 
1979). Laminin-1 consists of three different but related polypeptide chains: α1, β1, and γ1 
laminins, all coded by different genes. Laminin-1 mediates immediate cell-to-cell 
adhesion and is an essential component of most basement membranes of the body, such 
as those lining the epithelia and those surrounding blood vessels, peripheral nerves, and 
underlying the pial membranes of the brain (Martin and Timpl, 1987). Laminins are 
phylogenetically highly conserved, indicating a fundamentally important function 
throughout species, as also evidenced by the fact that antibodies against mouse EHS-
tumor laminin-1 detect laminin from human to goldfish and frog CNS (Liesi, 1985b; 
Murtomäki et al., 1992). 
 
1.2. Nomenclature of Laminins 
The nomenclature presently used for laminins was established in 1994 to allow 
distinctions among the growing number of laminin trimers all with variant α, β, and γ 
laminins (Burgeson et al., 1994). At present, genes for five α laminins, three β laminins, 
and six γ laminins (including netrins 1-3) have been identified with alternative splicing 
accounting for two additional isoforms of α3 laminin (Rousselle et al., 1991; Kariya et 
al., 2004; Table 2). The genes for these laminins code for a total of 14 different laminins, 
and when assembled, they form 15 different laminin heterotrimers (Tables 1 and 2).   
All laminins are named based on their respective homologies to the first identified 
and cloned mouse α, β, and γ laminins of laminin-1 (α1β1γ1; Timpl et al., 1979; Chung et 
al., 1979) and named based on the chronological order of publication with increasing 
numbers 1, 2, 3... Thus, laminin-1 (α1β1γ1) is the prototype of all presently known 
laminins and is known in the earlier literature as ”laminin” or the “EHS-tumor laminin” 
(Burgeson et al., 1994). Recently, yet another nomenclature was introduced as an attempt 
to further simplify the distinction of trimeric laminins (Aumailley et al., 2005). 
According to this most recent nomenclature, laminin-1 is called laminin-111, based on 
the first known laminins involved in formation of the trimer, α1, β1, and γ1 laminins 
(Aumailley et al., 2005). Similarly, the laminin with the first variant of α laminin, 
originally called merosin (Leivo and Engvall, 1988) and also known as laminin-2 
(α2β1γ1), is now known as laminin-211 (Aumailley et al., 2005). The laminin with the 
first variant of β laminin, originally known as s-laminin (Hunter et al., 1989) and also 
known as laminin-3 (α1 β2 γ1), is now called laminin-121 (Aumailley et al., 2005). In 
this thesis, the 1994 nomenclature (Burgeson et al., 1994) is used in line with the 
nomenclature used in all thesis publications. 
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Table 1. Laminin Nomenclature and Chain Assembly. 
1994 name 2005 name Chain assembly Reference 
laminin-1 laminin-111 α1β1γ1 Timpl et al., 1979 
laminin-2 laminin-211 α2β1γ1 Ehrig et al., 1990 
laminin-3 laminin-121 α1β2γ1 Engvall et al., 1990 
laminin-4 laminin-221 α2β2γ1 Engvall et al., 1990 
laminin-5 or 5A laminin-332 α3β3γ2 Rousselle et al., 1991 
laminin-5B laminin-3B32 α3Bβ3γ2 Kariya et al., 2004 
laminin-6 laminin-311 α3β1γ1 Marinkovich et al., 1992 
laminin-7 laminin-321 α3β2γ1 Champliaud et al., 1996 
laminin-8 laminin-411 α4β1γ1 Miner et al., 1997 
laminin-9 laminin-421 α4β2γ1 Miner et al., 1997 
laminin-10 laminin-511 α5β1γ1 Miner et al., 1997 
laminin-11 laminin-521 α5β2γ1 Miner et al., 1997 
laminin-12 laminin-213 α2β1γ3 Koch et al., 1999 
laminin-14 laminin-423  α4β2γ3 Libby et al., 2000 
laminin-15 laminin-523 α5β2γ3 Libby et al., 2000 
 
 
Table 2. Laminin Genes in Humans 
Chain Gene Reference 
α1 LAMA1 Nissinen et al., 1991 
α2 LAMA2 Vuolteenaho et al., 1994 
α3A LAMA3A Ryan et al., 1994 
α3B LAMA3B Ryan et al., 1994 
α4 LAMA4 Iivanainen et al., 1995b 
α5 LAMA5 Durkin et al., 1997 (G-domain) 
β1 LAMB1 Pikkarainen et al., 1987 
β2 LAMB2 Wewer et al., 1994 
β3 LAMB3 Gerecke et al., 1994 
γ1 LAMC1 Kallunki et al., 1991 
γ2 LAMC2 Kallunki et al., 1992 
γ3 LAMC3 Koch et al., 1999 
netrin-1 NTN1L Meyerhardt et al., 1999 
netrin-2 NTN2L Van Raay et al., 1997 
 
1.3. Structure of Laminin-1 
Rotary shadowing electron microscopy has visualized the EHS-tumor laminin-1 
as a cross-shaped heterotrimeric glycoprotein with one long arm and three short arms 
(Engel et al., 1981; Beck et al., 1993) with the individual laminin monomers (α1β1γ1) 
joined together by disulfide bonds (Figures 1 and 2). The structural data on laminin-1, 
gathered by various electron-microscopic techniques and primary structural analysis of 
the individual laminin monomers (Engel et al., 1981; Bruch et al., 1989), indicate that 
laminin-1 consists of three closely related short (34 to 48 nm) arms (domain III-VI) and 
one long (77nm) arm (domains I-II; see Figures 1 and 2). The primary structure of the 
laminin-1 trimer (α1β1γ1) has been determined both in the human and mouse 
(Pikkarainen et al., 1987, 1988; Nissinen et al., 1991; Sasaki et al., 1987, 1988; Sasaki 
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and Yamada, 1987). The three individual monomeric polypeptide chains forming 
laminin-1, α1 (300 to 440-kDa), β1 and γ1 (180 to 220-kDa each) laminins, vary in 
molecular mass depending on the tissue and species as well as on their degree of 
glycosylation (Engel et al., 1981; Beck et al., 1990, 1993; Burgeson et al., 1994; Timpl 
and Brown, 1996). Laminin-1 is a highly glycosylated protein with a very high 
carbohydrate content that accounts for up to 25 to 30% of its molecular mass (Chung et 
al., 1979; Knibbs et al., 1989). Laminin-1 has 74 potential glycosylation sites (Beck et 
al., 1990), which are located mainly in the long arm of laminin-1 and usually in positions 
b, c, or f of the heptad repeats (see below; Sasaki et al., 1987, 1988; Sasaki and Yamada, 
1987; Beck et al., 1990). Thus, the glycosylation sites are on the surface of the coiled-coil 
α-helix, enabling them to participate in various biological events, such as tumor cell 
adhesion, neurite outgrowth, and integrin-laminin interactions (Dennis et al., 1984; Dean 
et al., 1990; Chammas et al., 1991).  
 The long arm of laminin-1 contains the C-terminal domains I-II of all three 
individual laminin monomers (α1, β1, γ1) assembled into a triple-stranded α-helical 
structure (Ott et al., 1982; Paulsson et al., 1985; Figure 1). The domains III-VI of each 
individual laminin monomer (α1, β1, γ1) form one of the three short arms (Figure 1).  
The β1 and γ1 laminins are thought to first form a heterodimer followed by assembly of 
the α1 laminin into this dimer to ultimately form the trimeric structure of laminin-1 
(Utani et al., 1994).  
 The sequence homology between the long-arm domains of α1, β1, and γ1 
laminins is low, but they all contain repeating sequences of seven residues (abcdefg; 
Beck et al., 1990, 1993). The non-polar and hydrophobic residues a and d form the 
interacting edge between the α-helices, allowing helices to coil around each other. The 
key interaction is the stabilizing ionic bond between e and g positions of the heptad-
repeat sequence (Beck et al., 1993). Thus, the core of the triple α-helix consists of 
hydrophobic residues, and the polar residues (b, c, and f) are on the surface of the coiled-
coil structure. This coiled-coil structure is further stabilized by disulfide bonds between 
α1, β1, and γ1 laminins in the end of the C-terminus and in the region of domain II close 
to the N-terminal end of the long arm (Figure 2). Between domains I and II of β-laminin, 
there is a loop composed of a stretch of 40 amino acids called the α-domain (Beck et al., 
1990; Figure 1). This additional domain is incompatible with the α-helix structure of the 
coiled coil, and therefore it loops out from the coiled long arm (Beck et al., 1990). The C-
terminus of the α1 laminin contains an additional finger domain composed of five 
globular G-domains of about 200 amino acid residues each (Beck et al., 1990; Nissinen et 
al., 1991; Figures 1 and 2). This domain is a biologically highly active domain of the α1 
laminin, with several binding sites for laminin receptors. 
The three short arms of laminin-1 are formed by the N-terminal domains of the 
individual monomeric laminins and are all structurally closely related. Each short arm 
contains both globular and rod-like domains (Figure 1). The rod-like cysteine-rich 
domains have several 50 to 60 amino acid-long residues that are structurally related to the 
epidermal growth factor (EGF).  These domains are therefore called EGF-like domains 
(Pikkarainen et al., 1987, 1988; Engel, 1989; Beck et al., 1990). The short arm formed by 
the N-terminal domains III-VI of α1 laminin contains three cysteine-rich EGF-like 
domains: IIIa, IIIb, and V (Sasaki et al., 1988; Figure 1).  In the remaining two short arms 
formed by N-terminal domains III-VI of either β1 or γ1 laminins, the domains III and V 
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are the EGF-like domains (Sasaki et al., 1987; Sasaki and Yamada, 1987; Figure 1). The 
EGF-like domain III of γ1 laminin contains a functionally important binding site (γ1III4) 
for nidogen (Mayer et al., 1993; Figure 1). The two globular domains, IV and VI, are 
separated by the EGF-like domains, and both the β1 and γ1 laminin short arms contain 
one IV and one VI domain, respectively (Figure 1). In addition to one VI domain, the α1 
laminin also contains two IV-domains: IVa and IVb (Figure 1). According to primary 
structural analysis, the domains IV and VI of the short arms of laminin-1 contain 
mixtures of β-sheet and random coil structures (Pikkarainen et al., 1987, 1988; Beck et 
al., 1990; Nissinen et al., 1991). In addition, the VI domains contain several cysteine 
residues, which are necessary for formation of the disulfide bonds (Pikkarainen et al., 
1987, 1988; Beck et al., 1990; Nissinen et al., 1991). Altogether, α1 laminin is composed 
of nine, β1 laminin of seven, and γ1 laminin of six different domains (Sasaki and 
Yamada, 1987; Figure 1).     
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Figure 1. The domain structure of laminin-1 (α1β1γ) trimer according to the current 
nomenclature (Burgeson et al., 1994) indicated in Roman numerals, with the newly 
proposed nomenclature (laminin-111) in parenthesis (Aumailley et al., 2005). Hinge 
indicates an inter-domain bridge between the finger domains G3-G4 and G5. 
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1.4. Proteolytic Fragments of Laminin-1 
Initially, biological functions of the EHS-tumor laminin were studied by use of 
biochemically purified proteolytic fragments of laminin-1 (Engel et al., 1981; Ott et al., 
1982; Bruch et al., 1989).  These studies revealed some of the specific functional 
domains of this large multidomain protein (Figure 2; Table 3). Chymotrypsin (C), 
elastase (E), pepsin (P), and trypsin (T) were used to cleave laminin-1 into smaller 
fragments that were isolated, identified, and used for functional studies. The fragment 
P1/P1’ cleaved by pepsin, contains the inner region of the short arms of laminin-1. 
Several biological functions such as cell attachment (Timpl et al., 1983), nidogen binding 
(Paulsson et al., 1987), and mitogenic activity (Panayotou et al., 1989) have been mapped 
within the P1/P1’ region. The chymotrypsin fragment C1-4 contains the three short arms 
of laminin-1. The elastase fragment E1’ is similar to C1-4 but lacks domains from IV to 
VI of β1 laminin. These fragments have helped us to understand that the outer regions of 
the short arms of laminin-1 are important for Ca2+-dependent self-polymerization of 
laminin-1 (Bruch et al., 1989) and for binding of integrins (Aumailley et al., 1990b).  
The proteolytic fragments (C8-9, E8, T8) of the long arm of laminin-1 come from 
the α-helical C-terminal end of the laminin-1 trimer (Figure 2; Table 3). In addition, the 
fragments C3 and E3, derived from the C-terminal finger domain region of α1 laminin, 
are composed of the globular domains G4 and G5 of α1 laminin (Figure 2; Table 3). 
Several biological functions have been mapped to the C-terminal end of laminin-1. For 
example, the E8-fragment contains a neurite outgrowth-promoting domain of laminin-1 
(Edgar et al., 1984). The fragments of laminin-1 and their biological functions are 
summarized in Table 3.  The cleavage sites of the proteases and the regions 
corresponding to fragments are presented in Figure 2.  
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Figure 2. Schematic illustration of proteolytic fragments of laminin-1 and localization of 
the neurite outgrowth promoting RDIAEIIKDI peptide of γ1 laminin. Black dots (●) 
connected with lines near the cross and in the C-terminal end of domain I denote disulfide 
bonds between the three laminins. 
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Table 3. Proteolytic Fragments of Laminin-1 and Their Respective Functions.  
Fragment Domains Size (kDa) Function 
C1-4 
 
All three short arms  ~340 Ca2+ dependent polymerization1
C3, E3 
 
 
α1G4-5 and hinge ~50-55 Binding of heparin and 
heparansulfate2 
Dystroglycan binding3
C8-9 
 
Entire coiled coil and α1G1-3 ~550 Not detected1
E1’ 
 
 
 
E1 
 
 
 
E1X 
 
 
Subset of C1-4, lacking E1 and E10 
 
 
 
Subset of E1’, lacking γ1 VI domain 
and nidogen fragment from the 
nidogen binding site 
 
Subset of E1’, lacking nidogen 
fragment 
~450 
 
 
 
~300 
 
 
 
>330 
Binding of CBP30  from BHK 
cells4* 
Neural crest cell adhesion 5
Mitogenic6
Integrin binding7
E4 
 
 
VI and V domains of β1 chain 75 Inhibition of  Ca2+ -induced laminin 
aggregation8
E8 
 
 
 
 
 
 
 
 
 
 
 
 
C-terminal residues of α1,β1,γ1 chain 
and α1G1-3 
220-240 Cell attachment9
Neurite outgrowth promotion10
Heparin binding10
Integrin binding 7
Epithelial polarization of developing 
kidney tubuli11,12 Promotion of 
myoblast locomotion13 
Promotion of attachment and 
spreading of BHK cells4
Promotion of neuronal crest cell 
migration14  and proliferation of 
neuroepithelial cells15
E10, E10’ 
 
β1 IV domain 25, 20 Not detected16
25K 
 
C-terminal residues of coiled coil 25 Neurite outgrowth17
P1’ 
 
 
 
 
P1 
 
Short arm complex composed almost 
entirely of IIIa, IIIb, and V domains 
fragments joined through disulfide 
bonds 
 
Similar to P1’ but smaller 
~350 
 
 
 
 
~290 
Cell attachment18
Nidogen binding19
Mitogenic6
T8 C-terminal residues of coiled coil and 
α1G1-3 
Unknown Cell attachment20
 
C, chymotrypsin; E, elastase; P, pepsin and T, trypsin. 
 
* CBP30, carbohydrate-binding protein expressed only in embryonic kidney; BHK, baby hamster kidney 
cell. 
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1. Bruch et al., 1989   11. Sorokin et al., 1990 
2. Ott et al., 1982    12. Klein et al., 1988 
3. Gee et al., 1993    13. Goodman et al., 1989 
4. Sato and Hughes, 1992   14. Perris et al., 1989 
5. Desban and Duband, 1997  15. Drago et al., 1991 
6. Panayotou et al., 1989   16. Mann et al., 1988 
7. Aumailley et al., 1990b   17. Edgar et al., 1988 
8. Schittny and Yurchenco, 1990  18. Timpl et al., 1983 
9. Aumailley et al., 1987   19. Paulsson et al., 1987   
10. Edgar et al., 1984   20. von der Mark et al., 1991 
 
 
1.5. Biologically Active Peptide Domains of Laminins 
Molecular cloning of α1, β1, and γ1 laminins and additional laminins allowed the 
use of synthetic peptides and fusion proteins in analysis of the specific functional 
domains of laminins. Some of the peptides identified exhibit multifunctional properties 
such as promotion of neurite outgrowth, neuronal migration, and neuronal cell attachment 
(Table 4). The γ1 laminin-derived decapeptide (RDIAEIIKDI) and its KDI tripeptide are 
by far the best-studied synthetic peptides of laminins. The functions of these peptides 
have been investigated in vitro by use of human embryonic and rat embryonic or 
postnatal neurons, as well as in several in vivo studies (for references, see Table 4).  Other 
neuronally active, well-studied multifunctional peptides are the 
CSRARKQAASIKVAVSADR of the α1 laminin and the LRE tripeptide of the β2 
laminin (Table 4). However, many of the suspected neuronal functions of laminin-derived 
peptides are from studies using neuron-like cell lines, such as the rat pheochromocytoma 
PC12 cells (rat adrenal medullary tumor) or neuroblastoma – glioma hybrid cells (Graf et 
al., 1987; Tashiro et al., 1989; 1994; 1999; Kato et al., 2002; Suzuki et al., 2003; Table 
4). Thus, conclusions drawn from such studies regarding primary CNS neurons, not to 
mention extrapolation of their significance into mammalian CNS in vivo, have to be 
considered with caution (Table 4). 
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Table 4. Neuronally-Active Laminin-Derived Peptides.  
Location Peptide Neuronal function Reference 
α1 I CSRARKQAAS 
IKVAVSADR 
Neurite outgrowth Tashiro et al., 1989 
α1 I CYFQRYLI Neurite outgrowth and neuronal cell          
attachment 
 
Tashiro et al., 1994 
α1 I IKLLI Neurite outgrowth and neuronal cell 
attachment 
 
Tashiro et al., 1999 
α1 I EIKLLIS Integrin-mediated promotion of neuronal 
survival against glutamate excitotoxicity 
  
Gary and Mattson, 2001; 
Gary et al., 2003 
α1 III RGD Neurite outgrowth 
 
Tashiro et al., 1991 
α1 G KATPMLKMRT 
SFHGCIK 
Neurite outgrowth Skubitz et al., 1991 
α1 G KEGYKVRDLNIT
LEFRTTSK 
Neurite outgrowth Skubitz et al., 1991 
α1 G KNLEISRSTFDLL
RNSYGRK 
Neurite outgrowth Skubitz et al., 1991 
α1 G DGKWHTVKTEYI
KRKAF 
Neurite outgrowth Skubitz et al., 1991 
α1 G RKRLQVQLSI 
RT 
Neurite outgrowth Rickhard et al., 1996 
α2 G KNRLTIELEVRT Neurite outgrowth 
 
Rickhard et al., 1996 
α3 G4 RDSFVALYLSEG
HVIFALG 
Neurite outgrowth Suzuki et al., 2003 
α3 G4 KNSFMALYLSKG Neurite outgrowth and neuronal cell  
attachment 
 
Kato et al., 2002 
α3 G4 GNSTISIRAPVY Neurite outgrowth and neuronal cell 
attachment 
 
Kato et al., 2002 
α4 G LAIKNDNLVYVY Neurite outgrowth Ichikawa et al., 2005 
 
α4 G DVISLYNFKHIY Neurite outgrowth Ichikawa et al., 2005 
 
α4 G VIRDSNVVOLDV Neurite outgrowth Ichikawa et al., 2005 
 
α4 G CTLFLAHGRLVF
X  
Neurite outgrowth, with peptide in 
cyclic form 
 
Ichikawa et al., 2005 
 
α4 G4  DFMTLFLAHGRL
VFMFNVG 
Neurite outgrowth and cell attachment Suzuki et al., 2003 
β1 III YIGSR Neuronal attachment and cell attachment Graf et al., 1987 
 
β2 I LRE Neuronal cell attachment 
 
 
Motor neuron stop signal, inhibition of 
neurite outgrowth 
 
Promotion of motor axon growth 
Hunter et al., 1989, 
Hunter et al., 1991 
 
Hunter et al., 1991;  
Porter et al., 1995 
 
Brandenberg et al., 1996 
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γ1 I RDIAEIIKDI Neurite outgrowth, neurotrophic effect, 
neurotoxic effect 
 
Neuronal migration 
 
 
 
Nuclear translocation 
 
Axonal differentiation 
 
Axon guidance 
 
Modulation of electrical activity of 
neurons 
 
Activation of potassium currents via a 
G-protein-coupled mechanism 
Liesi et al., 1989, 2001b 
 
 
Liesi et al., 1992, 1995; 
Liesi and Wright, 1996 
 
 
Liesi et al., 1995  
 
Matsuzawa et al., 1996 
 
Matsuzawa et al., 1998 
 
Hager et al., 1998 
 
 
Liesi et al., 2001b 
 
 
γ1 I KDI Directional neurite outgrowth 
 
Regeneration after SCI 
 
Protection against kainic acid-induced 
neurotoxicity 
 
Neurite outgrowth 
 
Activation of potassium currents via a 
G-protein-coupled mechanism 
 
Enhanced axonal regeneration in glial- 
and myelin-rich environment 
 
Neurite outgrowth and promotion of 
neuronal survival 
 
Inhibition of AMPA, kainate, and 
NMDA receptors 
 
Protection against 6-OHDA-induced 
neurotoxicity 
Study I 
 
Study II 
 
Study III 
 
 
Liesi et al., 2001b 
 
Liesi et al., 2001b 
 
 
Liebkind et al., 2003 
 
 
 
 
 
Möykkynen et al., 2005 
 
 
Väänänen et al., 2006 
 
Amino acids: A alanine, R arginine, N aspargine, D aspartic acid, C cysteine, Q glutamine, E glutamic acid, 
G glycine, H histidine, I isoleucine, L leucine, K lysine, M methionine, F phenylalanine, P proline, S serine, 
T threonine, W tryptophan, Y tyrosine, V valine.  
References in bold indicate studies using primary neurons rather than neuron-like cells, such as PC12 rat 
pheochromocytoma cells or neuroblastoma-glioma hybrid cell lines. 
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1.6. Molecular Interactions of Laminin-1 
1.6.1. Binding of Laminins to Extracellular Matrix Proteins 
Laminins participate in assembly of basement membranes (BM) and play an 
important role in their maintenance (Yurchenco et al., 1992; Aumailley and Smyth, 
1998). At the ultrastructural level, BM is an extracellular structure located closely 
beneath the basal epithelial cells and consists of three layers: lamina rara, lamina densa, 
and lamina reticularis (Laurie et al., 1982; Yurchenco et al., 1992; Sasaki et al., 2004).  
Molecular interactions between the different BM proteins (laminins, type IV 
collagen, HSPG, nidogen/entactin, fibronectin) have been identified based on rotary 
shadowing electron microscopy, antibody studies, and more recently through the genetic 
approach. It is agreed that both laminin-1 and type IV collagen are the essential 
components of the inner basement membrane structure called “lamina densa”, and 
binding of laminin-1 to type IV collagen is thought to stabilize the BM structure.  
However, the manner of binding of these two molecules to each other is still under some 
debate. It has been proposed that two independently formed networks of laminin-1 and 
type IV collagen (Yurchenco et al., 1992; Timpl and Brown, 1996) are formed by self-
assembly and bound together to form a basement membrane structure via 
entactin/nidogen bonding. Spontaneous self-assembly of laminin-1 is believed to occur in 
a Ca+2-dependent manner (Schittny and Yurchenco, 1990), and formation of a type IV 
collagen network via interactions between the NC1 domains at the COOH-terminus of 
the type IV collagen molecule (Timpl and Brown, 1996).  
Nidogens 1 and 2 are believed to be particularly important for BM assembly due 
to their ubiquitous presence in different tissues, and their high affinity to the fourth EGF-
like repeat in III domain of γ1 laminin (Fox et al., 1991; Mayer et al., 1993) and to type 
IV collagen at triple helical regions close to the C-terminal globule of nidogen. Even 
though nidogen may be a stabilizing link between the networks of type IV collagen and 
laminin due to its high affinity to both matrix proteins (Aumailley et al., 1989; Fox et al., 
1991), genetic evidence indicates that nidogen binding to laminin is not essential for BM 
assembly (Mayer et al., 1998; Kim and Wadsworth, 2000).  This result implies that the 
original model of BM assembly may also be valid. In this model, type IV collagen has 
been reported to bind directly to laminin-1 via binding to the globular domains in the long 
and short arms of laminin-1 (Charonis et al., 1985; Laurie et al., 1986). These results are 
based on rotary shadowing electron microscopic studies using mixtures containing both 
purified type IV collagen and laminin-1. The direct binding was inhibited by antibodies 
against the E3 fragment of the globular long arm of α1 laminin (Charonis et al., 1986). 
As nidogen-laminin complexes are easy to detect in rotary shadowing microscopy 
(Yurchenco and Schittany, 1990), and no such structures were observed by authors 
reporting a direct interaction between laminin-1 and type IV collagen (Charonis et al., 
1985, 1986; Laurie et al., 1986), it is clear that a direct binding between laminin-1 and 
type IV collagen also exists. Laminin-1 may also be anchored to the type IV collagen 
network via additional interactions with the remaining BM proteins such as heparan 
sulfate proteoglycan proteoglycan (HSPG) perlecan (Noonan et al., 1991) that binds to 
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laminin-1 (Battaglia et al., 1992), nidogen (Mayer et al., 1995), and to type IV collagen 
(Battaglia et al., 1992).  
The multifunctional glycoprotein trombospondin, first isolated from platelets 
(Lawler et al., 1978), binds directly to the long arm of laminin-1 (Lawler et al., 1986). 
Agrin, a large multidomain HPSG existing in the BM of the neuromuscular junction 
(Reist et al., 1987), binds to near the center of the coiled-coil in the long arm of laminin-1 
(Denzer et al., 1998). The chondroitin sulfate proteoglycans (CSPGs) astrochondrin 
(Streit et al., 1993) and NG2 (Burg et al., 1996) also directly interact with laminin-1. 
However, the nature of the CPSG interactions with laminin-1, including the exact binding 
sites, is as yet unknown (Streit et al., 1993; Burg et al., 1996). The cell surface 
proteoglycan syndecan-1 (Saunders et al., 1989) binds to the E3 region of the globular C-
terminal domain of α1 laminin-1 (Salmivirta et al., 1994). 
 Heparin has laminin-1 binding activity, and its most important binding site is the 
E3 fragment region in the G-domain of laminin-1 (Ott et al., 1982). Sulfatides interact 
with this same binding site at the globular C-terminal end of α1 laminin (Taraboletti et 
al., 1990; Sorokin et al., 1992; Andac et al., 1999). Fibulins 1 and 2 are proteins not 
restricted to BM and have been reported to interact with laminins (Pan et al., 1993; Utani 
et al., 1997). No direct binding of laminin-1 with either tenascin (Lightner and Erickson, 
1990) or fibronectin has been reported. 
 
1.6.2. Binding of Laminin-1 to Its Receptors  
Soon after its discovery, laminin-1 was reported to mediate cell-to-ECM adhesion 
(Terranova et al., 1980; Carlsson et al., 1981). Adhesion of cells to laminin occurs via 
specific cell surface receptors, such as integrins (Languino et al., 1989; Goodman et al., 
1991) and non-integrin type laminin receptors, such as the 67/68-kDa laminin-receptor 
(Lesot et al., 1983; Rao et al., 1983; Clement et al., 1990).  
Integrins are heterodimeric receptors with two transmembrane subunits, 
designated α and β. Integrins serve as surface receptors for various ECM molecules, such 
as laminin (Buck et al., 1986; Tomaselli et al., 1988), fibronectin (Wayner and Carter, 
1987), vitronectin (Bodary and Mclean, 1989), and type IV collagen (Kramer and Marks, 
1989). Binding of integrins to the ECM molecules requires divalent cations and mediates 
bidirectional signaling between the ECM and the cytoplasm via their cytoplasmic 
domains linked to the cytoskeleton (Hynes, 2002). The integrins presently known to bind 
to laminin-1; their approximate binding sites on laminin-1 are presented in Figure 3 and 
in Table 5. 
The prototype of the laminin receptors is the non-integrin type 67/68-kDa laminin 
receptor (Lesot et al., 1983; Rao et al., 1983; Clement et al., 1990; Table 5) that mediates 
attachment of a number of cell types to laminin. It has two binding sites for laminin-1, 
one in the peptide G region (Castronovo et al., 1991) and another in the C-terminal region 
of the receptor, known as the peptide 11 domain (Landowski et al., 1995). The 67/68-kDa 
laminin receptor has a precursor protein, a 37-kDa protein, which is highly conserved 
through evolution (Ardini et al., 1998) and its cDNA is virtually identical to the 
ribosomal protein p40 (Rao et al., 1989; Ménard et al., 1997; Ardini et al., 1998). The 
mechanism by which 37-kDa protein configures to the mature 67/68-kDa laminin 
receptor is unknown, but it is thought that homo- or heterodimeriziation of the acylated 
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Figure 3. Schematic illustration of the binding sites of integrins on the laminin-1 
molecule.  
 
37-kDa protein might be involved (Rao et al., 1989; Buto et al., 1998).  The 67/68-kDa 
laminin receptor is able to induce a pattern of tyrosine phosphorylation and activate 
intracellular signaling pathways leading to modulation of target proteins (Brushkin-Harav 
and Littauer, 1998). Interestingly, prion protein (PrP), responsible for a group of 
spongiform encephalopathies such as scrapie in sheep, bovine spongiform 
encephalopathy in cattle, and Creutfelt-Jakob disease in humans (Prusiner, 1998), 
interacts with the 67/68-kDa laminin receptor (Rieger et al., 1997; Gauczynski et al., 
2001). The PrP shares the same binding site on 67/68-kDa laminin receptor with laminin-
1 (Rieger et al., 1997) a binding essential for propagation of the normal cellular PrP to 
the pathological scrapie form PrP (Gauczynski et al., 2001, 2006; Leucht et al., 2003). In 
addition, the cellular PrP, a normal component of cell membranes, is known to interact 
directly with laminin-1 (Graner et al., 2000; Table 5).  
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Table 5. Putative Receptors of Laminin-1 
 
Receptor Binding site on laminin-1 Reference 
Integrins: 
α1β1 
 
E1 fragment  
 
Goodman et al., 1991;  
Pfaff et al., 1994; 
Colognato-Pyke et al., 1995 
α2β1 E1 fragment 
 
 
N-terminus of β1 and γ1 laminin 
Languino et al., 1989; 
Pfaff et al., 1994 
 
Underwood et al., 1995; 
Nomizu et al., 1997 
α3β1 globular G1-G3 domains of α1 laminin Tashiro et al., 1999 
α6β1 globular G1-G3 domains of α1 laminin Aumailley et al., 1990b 
α7β1 globular G1-G3 domains of α1 laminin Kramer et al., 1991 
α6β4 globular G1-G3 domains of α1 laminin 
 
Lee et al., 1992 
α-dystroglycan globular G4-G5 domains of α1 laminin Ervasti and Campbell, 1993; 
Gee et al., 1993  
cranin 
(dystroglycan) 
 
globular G domain region of α1 laminin 
 
Smalheiser, 1993 
67/68-kDa 
laminin receptor 
 
YIGSR peptide in N-terminus of the β1 
laminin and 
C-terminal end of domain I of α1 laminin 
 
Graf et al., 1987 
 
Clement et al., 1990 
PrP RDIAEIIKDI peptide of γ1 laminin Graner et al., 2000 
 
PrP, prion protein 
 
The dystroglycan complex (DGC) is composed of two glycoprotein subunits. The 
extracellular domain, α-dystroglycan, is linked to the transmembrane domain of the 
receptor complex, called β-dystroglycan (Ervasti and Campbell, 1991; Ibraghimov-
Beskrovnaya et al., 1993). The latter has an intracellular part containing domains with 
putative signal transduction potential (Jung et al., 1995). The laminin – α-dystroglycan 
binding provides a link from the extracellular events to the cytoskeleton and is important 
for branching in epithelial morphogenesis of lungs, kidneys, and salivary glands (Sorokin 
et al., 1992; Durbeej et al., 1995; Durbeej and Ekblom, 1997; Table 5). The importance 
of these receptors is emphasized by the fact that both mice and embryonic bodies lacking 
β1 integrin (Stephens et al., 1995) or dystroglycan (Williamson et al., 1997) die during 
early development. Cranin, another laminin-binding protein, originally isolated from 
embryonic chicken brain and mouse fibroblasts (Smalheiser and Schwartz, 1987, 
Smalheiser, 1993), was later found to be a variant of dystroglycan (Smalheiser and Kim, 
1995). 
 
1.6.3. Binding of Laminin-1 to Other Molecules 
Various cell surface proteins, such as Ng-CAM (Grumet et al., 1993), β-amyloid 
precursor protein (APP: Narindraorasak et al., 1992), and acetylcholine-esterase (Vigny 
et al., 1983; Johnson and Moore, 2003) are known to bind laminin directly.  
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Many molecules, including serum amyloid P–a component of amyloid plaques 
(Coria et al., 1988)–and a normal component of basement membranes (Dyck et al., 
1980), bind to both human laminin-1 and laminin-2 in a Ca+2-dependent manner (Zahedi, 
1997). In addition, serum amyloid A forms a high affinity binding with laminin-1, and 
this binding site is suggested to exist in the short arm region of γ1-laminin (Ancsin and 
Kisilevsky, 1997). Amyloid precursor protein (APP) binds to the IKVAV sequence of α1 
laminin, and it may even be a laminin receptor (Narindrasorasak et al., 1992; Kibbey et 
al., 1993). Apolipoprotein E (apoE) forms a high affinity complex with laminin-1, and in 
vitro, apoE-laminin-1 substrate promotes growth, enlarges growth cones, and enhances 
the neurite branching of rat hippocampal neurons compared to neurons grown only on 
laminin-1 substrate (Huang et al., 1995). A mammalian homologue to the neuronal-glial 
cell adhesion molecule (Ng-CAM), the L1 –antigen binds to the laminin-1 G2 domain via 
sulfated HNK-1 carbohydrate epitopes (Hall et al., 1997). Due to the high glycosylation 
rate of the laminin-1 molecule, the surface of the coiled coil provides important binding 
site for carbohydrate-binding proteins. Lectins, such as carbohydrate binding protein 35 
(CBP35) and laminin-binding lectin (LBL), are known to bind to C-terminal sugar 
residues of laminin-1 (Woo et al., 1991; Bao et al., 1992). Laminin-1 has been shown to 
interact directly with both plasminogen and tissue-type plasminogen activator (t-PA; 
Salonen et al., 1984). This interaction suggests a mechanism regulating the plasmin-
mediated proteolysis of laminin-1 (Salonen et al., 1984). 
 
1.7. Biological Functions of Laminins in Non-Neuronal Tissues 
The functions and cellular distributions of laminin-1 were initially studied using 
either the biochemically purified protein, its proteolytic fragments, or polyclonal 
antibodies produced by immunizing rabbits with the entire 900,000 Dalton “native” 
laminin (Timpl et al., 1979).  The native laminin antibodies primarily recognize the N-
terminal domains of α1, β1, and γ1 laminins, for instance the P1/P1’ region in the center 
of the cross-shaped laminin-1 molecule. As we know now, many of the biologically 
active domains of laminin-1 localize in the C-terminal domains rather than in the center 
of the laminin cross. Thus, the quest for data on the biological functions of laminin-1, in 
particular the analysis of its role in the CNS, truly begun after primary structural 
characterization of laminins.  This allowed use of synthetic peptides and fusion proteins 
to identify small functional domains of laminins as well as genetic manipulations to test 
the biological significance of laminins. 
 
1.7.1. Laminins in Embryogenesis 
Laminins regulate tissue morphogenesis from the time before embryonic 
implantation (Leivo et al., 1980; Cooper and MacQueen, 1983; Dziadek and Timpl, 
1986; Smyth et al., 1999; Miner et al., 2004a) extending through organogenesis into the 
postnatal period (Farina et al., 1998; Morandi et al., 1999; Miner and Yurchenco, 2004) 
and adult life.  
Laminins are phylogenetically highly conserved, which is evidenced by molecular 
cloning of laminins from Drosophilia (Fessler et al., 1987; Montell and Goodman, 1988; 
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1989), sea urchin (McCarthy et al., 1987), leech (Luebke  et al., 1995), and zebrafish 
(Parsons et al., 2002), indicating a close sequence homology with the mammalian 
laminins. Therefore, it is not surprising that antibodies against mouse laminin-1 recognize 
laminins in the frog and goldfish CNS (Liesi, 1985b). In addition, genes for mammalian 
netrins (Van Raay et al., 1997; Meyerhardt et al., 1999; Wang et al., 1999), laminets 
(Nakashiba et al., 2000; Yin et al., 2002), and unc-6 genes of C. elegans (Hedgecock et 
al., 1990) code for proteins that are structurally and functionally similar and share also a 
considerable homology with β1 and γ1 laminins (Yurchenco and Wadsworth, 2004). 
Thus, structural and functional similarities between the laminins from sea urchin to 
mammalians suggest that laminins serve fundamental roles throughout species and 
evolution (Hutter et al., 2000).  
Laminin-1 was first detected at the morula stage of the developing mouse embryo 
(Leivo et al., 1980) between the individual cells and later even at the 2-cell stage (Cooper 
and MacQueen, 1983; Dziadek and Timpl, 1985). Laminin-1 (α1β1γ1) and laminin-10 
(α5β1γ1) are the only trimers detected at significant levels in mouse embryos at the 
implantational stage (during implantation, the embryonal cells penetrate the uterine 
stroma to form a connection with maternal capillaries; Klafky et al., 2001). Laminin-1 is 
essential at the stage of embryogenesis when the primordial germ layers are formed, and 
therefore mutations in laminin-1 genes (LAMA1, LAMB1, and LAMC1) cause 
embryonic disorganization, apoptosis, and lethality (Smyth et al., 1999; Miner et al., 
2004a; Miner and Yurchenco, 2004; Sasaki et al., 2004). The fundamental importance of 
these particular laminins is best demonstrated by the fact that none of the laminin-1 
knockouts (LAMA1, LAMB1, or LAMC1) are viable (Table 6; Miner et al., 2004a; 
Smyth et al., 1999). 
Even though the null mutations of α1, β1, and γ1 laminins are lethal at the earliest 
stages of embryonic development and cannot be used to study laminin function later in 
life, their importance extends far beyond the earliest stages of embryonic development. 
The central role of γ1 laminin, for example, is clearly emphasized by the fact that γ1 
laminin is present in 10 of the 15 trimers of laminin, it shares a homology with netrins 
and unc-6-coded proteins (Hedgecock et al., 1990), and its absence effectively prevents 
all BM assembly (Smyth et al., 1999). 
In addition to laminins α1, β1, and γ1, additional laminins are involved in 
mammalian embryogenesis. At the peri-implantation stage of the early embryogenesis, α5 
laminin is not required even though it is present (Miner et al., 1998). This is evidenced by 
the fact that the laminin α5-deficient homozygous mice survived past the implantation 
stage, but their defects were apparent after ED 9, and none of the homozygous embryos 
survived past ED 17 (Table 6; Miner et al., 1998). A number of additional laminin 
mutations have less serious consequences and are less life threatening. For instance, the 
LAMA2 mutation in humans leads to a congenital muscular dystrophy and alterations in 
the cerebral white matter detectable in magnetic resonance imaging as hypodensity 
(Farina et al., 1998; Morandi et al., 1999; Miyagoe-Suzuki et al., 2000). Structural 
alterations of the human CNS due to the LAMA2 mutation also include hypoplasia of the 
pons and cerebellum, and dilatation of the ventricles (Farina et al., 1998; Morandi et al., 
1999; Miyagoe-Suzuki et al., 2000).  
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Table 6. Laminin-Null Mutations 
 
Genotype –/ – Mouse Phenotype Reference 
LAMA1 lethal at peri-implational stage on ED 6.5 
 
Miner et al., 2004a 
LAMA2 demyelination of the PNS and CNS 
 
 
hearing-loss due to degeneration of cochlear and 
vestibular structures 
 
Matsumura et al., 1997; 
Chun et al., 2003 
 
Pillers et al., 2002 
LAMA4 neuromuscular dysfunction 
 
impaired maturation of micro-vessels resulting in a 
bleeding disorder 
 
Patton et al., 2001 
 
Thyboll et al., 2002 
LAMA5 lethal on ED 17, defects apparent on ED 9 
exencephaly, syndactyly, and placental 
dysmorphogenesis 
 
failure in formation of glomerular BM and possible  
absence of one or both kidneys 
 
incomplete lung development  
 
Miner et al., 1998 
 
 
 
Miner et al., 1999;  
Miner and Li, 2000 
 
Nguyen et al., 2002 
LAMB1 lethal at peri-implational stage on ED 5.5 
 
Miner et al., 2004a 
LAMB2 Impaired kidney function, and from an aberrant 
synaptic differentiation of the neuromuscular junction 
 
abnormal retinal development in form of altered 
morphology of retinal layers and disrupted synaptic 
connections 
 
Noakes et al., 1995a,b 
 
 
Libby et al., 1999 
LAMC1 lethal at peri-implational stage on ED 5, due to failure 
of BM formation 
 
Smyth et al., 1999 
LAMC2 neonatal blister formation of skin, bladder, and oral 
mucosa, early neonatal lethality due to malnutrition 
Meng et al., 2003 
 ED, embryonic day; BM, basement membrane 
 
Laminin α2 and laminin α4 are also important during development of the 
pancreatic BM and polarization of the acinar cells because the distribution of 
dystroglycan and α4β6 integrin on acinar cells is dependent on these laminins (Miner et 
al., 2004b). In the absence of both α2 and α4 laminins, the basal localization of α4β6 
integrin is significantly reduced, and dystroglycan is totally absent from the acinar cells, 
compared to controls. In addition, laminin-1, particularly α1 laminin, promotes epithelial 
polarization in vitro because antibodies against the E3 and E8 fragments inhibit 
conversion of mouse embryonic kidney mesenchyme into a polarized epithelium (Klein 
et al., 1988).  
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Interestingly, both normal implantation of the mouse embryo and development of 
all three germ layers occur in the absence of the additional major basement membrane 
proteins, such as perlecan, type IV collagen, and nidogen. Results from in vitro studies  
indicate that mouse embryonic bodies, null for both gene alleles (–/–) of either β1-
integrin or γ1 laminin, are unable to form a BM or undergo epiblast differentiation and 
cavitation (Li et al., 2002). Interestingly, partial but distinct rescue of both the γ1 
laminin– and β1 integrin–null embryonic bodies is achieved after addition of exogenous 
laminin-1, indicating the crucial role of laminin-1 for early embryogenesis and basement 
membrane assembly (Li et al., 2002). Thus, laminin-1 appears to be one of the key 
molecules for the earliest stages of embryonic development (Costell et al., 1999; 
Murshed et al., 2000; Pöschl et al., 2004).  
Even though laminin-1 is essential for the early embryogenesis, additional 
isoforms such as α5 laminin, and additional BM proteins such as collagen IV and 
perlecan, are equally important for the development and adult function of the body.  For 
example, the absence of type IV collagen results in death of the mouse embryo at ED 
10.5, indicating that the type IV collagen network is vital for stabilization of the basement 
membrane network (Pöschl et al., 2004). 
 
1.7.2. Laminins in Adult Mammalian Tissues  
In adult non-neuronal tissues, one of the primary functions of laminins is to 
provide mechanical stability and form barriers between cell types and organs by forming 
basement membranes. Apart from its role in the proper function and architecture of the 
BM, laminin-1 is an efficient attachment protein for a number of cell types, such as 
epithelial cells (Terranova et al., 1980), hepatocytes (Johansson et al., 1981), and 
fibroblasts (Couchman et al., 1983). Laminin-1 also stimulates spreading, proliferation, 
and differentiation of various types of cells including Schwann cells (McGarvey et al., 
1984), hepatocytes (Johansson et al., 1981), fibroblasts (Couchman et al., 1983; 
Aumailley et al., 1987), and myoblasts (Öcalan et al., 1988). Laminin-1 also promotes 
regenerative processes in non-neuronal tissues such as liver regeneration (Kato et al., 
1992; Wewer et al., 1992) and is involved in wound healing (Ryan et al., 1994; 
Kainulainen et al., 1998; Goldfinger et al., 1999). 
 The epidermal BM of the human skin expresses predominantly laminin-5 
(α3β1γ1; Rousselle et al., 1991), but recent results indicate that beneath the 
hemidesmisomes in the upper lamina densa, laminins α5, β1, β2, and γ1 are expressed 
and are believed to promote stable cell attachment (McMillan et al., 2006). Proliferation 
of bone-derived macrophages is stimulated by laminin-1 (Ohki and Kohashi, 1994), and 
stromal cells of the human bone marrow also express several laminins. Laminins α4, α5, 
β1, and β2, as well as γ1 laminin are not only synthesized by the stromal cells in vitro but 
are also localized in the human bone marrow in various locations such as in marrow cord, 
in arteriolar walls, and in the BM of endothelial sinusoidal cells in vivo (Vogel et al., 
1999; Siler et al., 2000). These individual laminins may assemble into four laminin 
trimers (from laminin-8 to laminin-11), which is in line with data indicating a role for 
laminins-10 and -11 in both adhesion and mitogenic activity of human hematopoetic cells 
(Siler et al., 2000). 
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In addition to laminin-1, vascular endothelial cell express laminin-8 (α4β1γ1) and 
laminin-10 (α5β1γ1) (Frieser et al., 1997; Sorokin et al., 1997). Laminins α4, β1, and γ1 
are synthesized by lymphoid cells (T-, B-, and NK cells) and may be assembled into 
laminin-8 trimer. Laminin-8 promotes lymphocyte migration, and after co-stimulation by 
the α6β1 integrin also adhesion and proliferation of T-cells (Geberhiwot et al., 2001). 
Laminin-1, -2, -5, and -10 are the predominant laminins in the human intestine (Turck et 
al., 2005). Recently, the function of these intestinal laminins has begun to emerge. 
Laminin-2, -5, and -10 mediate cellular adhesion and proliferation, while laminin-1 
mediates intestinal cell differentiation (Turck et al., 2005). Human urethral tissue also 
expresses laminins; the most prominently expressed laminin in urothelial cells is laminin-
5 (α3β3γ2), and in stromal cells the dominant laminins are laminin-8 (α4β1γ1) and 
laminin-9 (α4β2γ1) (Hattori et al., 2003). 
 
1.7.3. Role of Laminins in Human Disease 
Due to the central role of laminins in both developing and adult human tissues, it 
is not surprising that processes interfering with the normal functions of laminins are 
involved in the pathogenesis of human diseases. As mentioned earlier, some laminin 
mutations are lethal at the earliest stages of embryogenesis (see Table 6), but in some 
cases fetuses are viable, and symptoms first occur after birth, such as epidermolysis 
bullosa, or even later in life, such as congenital muscular dystrophy. Mutations in 
laminin-coding genes are involved in pathogenesis of several human diseases. Laminins, 
particularly laminin-2 (α2β1γ1) and laminin-4 (α2β2γ1), are present ubiquitously in the 
adult mammalian BM surrounding the skeletal muscle fibers (Sanes et al., 1990; Sasaki, 
2002). The α2 laminin deficiency has been taken as evidence for importance of these two 
laminin heterotrimers for the proper function and integrity of skeletal muscles. A 
mutation in the α2 laminin gene (LAMA2) causes a disorder called congenital muscular 
dystrophy, in which the alteration or absence of α2 laminin causes abnormalities in 
Schwann cell–axon interactions and weakens the skeletal muscles, leading to muscle 
fiber damage during muscle contractions (Helbling-Leclerc et al., 1995). Mutation in one 
of the three laminin-5 (α3β3γ2) subunits causes lethal Herlitz’s junctional epidermolysis 
bullosa, a severe skin blistering disease in newborns (McGrath et al., 1995).  
Laminin-1 has been shown to bind Lutheran, a blood group glycoprotein found on 
the cell membranes of erythrocytes, and this interaction is believed to mediate cell 
adhesion (Udani et al., 1998; El Nemer et al., 1998; Zen et al., 1999). In sickle cell 
anemia, Lutheran glycoproteins are over-expressed on the sickle cell erythrocytes (Udani 
et al., 1998; Zen et al., 1999). It has been suggested that the painful vaso-occlusion 
episodes typical for the disease are due to increased interactions between the Lutheran 
glycoprotein and laminin-1, resulting in an increase in adhesive properties of the sickle 
cell erythrocytes (Udani et al., 1998; El Nemer et al., 1998). 
Laminin-1 plays a major role in tumor cell growth and in metastasis via the 
vascular route (Engbring and Kleinman, 2003). Several active sites of laminin-1 are 
known to promote malignancy; for instance, the SIKVAV peptide derived from α1 
laminin promotes metastasis by stimulating tumor-cell attachment and migration (Tashiro 
et al., 1989), by promoting degradation of extracellular matrix, and by causing increased 
angiogenesis (Kanemoto et al., 1990; Grant et al., 1992; Engbring and Kleinman, 2003). 
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The laminin β1-derived peptide YIGSR (Graf et al., 1987) reduces tumor cell growth and 
metastasis (Sakamoto et al., 1991; Nomizu et al., 1993), probably due to inhibition of 
tumor vascularization (Sakamoto et al., 1991). However, melanoma cells with selected 
adhesion for YIGSR form larger and more numerous tumors when injected into mice 
(Yamamura et al., 1993), indicating that laminin peptides define subpopulations of tumor 
cells with different growth-inducing properties. Hepatocellular carcinoma (HCC) is the 
sixth most frequent cancer in the world, with high lethality (Parkin et al., 2005). Laminin-
5 is expressed in the primary nodule of HCC but not in normal or peritumoral tissue 
(Giannelli et al., 2003). In addition, the γ2 laminin of the laminin-5 trimer is associated 
with metastasis and worse HCC prognosis, offering a possible prognostic marker to 
identify micrometastasis in surrounding tissues (Giannelli et al., 2003).  
Mycobacterium leprae binds to G1-5 domains of α2 laminin, and this interaction 
may initiate the pathogenesis of leprosy by facilitating the entry of the bacteria into the 
Schwann cells (Rambukkana et al., 1997, 1998).  In malaria, interaction with the malaria 
parasite and the γ1 laminin is believed to play a crucial role in the invasion process 
(Vlachou et al., 2001; Arrighi et al., 2005). The γ1 laminin in the midgut of the malaria-
spreading mosquito (Anopheles gambia) gains the capacity to bind to the surface proteins 
of the malaria parasite, plasmodium berghei (Vlachou et al., 2001). Reducing the mRNA 
levels of γ1 laminin by RNAi techniques significantly reduces the amount of successfully 
developed oocytes in the mosquito midgut (Arrighi et al., 2005). 
 
2. LAMININS IN THE CENTRAL NERVOUS SYSTEM 
Initially, polyclonal antibodies against the native 900,000-Dalton laminin-1 
molecule were used to detect laminin-1 in the adult CNS (Alitalo et al., 1982). Laminin-1 
was detected in vascular BM, in the choroid plexus, and in the pial basement membranes 
(Alitalo et al., 1982). The first evidence of laminin expression in mammalian CNS in 
cells of neuroectodermal origin came from in vitro studies of early rat astrocytes (Liesi et 
al., 1983). Primary cultures from embryonic, newborn, and 5-day-old rat brain were 
investigated by using antibodies against native laminin-1. Double immunocytochemistry 
revealed that glial fibrillary acidic protein (GFAP) -positive astrocytes expressed laminin-
1 but were negative for fibronectin (Liesi et al., 1983).  Laminin-1 was also transiently 
localized in reactive astrocytes of the injured adult rodent brain (Liesi et al., 1984b), and 
in glial cells of regenerating CNS-systems, including the normal rat olfactory bulb (Liesi, 
1985b) and the CNS of the lower vertebrates (Liesi, 1985b). By specific techniques such 
as silver enhancing methods, laminin-1 was also detectable in neurons of adult rat 
hippocampal cell layers (Hagg et al., 1989; Chen and Strickland 1997; Hager et al., 1998; 
Indyk et al., 2003). This distribution of laminin-1 was to a large extent due to the fact that 
antibodies against native laminin-1 recognize primarily the N-terminal domains, e.g., the 
short arms of α1, β1, and γ1 laminins. As soon as domain-specific antibodies against 
different laminins and their biologically active domains became available, the distribution 
of laminins could be better approached, and it is presently well established that several 
different laminins exist not only in the BM structures but are also expressed by subclasses 
of neurons in the adult mammalian CNS. 
Laminins in CNS are not necessarily always secreted as heterotrimers. The first 
evidence for this came from by metabolic labeling of cultured cortical and olfactory bulb 
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astrocytes of rat brain (Liesi and Risteli, 1989). These cells secrete a heterodimeric 
variant of laminin-1 lacking the α1 laminin monomer (Liesi and Risteli, 1989). 
Immunostaining of mouse embryonic optic nerve confirmed the in vitro results. The glial 
cells expressed both β1 and γ1 laminins, but no α1 laminin expression appeared in mouse 
brain (Liesi and Risteli, 1989). In support of this view, homozygous mouse embryonic 
stem cells lacking γ1 laminin secrete α1 laminin independently, even with no γ1 laminin 
present (Smyth et al., 1999). Thus, laminins are secreted also as monomers without any 
pre-requirement of di- or trimerization. 
Studies using immunocytochemistry and polyclonal antibodies against the G-
domain of α2 laminin demonstrate α2 laminin expression along the chick optic pathway 
and in retinal ganglion cells (Morissette and Carbonetto, 1995). In addition, both poly- 
and monoclonal antibodies against the globular domains of α2 laminin detect expression 
of α2 laminin in dendritic spines of the adult rat and rabbit hippocampus (Tian et al., 
1997; Hagg et al., 1997).  Similar expression of α2 laminin is detected when mouse 
monoclonal antibodies against the two globular domains G4 and G5 of α2 laminin are 
used (Hagg et al., 1997). The anti-α2 antibody revealed α2 laminin expression in 
association with neuronal processes in the limbic structures of the adult rat and rabbit 
brain (Hagg et al., 1997). Monomers α1 (rat monoclonal antibody against the globular 
G4-domain) and α2 laminin (rabbit polyclonal antibody against the globular G1-3 
domains) exist in adult mouse meninges and in brain endothelia (Sasaki et al., 2002). The 
minor discrepancy between the reported CNS distributions of α laminins may be due to 
the differences in specificity of the antibodies used. The specific antigenic epitope of the 
globular G domain of α laminin recognized by one antibody may be hidden or masked in 
some CNS regions, perhaps due to the additional protein interactions. An antibody 
recognizing only the hidden epitope thus fails to demonstrate α laminin in the same CNS 
structures compared to the positive result for another antibody with different antigen-
specific binding site.  
In addition to α2 laminin, several other laminins are found in adult mammalian 
limbic areas of the mature mammalian CNS, for example in the rodent hippocampus. 
Neurons in CA1, CA3, and in the dentate gyrus mainly express α5, β1, and γ1 laminins 
and if assembled into a heterotrimer, laminin-10 (Chen and Strickland, 1997; Hager et al., 
1998; Nakagami et al., 2000; Chen et al., 2003; Indyk et al., 2003; III). Results from one 
in vitro study using rat hippocampal slice cultures support the in vivo findings and 
demonstrate, that γ1 laminin is synthesized and expressed by the hippocampal neurons 
(Grimpe et al., 2002). Tyrosine hydroxylase immunoreactive dopaminergic neurons of 
the adult rat substantia nigra and ventral tegemental area express γ1 laminin (Väänänen et 
al., 2006). In addition, a recent report using adult mice expressing laminin genes trapped 
with the βgeo (β-galactosidase neomyscin phosphotransferase) marker indicates that both 
β1 and γ1 laminin are expressed by hippocampal pyramidal cells, by retinal ganglion 
cells, and by neurons of the cerebral cortex (Yin et al., 2003). In addition, β1 and γ1 
laminins co-localize in these areas, indicating but not proving that β1 and γ1 laminins 
may assemble to form at least dimers but probably not trimers, as none of the neurons 
expres α laminins by the βgeo trapping method (Yin et al., 2003). Only brain vascular 
endothelial cells and choroid plexus were α5 laminin-positive by the βgeo trapping 
method in adult mice (Yin et al., 2003). 
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Experiments on 3.9LAMB1βgal transgenic mice (Sharif et al., 2004) support the 
gene trap data (Yin et al., 2003). Expression of the 3.9LAMB1βgal transgene 
recapitulated the expression of endogenous β1 laminin in some neurons of the adult 
mouse striatum, pons, hippocampus, thalamus, substantia nigra, and inferior and superior 
colliculi (Sharif et al., 2004).  Human and mouse retina express various laminin isoforms 
such as α3, α4, α5, β2, β3, γ2, and γ3 laminins, and these are distributed in the ECM of 
several compartments including the interphotoreceptor matrix, the inner, and the outer 
plexiform layers of the retina (Libby et al., 1999; Libby et al., 2000).  In addition, mRNA 
for α3, α4, β2, γ2, and γ3 laminins has been detected in both human and rat retina within 
fibers coursing through the inner and outer nuclear layers (Libby et al., 1999; Libby et 
al., 2000). This distribution pattern was consistent with the localization noted by 
immunocytochemistry, indicating that laminins are synthesized in the nuclear layers of 
the retina and deposited in the retinal matrices (Libby et al., 1999; Libby et al., 2000). 
Laminins are expressed in neuroectodermal cells not only in the normal adult 
CNS but also during various pathological processes of the mammalian CNS including 
neurodegenerative disorders and trauma (Liesi et al., 1984b; Bernstein et al., 1985; III, 
IV). Laminin-1 and the monomers α1 and γ1 laminin are localized in both pre-plaques 
and plaques of the Alzheimer brain (Murtomäki et al., 1992; Palu et al., 2002). In 
addition, reactive astrocytes of the Alzheimer and Down syndrome brain over-express α1 
and γ1 laminins (Murtomäki et al., 1992; Palu et al., 2002). After CNS injury, transient 
expression of laminin-1 is induced in reactive astrocytes of adult rat brain (Liesi et al., 
1984b), and both  α1 and γ1 laminins are expressed by reactive glia after spinal cord 
injury in adult rats (Liesi and Kauppila, 2002; II).  
Recently, small glycoproteins were identified and called as laminets, due to their 
structural relationship with the N-termini of α, β, and γ laminins and netrins (Nakashiba 
et al., 2000; Yin et al., 2002). Laminets are expressed by neurons of the adult mouse CNS 
and are found in thalamic nuclei, in the cerebral cortex, hippocampus, and olfactory bulb, 
as well as in the olfactory cortex (Yin et al., 2002). In addition, netrin-1, known to 
participate in commissural axon guidance during spinal cord development, continues to 
be expressed by neurons and oligodendrocytes of the adult rat spinal cord (Manitt et al., 
2001). Neurons of the adult rat and mouse brain synthesize netrin-4 in various locations, 
and netrin-4 mRNA-expressing neurons are found in the hippocampus, cerebellum, and 
cerebral cortex (Yin et al., 2000; Zhang et al., 2004). 
 
2.1. Laminins in Development of the Central Nervous System 
During embryonic and early postnatal development of the CNS, laminins 
participate in formation of the central nervous system by their involvement in neuronal 
migration and axon guidance. In the forming brain, all neuroectodermal cells throughout 
the pseudostratified epithelium of the presumptive neocortex express laminin-1 (Liesi 
1985a). If antibodies are used against the native laminin-1, laminin-1 appears to be 
transiently expressed during embryonic and early postnatal development of the CNS, and 
its expression correlates with neuronal migration and axon pathway formation (Liesi 
1985a; Cohen et al., 1987; McLoon et al., 1988; Liesi and Silver, 1988; Letourneau et al., 
1988; Morissette and Carbonetto, 1995).  In the adult CNS, laminin-1 is mainly localized 
in BM, but it is again transiently induced in reactive astrocytes by injury (Liesi et al., 
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1984b).  However, the distribution of laminins in the adult CNS is more widespread than 
analysis with laminin-1 antibodies indicates. Results from studies using domain-specific 
antibodies against laminins indicate that the glial distribution of laminins observed during 
the development of CNS shifts to neuronal expression in the mature CNS (Hagg et al., 
1997; Chen and Strickland, 1997; Nakagami et al., 2000; Grimpe et al., 2002; Chen et 
al., 2003; Indyk et al., 2003; Väänänen et al., 2006; III; IV; see chapter 2).   
The mRNA for several α, β, and γ laminins occurs in the developing human and 
rodent central nervous system, indicating that both neurons and glial cells do synthesize 
laminins (Libby et al., 2000; Liesi et al., 2001a; I, see Table 7). During embryonic 
development of the human spinal cord, several laminins are expressed in the floor plate 
region in the close vicinity of the commissural axons (I; see Table 7). In addition, some 
laminins show specific localization and can be found in subclasses of neurons; for 
example α1, α5, and γ1 laminins are expressed by the motor neurons of the ventral horn 
in the human embryonic spinal cord (I). This early expression of laminins in the 
developing mammalian and rodent CNS suggests their key role in normal CNS 
development.   
 
Table 7. Expression and Distribution of Laminins in Developing Human and Rodent 
CNS.  
Laminin mRNA 
expression 
Embryo 
species, age 
Localization Reference 
α1 + 
 
+ 
+ 
 
+ 
 
+ 
hu, 17 wk 
 
m, 15.5 d 
hu, 8-13 wk 
 
m, 11.5 d 
 
hu, 7-12 wk 
cerebellum, olfactory bulbs, 
neuroretina, choroid plexus 
meninges 
neurons of brain and spinal 
cord 
meninges and BM 
surrounding spinal cord 
spinal cord, floor plate, 
motor neurons 
Vuolteenaho et al., 1994 
 
Miner et al., 1997 
Liesi et al., 2001a 
 
Sasaki et al., 2002 
 
Study I 
α2 + 
 
- 
+ 
+ 
 
+ 
hu, 17 wk 
 
m, nb 
m, 17.5 d 
hu, 8-13 wk 
 
m, 11.5 d 
cerebellum, olfactory bulbs, 
neuroretina, choroid plexus 
- 
brain 
neurons of brain and spinal 
cord 
meninges and BM 
surrounding spinal cord 
Vuolteenaho et al., 1994 
 
Bernier et al., 1995 
Miner et al., 1997 
Liesi et al., 2001a 
 
Sasaki et al., 2002 
α3 + 
 
 
 
 
 
+ 
- 
+ 
m, 13.5-17.5 d 
 
 
 
 
 
m, 17.5 d 
rat, nb 
hu, 8-13 wk 
trigeminal ganglion, 
thalamus, subependymal 
germinal layer, 
telencephalic 
neuroectoderm, Rathke’s 
pouch 
brain 
retina 
neurons of brain and spinal 
cord 
Galliano et al., 1995 
 
 
 
 
 
Miner et al., 1997 
Libby et al., 2000 
Liesi et al., 2001a 
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α4 - 
+ 
- 
+ 
hu, 20 wk  
m, 17.5 d 
rat, nb 
hu, 8-13 wk 
- 
brain 
retina 
neurons of brain and spinal 
cord 
Iivanainen et al., 1995b 
Miner et al., 1997 
Libby et al., 2000 
Liesi et al., 2001a 
α5 + 
- 
+ 
m, 17.5 d 
rat, nb 
hu, 8-13 wk 
 
hu, 7-12 wk 
brain 
retina 
neurons of brain and spinal 
cord 
spinal cord, motor neurons  
Miner et al., 1997 
Libby et al., 2000 
Liesi et al., 2001a 
 
Study I 
β1 + 
+ 
 
 
+ 
 
+ 
 
- 
m, 12 d 
hu, 18-19 wk 
 
 
hu, 8-13 wk 
 
hu, 7-12 wk 
 
m, nb, 
3.9LAMB1βgal 
transgene  
retina 
choroid plexus, olfactory 
bulb, cerebellum 
 
neurons of brain and spinal 
cord 
spinal cord, floor plate 
 
cortex, hippocampus, 
striatum, thalamus, 
cerebellum 
Sarthy and Fu, 1990 
Iivanainen et al., 1995a 
 
 
Liesi et al., 2001a 
 
Study I 
 
Sharif et al., 2004 
β2 + 
 
 
- 
- 
+ 
hu, 18-19 wk 
 
 
rat, nb 
rat, 18 d  
hu, 8-13 wk 
choroid plexus, olfactory 
bulb, neuroretina, 
cerebellum 
retina 
olfactory bulb 
neurons of  brain and spinal 
cord 
Iivanainen et al., 1995a 
 
 
Libby et al., 2000 
Crandall et al., 2000 
Liesi et al., 2001a 
β3 + rat, nb 
hu, 7-12 wk 
retina 
spinal cord, floor plate 
Libby et al., 2000 
Study I 
γ1 + 
 
 
 
 
+ 
+ 
 
+ 
 
- 
hu, 17 wk 
 
 
 
 
m, 14 d, nb 
hu, 8-13 wk 
 
hu, 7-12 wk 
 
m, 12-18 d 
choroids plexus, meninges, 
cortical plate, brain 
intermediate, ependymal 
zone, cerebellum, olfactory 
bulb 
brain endothelia 
neurons of brain and spinal 
cord 
spinal cord, floor plate, 
motor neurons 
BM of choroid plexus, 
neuroectoderm, and 
capillaries of the brain 
Kallunki et al., 1992 
 
 
 
 
Sugiyama et al., 1995 
Liesi et al., 2001a 
 
Study I 
 
Gersdorff et al., 2005 
γ2 + 
 
+ 
- 
+ 
hu, 17 wk 
 
m, 14 d, nb 
rat, nb 
hu, 8-13 wk 
choroid plexus, cerebellum, 
brain  
brain 
retina 
neurons of brain and spinal 
cord 
Kallunki et al., 1992 
 
Sugiyama et al., 1995 
Libby et al., 2000 
Liesi et al., 2001a 
γ3 - 
- 
rat, nb 
m, 12-18 d 
retina 
BM of choroid plexus, 
neuroectoderm, and 
capillaries of the brain 
Libby et al., 2000 
Gersdorff et al., 2005 
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netrin-1 + 
+ 
 
+ 
m, 10.5-11.5 d 
hu, 8-13 wk 
 
hu, 7-12 wk 
spinal cord, floor plate 
neurons of brain and spinal 
cord 
spinal cord, floor plate 
 
Serarfini et al., 1996 
Liesi et al., 2001a 
 
Study I 
netrin-2 + hu, 8-13 wk neurons of brain and spinal 
cord 
Liesi et al., 2001a 
netrin-3 + 
 
 
- 
m, 11.5-14.5 d 
 
 
m, 13.5-15.5 d 
motor column of spinal 
cord, thalamus, ganglia of 
cranial nerves 
motor neurons, 
sympathetic, 
and sensory ganglia 
Wang et al., 1999 
 
 
Seaman and Cooper, 2001 
netrin-4 + 
 
m, 11.5-18.5 d 
 
ventricular zones,  spinal 
cord and especially floor 
plate  
Yin et al., 2000 
 
 
 
Abbreviations: hu, human; m, mouse; nb, newborn; d, day; wk, week. References in bold indicate studies 
in which the distribution and cellular localization of laminins in the developing CNS are not presented in 
detail. 
2.1.1. Neuronal Migration and Axon Guidance in General 
Neurons are generated from neuroectodermal precursors lining the presumptive 
ventricular walls of the developing brain, and they migrate long distances to their final 
destinations. In the early 1970s, the radial glial guidance model of neuronal migration 
introduced and was the only model until recently (Sidman and Rakic, 1973). According 
to this model, neuronal migration occurs via guidance of the radially oriented glial-cell 
processes (Sidman and Rakic, 1973; Rakic, 1990). Glial cells are considered to contain 
all the molecular and physical guidance cues that migratory neurons need and to provide 
all the directionality required (Sidman and Rakic, 1973; Rakic, 1990). In recent years an 
alternative migration model, the neurite-extension-nuclear-translocation-model, has been 
presented. This model was first introduced by the pioneering studies of Morest (1970) 
using a rapid Golgi method to analyze neuronal migration of subcortical and cortical 
neurons of the mammalian brain. According to this model, neurons migrate by extending 
a neurite which forms appropriate contacts without any particular dependence on glial 
guidance. This is followed by nuclear translocation inside neuronal-performed processes 
(Nakatsuji and Nagata, 1989; Liesi, 1992; Hager et al., 1995; Schaar and McConnell, 
2005). Recent findings using both the rapid Golgi method and confocal laser microscopy 
of the postnatal rat cerebellum support this neurite-extension-nuclear-translocation model 
(Liesi et al., 2003). External granule cells of the rat cerebellum migrate via extension of a 
leading process and move independently from the radial glial cells regardless of their 
migratory path, whether tangential, horizontal, or oblique (Liesi et al., 2003).  
During embryonic development, directionality of axonal growth cones is 
determined by their response to local environmental guiding factors and long-range 
guidance cues secreted from final or intermediate targets to form chemotactic gradients 
along the pathways of the migrating growth cones (Hedgecock et al., 1990; Serafini et 
al., 1996, Tessier-Lavigne and Goodman, 1996; Kidd et al., 1999). Membrane-bound, or 
secreted short-range guidance cues also participate in growth cone migration to allow 
directional changes at specific checkpoints, such as crossing of the ventral midline 
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(Tessier-Lavigne and Goodman, 1996; Deiner et al., 1997; Cooper, 2002). Large 
numbers of different guidance receptors are expressed at surfaces of growth cones at all 
times, and the guidance given may either be attractive or repellent, depending on the 
identity of the guiding cue. These chemorepulsive guidance cues promote filopodial 
retraction and cause collapse of the growth cones, leading the growth cones to turn away 
from the ligand source (Hedgecock et al., 1990; Kolodkin et al., 1993; Luo et al, 1993; 
Cooper, 2002).    
According to this neurite-extension-nuclear-translocation-model of neuronal 
migration, neuronal migration and axon guidance are closely related events and differ 
from each other only in that the nucleus is allowed to move during migration but is kept 
in its place during axon growth.  It is thus understandable that the same molecules, 
including laminins and CAM, often seem to participate in both neuronal migration and 
axon guidance. The following sections will concentrate on the role of laminins in 
neuronal migration and axon growth. 
2.1.2. Laminins in Neuronal Migration 
Migrating neurons receive various guidance signals from the environment to 
control their movement, speed, and direction. In the early 1980’s, laminin-1 was 
identified as a potent promoter of neurite outgrowth of migratory CNS neurons in vitro 
(Baron Van Evercooren et al., 1982; Manthorpe et al., 1983; Liesi et al., 1984a) and was 
localized in spatial and temporal correlation with neuronal migration in vivo (Liesi, 
1985a). These findings led to a proposal for an important role for laminin-1 in neuronal 
migration, but this role was soon put into question by the data that antibodies against the 
native EHS laminin-1 fail to inhibit neuronal migration on a laminin-1 substratum 
(Lindner et al., 1986). Identification of a neurite outgrowth domain of γ1 laminin in the 
C-terminal domain of γ1 laminin (Liesi, et al., 1989) resolved this controversy because 
antibodies against this neurite outgrowth-promoting domain of γ1 laminin were found to 
inhibit neuronal migration both in vitro (Liesi et al., 1992) and in vivo (Liesi et al., 1995). 
Thus, the polyclonal antibodies against native laminin-1, failed to prevent neuronal 
migration because they bind to the unrelated domains in the P1 fragment of laminin-1 
(Ott et al., 1982; Lindner et al., 1986; Liesi, 1990; Liesi et al., 1992), whereas the neurite 
outgrowth-promoting part of laminin-1 molecule is located in the C-terminus (Martin and 
Timpl, 1987; Liesi et al., 1989; Paulsson, 1992; Liesi et al., 2001b). 
In addition to laminin-1, other laminins are known to participate in neuronal 
migration, such as laminin-2, which promotes olfactory neuronal migration in vitro 
(Calof and Lander, 1991). A recombinant fusion protein bearing the three amino-acid-
long Leu-Arg-Glu (LRE) adhesive site in the C-terminus of β2 laminin (Hunter et al., 
1989, 1991) inhibits neuronal migration by a gated mechanism (Porter and Sanes, 1995). 
This indicates that neurons migrate on a surface coated with the recombinant LRE 
fragment of β2 laminin but not onto LRE containing β2 laminin surfaces (Porter and 
Sanes, 1995). The LRE site of β2 laminin may thus provide polarity and directionality for 
the migrating neurons during the CNS development. The small secretory proteins, 
netrins, share structural homology with β1 and γ1 laminins, and participate also in 
neuronal migration in the nervous system of C. elegans (Hedgecock et al., 1990) and in 
the CNS of various mammals (Schwarting et al., 2004; Yurchenco and Wadsworth, 
2004). 
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2.1.3. Laminins in Axon Growth 
That laminin-1 promotes neurite outgrowth of central and peripheral neurons was 
one of the first of its functions to be discovered. It was first observed on postmitotic 
sensory neurons from 9- to 10-week-old human fetuses cultivated on a laminin-1 
substrate in a medium containing nerve growth factor (NGF; Baron van Evercooren et al., 
1982). Manthorpe and colleagues (1983) demonstrated, using tissue culture methods, that 
laminin-1 stimulates the neurite outgrowth of neurons derived from various locations of 
both the PNS and CNS of rodent and avian embryos. Simultaneously, it was observed 
that laminin-1 promotes neurite outgrowth and attachment of neurons derived from the 
postnatal rat brain (Liesi et al., 1984a). This neurite growth-supporting effect of laminin-
1 was further verified by additional in vitro studies that used neurons derived from 
sympathetic ganglia of chick embryos (Edgar et al., 1984) and rat embryonic 
hippocampus (Lein et al., 1992). 
Transient laminin-1 expression during the embryonic developmet of axonal 
pathways in both avian (Cohen et al., 1987) and in rodent CNS (Liesi and Silver, 1988; 
Letourneau et al., 1988) supports these in vitro findings. In chick embryos, laminin-1 
expression is initiated just before the first pioneer axons of retinal ganglion cells appear 
during the formation of the chick optic pathway (Cohen et al., 1987). Punctate deposits of 
laminin-1 are expressed in a similar manner in the developing mouse optic nerve, in 
which the expression of laminin-1 in the optic stalk area appears just before the first 
axons enter the optic nerve (Liesi and Silver, 1988), indicating its role in axonal 
elongation and optical pathway formation. Punctate and transient immunoreactivity for 
laminin-1 is present also on the surfaces of neuroepithelial cells in the marginal zones 
through which the mouse ventral longitudinal pathway extends during the development of 
the mouse brain (Letourneau et al., 1988). This spatial and temporal correlation strongly 
indicates a functional link between laminin-1 expression and enhanced neurite outgrowth.  
Use of synthetic peptides and fusion proteins as culture substrates led to 
identification of a number of laminin monomers specifically involved in neurite 
outgrowth and axon growth. One of the best studied is γ1 laminin and the peptides 
derived from it (Liesi et al., 1989; Matsuzawa et al., 1998; Liesi et al., 2001b; Liebkind 
et al., 2003; I). Approximately 20 different laminin-derived peptides promoting neurite 
outgrowth have been identified, and 11 of these are located in the laminin-1 trimer (Table 
3). These peptides localize in the globular domains of laminins α1, α2, α3, and α4, and in 
the N-terminal domains of α1 and γ1 laminins (Table 3). However, most of the studies 
have utilized neuron-like cells derived from tumor cell lines (Tashiro et al., 1989; 1994; 
1999; Kato et al., 2002; Suzuki et al., 2003). What remains unclear is how many of these 
peptides are effective neurite-outgrowth promoters of primary neurons. 
Interestingly, some of the synthetic peptides derived from laminins may show the 
opposite effects or have dual functions. The decapeptide (RDIAEIIKDI) derived from the 
C-terminus of γ1 laminin simulates the effect of laminin-1 in physiological 
concentrations but has a specific neurotoxic effect at higher concentrations (Liesi et al., 
1989). The tripeptide LRE derived from the C-terminus of β2 laminin inhibits neurite 
outgrowth promoted by other ECM molecules (Porter et al., 1995). In contrast, the same 
LRE tripeptide promotes neurite outgrowth in other situations, indicating that the 
assembly of this peptide with other laminins, combined with the three-dimensional 
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structure of the trimer may have an influence on the outcome (Brandenberger et al., 
1996).    
Decapeptide, RDIAEIIKDI, located in the C-terminus of γ1 laminin, bears the 
neurite outgrowth function of laminin-1, and promotes the neurite outgrowth of central 
neurons in both the soluble and substrate-bound form in organotypic cultures of neonatal 
rodent spinal cord (Liesi et al., 1989). In vitro studies using rat embryonic hippocampal 
neurons demonstrate that the decapeptide promotes axonal differentiation (Matsuzawa et 
al., 1996) and provides a directional axon-growth-promoting capacity independent of any 
chemotrophic gradient (Matsuzawa et al., 1998). The shortest biologically active domain 
of the γ1 laminin that promotes survival and neurite outgrowth of human embryonic 
neurons is the tripeptide sequence KDI, derived from the decapeptide RDIAEIIKDI 
(Liesi et al., 2001b). This three-amino-acid short peptide not only promotes neurite 
outgrowth but it may also participate in commissural axon guidance during embryonic 
development of human spinal cord (I). Matrigel culture experiments further verified the 
role of γ1 laminin in commissural axon guidance by revealing that the KDI provides 
chemotrophic guidance cues for the dorsal spinal cord neurons as does netrin-1 (I). The 
KDI tripeptide also promotes axonal elongation in the harsh environment of adult human 
spinal cord in vitro, probably by overriding the glial and myelin-derived inhibitory 
signals (Liebkind et al., 2003) and in vivo it promotes functional recovery of SCI in adult 
rats after complete transection of the spinal cord (II). The tripeptide not only reduced 
tissue damage at the lesion site but also enabled the regenerating neurites to grow through 
the transection area of the injured spinal cord (II). 
  
2.2. Regeneration of the Central Nervous System 
2.2.1. General Principles 
The peripheral nervous system of adult mammals is capable of regeneration, 
regeneration of damaged mammalian nerves is, however, slow and does not always 
guarantee functional recovery. Axonotomy of peripheral nerves leads to Wallerian 
degeneration, a process by which the distal portion of the damaged axon degenerates. 
Schwann cells begin to catabolize myelin and later even axonal fragments; macrophages 
are recruited as well to the site and participate in the phagocytosis of axonal- and myelin-
derived debris. Due to the secretion of various chemotrophic factors and the formation of 
guidance channels by the remaining Schwann cells, the proximal stumps of degenerated 
axons can develop new growth cones and regenerate. Wallerian degeneration occurs also 
in adult mammalian CNS as a response to trauma but without leading to any significant 
axonal regeneration or functional restitution. Initially, the affected CNS neurons attempt 
to re-establish the connections of the damaged axons, but soon after, growth cones 
collapse and degenerate (Ramón y Cajal, 1928; Johnson, 1993; Stichel and Müller, 1998). 
In addition, some fiber growth may occur from uninjured axon terminals located close to 
a denervated target cell. This type of nerve fiber growth, called collateral sprouting, 
extends only over short distances and rarely achieves any functional regeneration (Ramón 
y Cajal, 1928; Stichel and Müller, 1998). 
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Lack of regeneration in the mammalian CNS is due not to any intrinsic inability 
of CNS neurons to produce new neurites, but rather to environmental factors preventing 
regeneration in the CNS (Richardson et al., 1980; Benfey and Aguayo, 1982). This has 
been demonstrated in studies in which peripheral nerve grafts enhanced the regeneration 
of the injured CNS axons (Richardson et al., 1980; Benfey and Aguayo, 1982). The 
regeneration-hostile environment of the CNS can also be neutralized by exogenous 
administration of either laminin-1 (David et al., 1995; McKeon et al., 1995) or of the γ1 
laminin-derived KDI tripeptide (Liebkind et al., 2003).  In addition, there exist 
differences between the CNS structures and regeneration ability; for example, neurons 
and neurites of the olfactory bulb of the mammalian CNS regenerate after injury 
(Graziadei and Monti Graziadei, 1983). Severed spinal cord and optic nerves of the lower 
vertebrates also regenerate (Yin and Selzer, 1983; Domeniconi and Filbin, 2005). In 
addition, lesioned axons of immature mammalian embryonic CNS regenerate (Ramón y 
Cajal, 1928; Bates and Stelzner, 1993), and the mammalian brain may have a critical age 
of development after which no regeneration occurs. In newborn rats, CNS regeneration 
does not occur after PN day 8 (Smith et al., 1986) and is in temporal correlation with 
CNS myelination (Caroni and Schwab, 1988).  
Also contrary to previous beliefs as to the static nature of the brain, recent studies 
demonstrate that neurogenesis, the birth of new neurons, occurs at least in three specific 
regions of the adult mammalian CNS, namely in the olfactory bulb, in the subventricular 
zone, and in the dentate gyrus of the hippocampus (Palmer et al., 1995; Johansson et al., 
1999; Emsley et al., 2005). Although these findings demonstrate no principal inability of 
the CNS to regenerate, in clinical practice, the CNS capacity to recover after tissue 
damage is very limited. This lack of regenerative capacity makes the CNS more 
vulnerable to trauma such as spinal cord injury and to degenerative disorders such as 
ALS or Alzheimer’s disorder.  
 
2.2.2. The Glial Scar  
One of the major environmental factors thought to hamper regeneration in the 
adult mammalian CNS is formation of the glial scar (Ramón y Cajal, 1928; Stichel and 
Müller, 1998; Fawcett and Asher, 1999). Reactive gliosis or glial scarring, regardless of 
the cause, is the usual injury response of the damaged CNS (Ramón y Cajal, 1928; 
Stichel and Müller, 1998; Fawcett and Asher, 1999). In CNS injuries such as in spinal 
cord injuries, this scar blocks neurite outgrowth through the injury site by forming either 
a physical or a molecular barrier (Ramón y Cajal, 1928; Canning et al., 1996; Stichel and 
Müller, 1998; Fawcett and Asher, 1999).  
The early glial scar consists of myelin debris derived from the myelin sheaths of 
the damaged axons and of those oligodendrocytes surviving the primary injury (Fawcett 
and Asher, 1999). A rapid migration of mircroglia and blood-derived macrophages to the 
injury site follows (Kreutzberg, 1996). Later, approximately one week after the injury, 
oligodendrocyte precursor cells (Keirstead et al., 1998) and, in cases of meningeal 
rupture, also meningeal cells migrate to the scar area (Mathewson and Berry, 1985; 
Fawcett and Asher, 1999). After the CNS lesion, oligodendrocyte precursor cells increase 
in number and up-regulate their expression of chondroitin sulphate proteoglycan (CSPG), 
a major inhibitory protein for axonal regeneration (Levine, 1994; McKeon et al., 1995; 
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Canning et al., 1996; Fawcett and Asher, 1999). In addition, multipotential progenitor 
cells, originating from the spinal cord’s central canal, infiltrate to the glial scar, but the 
role of these cells in SCI remains unclear (Johansson et al., 1999). Initially after the 
trauma, the number of astrocytes declines, due to the direct damage of astrocytes, but 
after a few days astrocytes become hypertrophic and up-regulate the production of glial 
fibrillary acidic protein (GFAP; Latov et al., 1979; Mathewson and Berry, 1985). In 
addition, astrocytes enhance the expression of the neurite outgrowth-inhibiting CSPG 
protein (Levine, 1994). Astrocytes proliferate rapidly and in the final stages of glial scar 
formation, they fill the hollow space caused by the primary lesion and are the dominant 
cell type of scar tissue (Latov et al., 1979; Mathewson and Berry, 1985; Levine, 1994; 
Fawcett and Asher, 1999). Glial scar formation into the well-developed stage with 
proliferating reactive astrocytes takes up to seven days in a cerebellum lesion model of 
the adult rat (Levine, 1994). The glial scar formation aims to enclose the damaged site in 
order to prevent secondary injuries, but in doing so, glial cells have been thought even to 
form a mechanical barrier blocking neurite regrowth (Levine, 1994; Profyris et al., 2004). 
However, that regenerating axons can enter and elongate in the glial scar, indicates that 
scar tissue is unlikely to form an impermeable physical barrier for regenerating neurites 
(Li and Raisman, 1995; Stichel et al., 1999; Liebkind et al., 2003; II).  
The glial scar environment is extremely hostile for regenerating axons. Glial cells 
at the lesion site (astrocytes, microglia, meningeal cells, and oligodendrocytes) express 
various inhibitory molecules causing the regenerative growth cones to collapse. 
Especially proteoglycans such as CSPG, expressed both by reactive astrocytes and by 
oligodendrocyte precursor cells of the glial scar, inhibit axon regeneration (Levine, 1994; 
McKeon et al., 1995; Canning et al., 1996).  Proteins such as tenascin, produced by 
astrocytes (Lochter et al., 1991; Meiners et al., 1995), and myelin-derived inhibitory 
molecules (McKerracher et al., 1994; Mukhopadhyay et al., 1994; GranPré et al., 2000; 
Kottis et al., 2002; Profyris et al., 2004) form an additional soluble barrier hampering 
axonal regeneration.  
  
2.2.3. Myelin-Derived Inhibition 
In addition to the glial scar, even myelin sheaths of the damaged nerve fiber tracts 
release neurite outgrowth-inhibiting molecules. In recent years, three major myelin-
derived inhibitors have been characterized: myelin-associated glycoprotein (MAG; 
McKerracher et al., 1994; Mukhopadhyay et al., 1994), oligodendrocyte-myelin 
glycoprotein (OMgp; Kottis et al., 2002), and Nogo-A (GranPré et al., 2000; Domeniconi 
and Filbin, 2005). These inhibitors do not share structural similarity, but they all locate on 
the innermost lamella of the myelin membrane. The localization of the myelin-derived 
inhibitors, in close contact with axons, enables them to effectively hamper regeneration 
of injured axons (David and Lacroix, 2003; Domeniconi and Filbin, 2005).  
MAG is a member of the immunoglobulin superfamily and has both neurite 
outgrowth-promoting and -inhibiting properties (Mukhopadhyay et al., 1994). Neurite 
outgrowth promotion is demonstrated on embryonic and immature postnatal rat neurons, 
indicating that receptors mediating inhibition develop later in nervous system 
development (DeBellard et al., 1996; Cai et al., 2001). Nogo is a 250-kDa glycoprotein 
existing in three isoforms (Nogo-A, Nogo-B, and Nogo-C) all encoded by a single gene 
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and generated by alternative splicing and usage of alternative promoters (Caroni and 
Schwab, 1988; GranPré et al., 2000). Nogo-A contains two domains capable of neurite 
outgrowth inhibition, one in the aminoterminal (Amino-Nogo) and the other in the 
extracellular loop of 66 amino acids, Nogo-66 (GranPré et al., 2000; Huber and Schwab, 
2000).  Nogo-A is expressed by both oligodendrocytes and neurons of the CNS. OMgp, 
with a molecular mass of 110 kDa, is highly expressed by mature oligodendrocytes 
(Kottis et al., 2002). The neurite-outgrowth inhibition and growth cone-collapse capacity 
of OMgp is similar to that produced by Nogo-66 (Wang et al., 2002a).  
Interestingly, all three myelin-derived inhibitors (MAG, OMgp, and Nogo-A) 
interact with the same Nogo-66 receptor (Wang et al., 2002b). This Nogo-66 receptor is a 
glycosylphosphatidyl-inositol protein, and for the proper transduction of the inhibitory 
signal, a co-receptor, p75 neurotrophin receptor, is required. The Nogo-66 receptor / p75 
receptor complex mediates the inhibition signaling of all three myelin-derived inhibitors, 
although the exact mechanism remains unclear (Wang et al., 2002b).  
The neurite outgrowth-inhibiting molecules present in myelin are tempting novel 
targets for intervention to enhance CNS regeneration. The effects of myelin-derived  
inhibitory proteins can be reduced by using specific antibodies antagonizing the known 
receptors or inhibiting the intracellular signal transduction of the myelin-derived  
inhibitory proteins (David and Lacroix, 2003). Blocking only one of these inhibitory 
proteins would leave the rest of the inhibitors to exert their effect. However, in using the 
monoclonal antibody IN-1 against Nogo-A, some reduction in inhibition and promotion 
of long-distance axon regeneration becomes evident (Schnell and Schwab, 1990; 
Thallmair et al., 1998; Huber and Schwab, 2000). Myelin-derived inhibitors (Nogo-66, 
OMgp, and MAG), do mediate their functions via the same Nogo-66 receptor (Wang et 
al., 2002b). In a study using a peptide antagonist consisting of N-terminal residues of 
Nogo-66, researchers were able to block Nogo-66 receptor and myelin-derived inhibition 
in vitro, but in animal experiments achieved only partial functional recovery and axonal 
regeneration (GrandPre et al., 2002). In addition, recent findings using Nogo-mutant mice 
have been in conflict with findings from studies using antibodies, and with best only 
scarce axonal re-growth reported (Simonen et al., 2003; Zheng et al., 2003). 
  
2.2.4. Growth Factors 
Classical studies by Albert Aguayo indicate that damaged CNS axons can indeed 
form new process in a proper local environment; for instance, a peripheral nerve graft 
containing Schwann cells supports axonal growth into and through the graft (Richardson 
et al., 1980; Benfey and Aguayo, 1982). In response to injury, that Schwann cells of the 
PNS express various neurotrophic factors may partially explain the regeneration capacity 
of the injured peripheral nerves (Meyer et al., 1992; Olson, 1997). The widespread 
expression of neurotrophic factors and their receptors, combined with their known neurite 
outgrowth as well as cell-survival-promoting effects, makes nerve growth factors an 
interesting and potential group for alternative therapy approaches (Levi-Montalcini, 
1987; Olson, 1997). 
 Attempts to promote regeneration and neuronal survival be means of growth 
factors have shown some potential. In addition to autologous peripheral nerve grafts, 
axonal regrowth and improvement of behavioral functions have occurred with grafts 
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containing modified fibroblasts over-expressing nerve-growth factor (NGF; Tuszynski et 
al., 1996). Cheng and co-workers demonstrated significant functional recovery after 
transection of adult mammalian spinal cord by using combination treatment with a 
peripheral nerve graft and acidic fibroblast growth factor (aFGF) (Cheng et al., 1996). In 
this experiment, rat spinal cord was transected at vertebra T8 level, followed by removal 
of 5 mm of the cord, after which the gap was bridged with a peripheral nerve graft and 
stabilized by fibrin glue containing aFGF (Cheng et al., 1996). In addition, in adult rat 
SCI models, Schwann cell grafts or embryonic spinal cord grafts combined with an 
infusion of brain-derived neurotrophic factor (BDNF, Bregman et al., 1997, 1998; 
Coumans et al., 2001), neurotrophin-3 (NT-3; Bregman et al., 1997; 1998, Coumans et 
al., 2001), or both BDNF and NT-3 (Xu et al., 1995; Bregman et al., 1997, 1998) 
prevented atrophy and enhanced axonal growth within grafts. Even though neurotrophic 
factors often result in significant axonal growth inside the grafts, they fail to re-innervate 
of damaged nerve fibers outside the graft (Blesch et al., 2002). CNS trauma leads also to 
acute local ischemia, which may contribute to secondary degeneration. Factors that 
increase angiogenesis, such as vascular endothelial growth factor (VEGF), may be 
essential to reduce hypoxia and revasculate the injury site. After contusion SCI in adult 
rats, VEGF promotes functional recovery and reduces tissue damage at lesion site 
(Widenfalk et al., 2003).  
Growth factors may also promote the CNS regeneration by inhibiting factors 
known to hamper the axonal regeneration (Lindholm et al., 1992) or by inducing the 
expression of other more potent neurotrophic factors (Lindholm et al., 1990; Blesch et 
al., 1999). Transforming growth factor β (TGF-β) causes increased NGF expression in 
cultured astrocytes (Lindholm et al., 1990), and after adult rat SCI, genetically modified 
fibroblasts expressing augmented amounts of leukemia inhibitory factor up-regulate the 
expression of neurotrophin-3 (Blesch et al., 1999). Mircroglia and macrophages up-
regulate their mRNA synthesis of TGF-β after penetrating injury to the adult rat cerebral 
cortex (Lindholm et al., 1992). The TGF-β also modulates the proliferation of reactive 
astrocytes by inhibiting their mitosis (Lindholm et al., 1992). The fact that astrocytes are 
the prominent cell type of the glial scar suggests that the elevated TGF-β expression by 
microglia aims to restrict the formation of the glial scar known to hamper axonal 
regeneration (Lindholm et al., 1992).  
Large-scale apoptosis of oligodendrocytes during CNS trauma leads to 
demyelination of even undamaged nerve fibers which have survived the initial lesion. 
Demyelination decelerates the conduction of these nerve fibers, hampering patients’ 
functional recovery (Shuman et al., 1997; Profyris et al., 2004). If the apoptosis of 
oligodendrocytes could be prevented, much of the secondary destruction of axonal tracts 
could be spared.  The cause of oligodendrocyte mass apoptosis is the loss of the trophic 
support from the environment and the activation of surface death receptors such as tumor 
necrosis factor (TNFα; Barres et al., 1992; Casaccia-Bonnefil, 2000). Axolemmal, 
epidermal growth-factor-like molecules called β-neuregulins enhance oligodendrocyte 
survival. The effects of β-neuregulins are modified by insulin-like growth factor-1 (IGF-
1) and by NGF, both of which signal, as do β-neuregulins, via the tyrosine kinase system 
(Barres et al., 1993; Vartanian et al., 1997). These factors promote oligodendrocyte 
survival by blocking the intracellular apoptosis default pathways (Barres et al., 1993; 
Vartanian et al., 1997). 
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2.2.5. Role of Macrophages 
Shortly after CNS injury, microglial cells enter the lesion site, and even blood-
derived macrophages migrate to the injury area. Activation of microglia occurs at the 
lesion site within the first hours after injury, and large numbers of activated and dividing 
microglia also migrate to the site (Giulian et al., 1989; Kreutzberg, 1996). Activated 
neutrophils are also recruited and within hours accumulate at the injury site (Taoka et al., 
1997). This activation is only momentary, however, with the number of neutrophils 
starting to decline 48 hours post-injury (Taoka et al., 1997). As levels of neutrophils 
decline, monocytes begin to activate and differentiate into macrophages. Pro-
inflammatory mediators such as TNFα and colony-stimulating factor-1 (CSF-1; Lotan et 
al., 1994) as well as ligand binding to microglial complement receptor 3 and mannose 
receptors (Fitch et al., 1999) all mediate macrophage activation. Animal models indicate 
that macrophage presence at an injury site does not decline until 7 days post-injury, and 
microglia are present up to 2 to 4 weeks after the primary lesion of the adult rat spinal 
cord (Popovich et al., 1997). Chronic activation of microglia and macrophages may cause 
them to deform into lipid-containing ghost cells, and to remain at the lesion site for 
months (Popovich and Jones, 2003). The main function of these cells is phagocytosis of 
necrotic material, but activated microglia may also release free radicals and nitric oxide, 
and to secrete pro-inflammatory cytokines as well as glutamate, with a negative impact 
on the local environment and on regeneration (Leskovar et al., 2000). 
In spinal cord injury and in axon damage in general, microglia as well as 
macrophages participate in Walerian degeneration by phagocytozing myelin debris and 
the distal part of the transected axon. In PNS trauma, activated macrophages are believed 
to be pro-regenerative, due to their rapid phagocytosis of myelin debris (Perry and 
Brown, 1992). In addition, massive and rapid macrophage infiltration into the lesion site 
occurs after CNS injury in lower vertebrates, in which regeneration does occur (Wilson et 
al., 1992; Perry and Brown, 1992). The number of macrophages entering the mammalian 
CNS lesion, for example in an injured rat optic nerve is low but increases after local 
injection of cytokines TNF-α and CSF-1 into that optic nerve (Lotan et al., 1994). Results 
from a recent comparison study contradict earlier views and demonstrate that macrophage 
density and cytokine production are higher, even at early time-points, at the spinal cord 
lesion site of an adult rat than in injured peripheral rat sciatic nerve (Leskovar et al., 
2000). TNF-α-activated macrophages are known, however, to lead to increased 
permissiveness of injured optic nerve to neuronal adhesion in vitro, which is important 
for further axonal regrowth (Lotan et al., 1994). Activated macrophages thus offer an 
attractive therapeutic intervention for CNS injuries, and enhanced regeneration has been 
demonstrated in animal studies (adult rat) by grafts containing pre-activated macrophages 
both in optic nerve injury (Lazarov-Spiegler et al., 1996, 1998) and in SCI models 
(Rapalino et al., 1998). No detailed regeneration mechanism has yet been reported. 
Macrophages may enhance the clearance of damaged myelin from the lesion site and 
produce regeneration-promoting growth factors and cytokines (Lazarov-Spiegler et al., 
1996; 1998; Rapalino et al., 1998). 
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2.2.6. Role of Laminins in Regeneration 
In the CNS, laminin-1 was initially identified as a protein produced by cultured 
astrocytes (Liesi et al., 1983). It was soon found to promote neurite outgrowth of 
peripheral sensory neurons (Baron Van Evercooren et al., 1982) and of neurons derived 
from the CNS (Manthorpe et al., 1983; Liesi et al., 1984a). The relation between 
expression of laminin-1 and CNS trauma was first demonstrated with unilateral 
stereotaxic injections of the neurotoxin kainic acid into the neostriatum of adult rat brain. 
This lesioning of the rat brain induced a local and transient expression of laminin-1 in 
reactive astrocytes within 24 hours post-injury, with a decline within a month (Liesi et 
al., 1984b). In addition, a crush of goldfish optical nerve leads to massive glial-derived 
laminin-1 expression, and the retinal explants extracted from the damaged nerves of 
goldfish extend long regenerating neurons on a laminin-1 substrate (Hopkins et al., 
1985). 
The adult mammalian peripheral nervous system (PNS) is capable of regeneration 
and contains laminin-1-expressing Schwann cells (Cornbrooks et al., 1983). In addition, 
astrocytes of the only regenerative part of the adult mammalian CNS, the olfactory bulb 
(Graziadei and Monti Graziadei, 1983), continuously express laminin-1, as do the 
astrocytes of the lower vertebrate CNS (Liesi, 1985b). Embryonic as well as the newborn 
mammalian CNS expresses various laminins, particularly laminin-1 (Liesi et al. 1985a; 
Vuolteenaho et al., 1994; Libby et al., 2000; Liesi et al., 2001a; I) and is capable of 
regeneration, though not after the critical age coinciding with oligodendrocyte maturation 
(Smith et al., 1986; Caroni and Schwab, 1988). The regeneration-capable mammalian 
PNS continues to express laminin, but in the adult mammalian CNS its expression is 
generally low (Luckenbill-Edds, 1997). These observations indicate that laminin-1 
expression correlates with the regeneration property. 
In addition to laminin-1, expression of γ1 laminin is related to CNS trauma (Liesi 
et al., 1984b; Liesi and Kauppila, 2002, II). Recent studies indicate that γ1 laminin 
expression is induced in reactive astrocytes after SCI of the adult rat (Liesi and Kauppila, 
2002, II) and that reactive glia surrounding the necrotic area after cerebral ischemia 
expresses γ1 laminin (Liebkind et al., unpublished findings). In vitro studies on adult 
neurons demonstrate that laminin-1 both promotes regeneration and reverses growth 
inhibition of myelin and scar-associated proteins (David et al., 1995; McKeon et al., 
1995). More recently, KDI-tripeptide, derived from γ1 laminin, has been shown to 
promote neuronal survival, allowing neurite extension in the white matter of the adult 
human spinal cord, an environment known to be inhospitable to axonal regeneration 
(Liebkind et al., 2003). These findings further emphasize the key role of laminins in 
regeneration. 
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2.3. Methods of Regenerating the Adult CNS 
2.3.1. Current Treatment 
Current treatment of an acute spinal cord injury concentrates upon abolishing 
compression by stabilizing the spinal canal, and reducing swelling that will cause 
additional damage even when the spine is decompressed. The primary injury involves 
destruction of local neuronal tissue caused by mechanical trauma. This is followed by 
secondary injury by activation of progressive pathological processes leading to full-scale 
SCI or TBI (Gunnarsson and Fehlings, 2003; Profyris et al., 2004). During these 
destructive processes, the neural tracts left intact by the initial trauma are also often 
destroyed. The secondary destructive processes associated with SCI and TBI include 
edema, ischemia, excitotoxicity, inflammation, massive release of pro-inflammatory 
cytokines, and apoptosis (Profyris et al., 2004). Attempts to neutralize these secondary 
and destructive cascades have produced various therapeutic interventions, but thus far, 
none has proven efficient. 
After an acute SCI, surgical approaches to stabilize the injured spine and to 
decompress the spinal cord are a common praxis in the initial therapy. However, clinical 
studies concerning the outcome after decompression operations in both SCI and TBI are 
rather limited (Gunnarsson and Fehlings, 2003). After SCI, decompression is 
recommended, whether in anterior or in focal compression of the spinal cord (for review, 
see Gunnarsson and Fehlings, 2003). Elevated intracranial pressure in TBI can be 
effectively treated with high-dose mannitol leading to a significantly better short- and 
long-term outcome (Cruz et al., 2002).  A high-bolus dose of metylprednisolone within 8 
hours post-injury (30 mg/kg, following 5.4 mg/kg/h over 24 h) was earlier considered a 
standard procedure in an acute SCI, but the latest randomized clinical trials have been 
controversial (Fehlings and Baptiste, 2005), and metylprednisolone is presently 
considered only one option (Fehlings and Baptiste, 2005). In addition, lifelong and 
multidimensional rehabilitation (physical, occupational therapy) is an important part of 
the long-term care of an SCI victim suffering from spasticity of the muscles, pain, and 
gastro-intestinal and sexual dysfunction.  
 
2.3.2. Future Prospects 
2.3.2.a. Neuronal Precursor Cells  
During the past few years, possibilities for stem-cell therapy have attracted much 
attention and raise hope among the paralyzed, although clinical findings on stem cells are 
few and have remained controversial (Saviz et al., 2002; Rabinovich et al., 2003). 
Neuronal stem cells can be isolated from both embryonic (Stokes and Reier, 1992) and 
adult CNS (Palmer et al., 1995; Shihabuddin et al., 2000) and nasal epithelium (olfactory 
ephitelial cells; Schwartz Levey et al., 1991). In addition, stem cells from non-neuronal 
sources can be induced to differentiate into neuronal stem cells such as bone marrow 
(marrow stromal cells; Kopen et al., 1999) and blood (hematopoietic stem cells; Hao et 
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al., 2003). These multipotential neuronal precursor cells are very resistant to hypoxia and 
injury as well as being proliferatively active and able to produce both neurons and glial 
cells (Kulbatski et al., 2005). Stem cells can be transplanted in various ways, often 
grafted into the lesion cavity or near the lesion site, but also administered by intrathecal, 
intraventricular, and even intravenous means (Kulbatski et al., 2005). Despite all of the 
promising features of the neural precursor cells, it is uncertain whether these cells really 
gain all these functions when applied locally into the injured tissue (Schultz, 2005). In 
addition, knowledge of how to control the destinations, connections, and relationships of 
the transplanted neuronal stem cells in the diseased CNS is still very limited. 
Differentiation of embryonic stem cells (ES) into the desired neuronal cell type and 
maintenance of an appropriate level of purity is not trouble-free; because even a few 
remnants of undifferentiated ES cells are able to differentiate into various tumor types 
(Gruen and Grabel, 2006). Disadvantages of ES-cell therapy also include various political 
and ethical considerations.   
However, several attempts have been made to use stem cells to enhance 
mammalian CNS regeneration. Improved motor function after rat spinal cord contusion 
injury by use of fetal spinal cord transplants was first reported in the early 1990’s (Stokes 
and Reier, 1992). Mouse ES cells differentiate into oligodendrocytes, astrocytes, and 
neurons after transplantation, leading to improved locomotion and weight support of the 
hind limbs (McDonald et al., 1999). Murine neuronal stem cell (C17.2 fetal mouse clone) 
implantation into a 4-mm longitudinal cut at the T9 to T10 level of the rat spinal cord 
midline has resulted in improvement of locomotion compared to that of controls (Teng et 
al., 2002). Recent findings indicate that even adult transplanted rat neuronal stem cells 
can survive, differentiate, integrate, and grow along the endogenous axon pathways in the 
host adult spinal cord (Vroemen et al., 2003).  
In the adult mammalian olfactory bulb, neurogenesis occurs throughout life 
(Johansson et al., 1999; Emsley et al., 2005). This has emerged from studies using these 
pluripotent cells of the olfactory ensheathing glia as transplants, resulting in functional 
recovery from corticospinal tract lesions and regeneration of sensory axons after 
rhizotomy (Ramon-Cueto and Nieto-Sampedro, 1994; Li et al., 1997). Rats with a 
hemisectioned cervical spinal cord, olfactory ensheathing cell transplants also improve 
their breathing and climbing ability (Li et al., 2003). In addition, after total transection of 
the rat spinal cord at the T9 level, transplantation of olfactory ensheathing glia and 
Matrigel mix enhances locomotive and sensation recovery. Eight months after surgery, 
2.5-cm axon regeneration was observable (Ramon-Cueto et al., 2000).  The mechanism 
by which olfactory ensheathing cells or stem cells in general promote regeneration is 
unknown (Schultz, 2005; Kulbatski et al., 2005). Stem cells may improve recovery by 
reintegrating into the host CNS, proliferating, making appropriate connections with 
surrounding cells, and gradually replacing the damaged and dying differentiated neuronal 
cells at the lesion site. Alternatively, stem cells may aid the survival of endogenous cells 
by producing ECM components and neurotrophins providing a regeneration-promoting 
environment (Schultz, 2005; Kulbatski et al., 2005); for instance olfactory ensheathing 
cells produce growth factors such as NGF and BDNF but also express high-affinity 
neurotrophin receptors on their cell membrane (Woodhall et al., 2001; Bianco et al., 
2004). 
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Published stem cell therapy-experiments on humans are few, and the results are 
still controversial. Neuronal cells from a human embryonic carcinoma cell line have been 
transplanted into brains of patients suffering from stroke (Saviz et al., 2002), but thus far 
with no evidence of clinical improvement. Some positive effects are reported from 
clinical SCI studies, e.g., partial recovery of sensation or contraction of some initially 
paralyzed muscles (Rabinovich et al., 2003). Stem cell transplantation is also an attractive 
strategy for the treatment of neurodegenerative disorders such as ALS and Parkinson’s 
disease (PD). Human fetal mesencephalic dopaminergic neurons survive transplantation 
into the brains of PD patients, and according to hisopathological analyses, dopaminergic 
neurons are even able to partially reinnervate the striatum (Lindvall et al., 1990; 
Kordower et al., 1995). However, the functional recovery of PD patients after nigral stem 
cell transplantations has shown a high degree of variability despite successful 
transplantation (Lindvall et al., 1990; Brundin et al., 2000; Olanow et al., 2003). 
Hematopoietic mononuclear stem cells from umbilical cord blood cause an increased 
lifespan in the SOD1 G93A-mutated mouse in an ALS animal model (Ende et al., 2000). 
In contrast, ALS clinical trials using autologous intrathecal transplantation of 
hematopoietic CD34+ stem cells derived from peripheral blood have shown no clinical 
efficacy (Janson et al., 2001). Despite the initial positive results from animal models, 
further studies are needed before stem cells are ready for clinical practice to treat CNS 
injuries and neurodegenerative disorders.  
 
2.3.2.b. Laminins and KDI as Tools 
Laminin-1 is one of the most potent known promoters of neurite outgrowth 
(Baron Van Evercooren et al., 1982; Manthorpe et al., 1983; Liesi et al., 1984a; Liesi, 
1985a; Cohen et al., 1987) and regeneration (Liesi et al., 1984b; Liesi, 1985b). In 
addition to laminin-1 heterotrimer, laminin-derived peptides have been demonstrated to 
enhance neuronal survival, migration, proliferation, and regeneration (Liesi, 1990; Liesi 
et al., 1995; Matsuzawa et al., 1996; Liebkind et al., 2003; I, II, III). Evidence from 
hippocampal slice cultures derived from newborn rats indicates that γ1 laminin 
expression is essential for early postnatal axonal regeneration (Grimpe et al., 2002). The 
targeted down-regulation of γ1 laminin translation by use of antisense targeting 
techniques leads to nearly complete inhibition of γ1 laminin expression. In the absence of 
γ1 laminin, axonal regeneration is hampered, and early postnatal mossy fibers are unable 
to regenerate (Grimpe et al., 2002). 
The up-regulation of laminin-1 expression seen in CNS trauma may be Nature’s 
attempt to make the surrounding environment more suitable for regeneration (Liesi et al., 
1984b; Liesi and Kauppila, 2002). Culture experiments support this view. In lesion 
experiments, addition of exogenous laminin-1 overrides both myelin- and glial-scar-
derived inhibition of axon growth (David et al., 1995; McKeon et al., 1995). Recently, 
the KDI tripeptide of C-terminal γ1 laminin has also, in adult human spinal cord, been 
able to override the environmental inhibitors of axon growth, allowing axonal elongation 
in the white matter (Liebkind et al., 2003). The tripeptide KDI (Lys-Asp-Ile) is the 
shortest biologically active part of the decapeptide (RDIAEIIKDI) identified in1989 as a 
neurite outgrowth domain of γ1 laminin (Liesi et al., 1989). Recent data indicate that KDI 
tripeptide enhances both neurite outgrowth and viability of cultured human embryonic 
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neurons (Liesi et al., 2001b; Liebkind et al., 2003). In organotypic cultures of human 
spinal cord explants, the KDI tripeptide attracts directional neurite outgrowth of dorsal 
spinal cord neurons (I). The ability of KDI tripeptide to enhance neurite outgrowth seems 
to be potent even after injury to the adult mammalian CNS. In an adult SCI model, 
experiments using the soluble KDI tripeptide as treatment (II) demonstrated that KDI 
promotes axonal regeneration after complete transection of the spinal cord and enhances 
the functional recovery (II). 
The KDI tripeptide is also an efficient protector against various neurotoxins in 
vivo. Recent data from animal studies on the adult rat demonstrate that the KDI is able to 
protect hippocampal neurons against kainic acid-induced excitotoxicity (III), and protect 
dopaminergic neurons of the substantia nigra against the neurotoxic effects of 6-
hydroxydopamine (6-OHDA, Väänänen et al., 2006). These results further verify the role 
of KDI as a multipotent neuronal regeneration enhancer and protector peptide. Based on 
recent results from our laboratory, the KDI tripeptide is a universal inhibitor of ionotropic 
glutamate receptors such as AMPA, kainate, and NMDA (Möykkynen et al., 2005). This 
is interesting, because glutamate excitotoxicity plays a central role in the various types of 
pathogenesis of CNS (Hynd et al., 2004; Heath and Shaw, 2002) as well as in CNS 
trauma (Arundine and Tymianski, 2004; Profyris et al., 2004), and this partially explains 
the protective role of KDI tripeptide in kainic acid-induced excitotoxicity. The γ1 laminin 
and its biologically active KDI tripeptide have the capacity to neutralize some of the 
central factors hampering axonal re-growth after SCI, namely myelin- and glial-scar-
derived inhibition as well as glutamate excitotoxicity, thus providing a potent alternative 
for future CNS-trauma therapies.       
 
2.4. Neuronal Death in the Adult CNS 
2.4.1. General Aspects 
The mechanisms of neuronal death are poorly understood. However, two major 
categories exist: apoptosis and necrosis, each depending on the cause of the neuronal 
death. Degeneration during development, but in addition during acute, and chronic injury, 
is suggested to occur via programmed cell death, apoptosis (Yuan and Yanker, 2000). In 
apoptosis, transcription of the specific genes of the affected cell is activated in a caspase-
dependent manner causing shrinkage of both soma and nucleus and leading to chromatin 
condensation; eventually, the DNA is fragmentated leading to cell death. Another 
mechanism of death occurring often in non-physiological conditions is called necrosis 
(Yuan et al., 2003). Typical for necrosis is rapid dilatation of the endoplasmatic 
reticulum, Golgi apparatus, and nuclear membrane, leading to swelling and bursting of 
the entire cell. However, the same insult can induce both apoptosis and necrosis, 
depending on cell type, localization, size of the insult, and various environmental factors. 
Glutamate excitotoxicity leading to elevated intracellular Ca2+ may initiate a necrotic 
cascade instead of the caspase-dependent apoptosis (Yuan et al., 2003). Necrosis is also 
an energy-independent event, and loss of mitochondrial energy metabolism may force the 
cells to enter the necrotic cell-death pathway (Ankarcrona et al., 1995). In addition, 
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necrosis is not always necessarily associated with pathologic conditions; physiological 
necrosis may be part of normal CNS development (Yuan et al., 2003).   
In the adult mammalian CNS, neuronal death/degeneration often refers to those 
non-physiologic conditions occurring in the adult human CNS, such as following 
cerebrovascular lesions (CVL) leading to ischemia (stroke, hemorrhage), trauma (TBI or 
SCI), or the pathogenesis of neurodegenerative disorders. Neurodegenerative diseases can 
be divided roughly into groups affecting cognitive areas of the brain (Alzheimer’s, AD) 
or disorders affecting mostly motor functions (Parkinson’s disease, PD, amyotrophic 
lateral sclerosis, ALS). In AD, degeneration of the neocortex and of limbic structures, 
particularly the hippocampus and amygdala, leads to early impairment of memory and of 
other intellectual functions (Blennow et al., 2006).  In PD, degeneration of the 
dopaminergic neurons of the substantia nigra leads to clinically defined Parkinsonism 
with tremor, bradykinesia, rigidity, and problems in initiation and halting of movement 
(Fahn and Sulzer, 2004). ALS is a progressive neurodegenerative disorder that affects 
both upper and lower motor neurons, but often spares neurons responsible for cognitive 
functions (Bruijn et al., 2004). 
Regardless of the cause of neuronal death/degeneration, its pathogenic processes 
share similar features (Kanazawa, 2001).  The pathogenesis of ischemia due to the CVL 
(Arundine and Tymianski, 2004), CNS trauma (Profyris et al., 2004), and AD (Hynd et 
al., 2004), as well as in ALS (Heath and Shaw, 2002) and PD (Fahn and Sulzer, 2004), 
involves glutamate-induced excitotoxicity. Other common features of pathogenesis 
related to neuronal degeneration are oxidative stress, mitochondrial dysfunction, and 
protein aggregation (Kanazawa, 2001; Troulinaki and Tavernarakis, 2005).  
 
2.4.2. Glutamate-Induced Neurotoxicity 
Glutamate is one of the major excitatory neurotransmitters of the mammalian 
CNS.  During synaptic transmission, glutamate is released from the presynaptic nerve 
endings into the synaptic cleft in order to bind to the glutamate receptors of the 
postsynaptic neuron on the other side of the synaptic cleft. The excitatory action of 
glutamate is terminated by an effective uptake system for glutamate from the synaptic 
cleft mediated by both pre- and postsynaptic neurons and by surrounding glial cells. Two 
distinct classes of glutamate receptors exist on the post-synaptic cell membranes of 
mammalian CNS: ionotropic and metabotropic receptors (Ozawa et al., 1998). The 
ionotropic receptors are divided into subclasses according to their preferred ligands: 
kainate, α-3 -amino-hydroxy-5-methyl-4-isoxalolepropionate (AMPA) and N-methyl-D-
aspartate (NMDA)-receptors (Ozawa et al., 1998). Because the NMDA receptors are the 
most permeable to Ca2+, their prolonged activation by glutamate posses the capacity to 
initiate a massive Ca2+ influx which can result in necrosis and apoptosis of the CNS tissue 
via formation of oxygen radicals, overstimulation of proteases, and transcriptional 
activation of pro-apoptotic proteins (Arundine and Tymianski, 2003).  This excessive 
Ca2+ influx phenomenon triggered by glutamate is called excitotoxicity, meaning literally 
that glutamate can excite cells to death. Various brain insults can induce glutamate 
excitotoxicity and neuronal death. For example after CNS trauma such as SCI or TBI, 
large concentrates of glutamate are released from the damaged cells, resulting in an 
uncontrolled and continuous depolarization and influx of Ca2+ into the nearby neurons 
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(Arundine and Tymianski, 2004; Profyris et al., 2004). Glutamate excitotoxicity is also 
involved in the pathogenesis of various neurodegenerative diseases such as Alzheimer’s 
(Hynd et al., 2004), Parkinson’s (Fahn and Sulzer, 2004), and ALS (Heath and Shaw, 
2002). Long-term exposure of neurons even to moderately elevated concentrations of 
glutamate gradually results in mitochondrial production of reactive oxygen species 
leading to oxidative damage and cell death (Singh et al., 2003).  
Glutamate receptors thus provide good targets for various therapeutic and 
neuroprotective interventions. Blocking the glutamate receptors by use of competitive 
antagonist such as MK801 (Hahn et al., 1988) or APV (2-amino-5-phosphonovalarate; 
Choi et al., 1988) protects neurons against glutamate-induced excitotoxicity in vitro. 
However, administration of these strong glutamate receptors antagonists to patients has 
produced adverse side-effects (drowsiness, hallucinations and coma; Palmer, 2001). 
Clinically acceptable therapy should therefore guarantee the physiological function of 
glutamate receptors.  Today, only a few drugs in clinical use exert their effect on the 
glutamate system, and beneficial effects have been very modest (Miller et al., 2003; 
Lipton, 2004). Memantine is a low-affinity but highly selective NMDA receptor 
antagonist approved for treatment in Alzheimer’s disease (Lipton, 2004).  Riluzole, used 
in ALS therapy (Bensimon et al., 1994; Miller et al., 2003), acts via inactivation of 
voltage-dependent sodium channels (Urbani and Belluzzi, 2000) and slows the 
inactivation of voltage-gated potassium channels present in the presynaptic cleft (Xu et 
al., 2001). Riluzole may thus reduce excitability of the affected neurons and inhibit 
further glutamate release, leading to a reduction in excitotoxicity (Xu et al., 2001). In 
addition, riluzole may interact directly with the glutamate receptors by blocking the 
NMDA receptors in a non-competitive manner (Debono et al., 1993). 
 
2.4.3. Animal Models of Neuronal Degeneration: Kainic Acid-induced 
Neurotoxicity 
Kainic acid (KA) is a neurotoxic analogue of the common CNS excitatory 
neurotransmitter glutamate. KA binds to both AMPA and kainate receptors, known as 
non-NMDA-type glutamate receptors. Glutamate excitotoxicity was previously thought 
to be mediated solely via NMDA receptors, but recent findings indicate that AMPA and 
kainate receptors are also actively involved in excitotoxic neuronal death (Chen et al., 
1995; Hermann et al., 2001). Inducing glutamate excitotoxicity by KA is a practical 
method to study factors affecting the glutamate system, and it has the ability to mimic 
inflammatory and glial cell responses to excitotoxicity. This has made KA a useful model 
for CNS insults such as trauma, epilepsy, and AD (Wang et al., 2005). 
Systemic, intrahippocampal, or intracerebroventricular administration of KA into 
adult rats is known to cause a sequence of behavioral, electro- encephalographic (Ben-Ari 
et al., 1980), and body-temperature changes (Ahlenius et al., 2002). These events are 
followed by neurodegenerative changes, particularly in the hippocampus, where KA-
induced neurodegeneration is well characterized. In the adult rat hippocampus, CA1 and 
CA3 pyramidal neurons as well as interneurons in the hilus of the dentate gyrus are 
particularly vulnerable to KA (Ben-Ari, 1985; Grooms et al., 2000). The cells with 
highest tolerance to glutamate excitotoxicity in the rat hippocampus are the CA2 
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pyramidal cells and glomerular cells of the dentate gyrus (Grooms et al., 2000; Oprica et 
al., 2003).  
The central role of the glutamate-induced excitotoxicity in the etiology of various 
disorders affecting the CNS and the possibilities provided by the KA model has led to a 
search for glutamate-receptor inhibitors to achieve pharmacological interventions for 
neuronal disorders. Toxic effects of KA and glutamate can be prevented by various 
glutamate receptor inhibitors. MK-801, an NMDA blocker (Faden et al., 1988b; Liu et 
al., 1997), NBQX, an AMPA/kainate receptor blocker (Wrathall et al., 1994), and the 
recent selective AMPA receptor antagonist CNQX (Hermann et al., 2001) have all 
efficiently protected against KA-induced neuronal death in the laboratory environment, 
but results from clinical and randomized trials have been poor (Muir and Lees, 2003; 
McAdoo et al., 2005). In clinical trials, drowsiness and even coma are often-reported 
side-effects of high-affinity glutamate receptor blockers with a slow off-rate (reflecting a 
long dwell time), indicating a simultaneous blockage of normal synaptic transmission 
(Palmer, 2001). However, drugs with high affinity for and selective blockage of NMDA 
receptors but a slightly faster off-rate can be beneficial, e.g., ketamine used as an 
anesthetic (Lipton, 2004). A new selective and low-affinity NMDA blocker (memantine) 
recently introduced into AD therapy, and the NMDA receptor and Na+-channel inhibitor 
(riluzole) used in ALS therapy (Bensimon et al., 1994; Miller et al., 2003) are examples 
of glutamate inhibitors in clinical practice.  
In my thesis work (III), we were the first to demonstrate a link between the 
laminins and glutamate receptor function. What has, however, been demonstrated is that 
KA administration intrahippocampally into the adult rat brain induces excitotoxic damage 
leading to a simultaneous decline in γ1 laminin expression (Chen and Strickland, 1997; 
Nagai et al., 1999; Indyk et al., 2003).  Hippocampal neurons usually express γ1 laminin, 
but KA induces drastic reduction in expression, probably due to activation of the 
plasminogen/plasmin system (Chen and Strickland, 1997; Nagai et al., 1999; Indyk et al., 
2003). My thesis studies demonstrate that γ1 laminin and its biologically active KDI 
tripeptide protected adult rat hippocampal neurons against KA-induced excitotoxicity and 
neural death, verifying the link between the laminins and the glutamate system (III). 
These findings might be explained by recent observations from our laboratory indicating 
that γ1 laminin-derived functional KDI tripeptide acts as a universal inhibitor of 
ionotropic glutamate receptors such as AMPA, kainate, and NMDA (Möykkynen et al., 
2005). The KDI tripeptide almost completely inhibits AMPA-receptor currents in a dose-
dependent and non-competitive manner in human neocortical neurons. Similarly, the KDI 
tripeptide produces 50% inhibition of NMDA receptor currents in neocortical neurons 
and almost complete inhibition of kainate receptor currents in HEK 293 cells. 
 
2.4.4. Amyotrophic Lateral Sclerosis (ALS) 
ALS, also known as Lou Gehrig’s disease, was first described by the French 
neuroscientist and physician Jean-Martin Charcot in 1869. Characteristics of this disease 
include selective dysfunction and death of neurons in motor pathways resulting in 
spasticity, hyperreflexia (upper motor neurons), generalized weakness, muscle atrophy, 
and paralysis (lower motor neurons). Patients with ALS die on the average five years 
after diagnosis, and the cause of death in most cases is respiratory failure. ALS affects 
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only motor neurons, whereas the other types of neurons in the CNS, for example the ones 
responsible for cognitive functions, remain intact (Bruijn et al., 2004). The cause of ALS 
is unknown, but the great variability in its clinical course indicates that many causative 
factors may be involved.  
Of all ALS cases, 10% are familial (FALS), and 25% of these patients carry a 
mutation in chromosome 21 (Bruijn et al., 2004). This mutation is an autosomal 
dominant one and is located in the SOD-1 gene, which encodes copper/zinc superoxide 
dismutase (Cu/ZnSOD, Rosen et al., 1993).  Over 100 reported SOD-1 mutations cause 
inherited ALS in humans (Andersen et al., 2003).  The function of this ubiquitously 
expressed polypeptide is to convert superoxide, a toxic by-product of mitochondrial 
phosphorylation, into hydrogen peroxide and H2O. The SOD-1 mutation fails, however, 
to explain the degeneration of motor neurons. Transgenic knock-out mice lacking the 
SOD-1 gene do not develop motor neuron disease (Reaume et al., 1996), and the level of 
SOD-1 activity in transgenic mice expressing mutant SOD-1 remains unchanged (Gurney 
et al., 1994; Bruijn et al., 1997). It is more likely that the mutated SOD-1 gains one or 
more toxic properties, independent of levels of SOD-1 activity. The numerous 
experiments done on transgenic animal models (Gurney et al., 1994; Bruijn et al., 1997; 
Nagai et al., 2001) and on humans (Andersen et al., 1997) have been concentrating 
mainly on mutated SOD-1 effects on neurons. The mutated gene is, however, expressed 
widely, and it is possible that the toxic cascade of SOD-1 may be at least partially 
mediated by neuroglial cells such as astrocytes (Barbeito et al., 2004).  Another 
genetically linked form of ALS, the juvenile ALS, bears a mutation in gene coding for 
protein ALSin and is suggested to cause defects in microtubule assembly (Hadano et al., 
2001; Millecamps et al., 2005). 
Oxidative stress has been suggested to cause cell damage when the mutated 
enzyme Cu/ZnSOD runs backwards, creating a superoxide which then combines with 
nitric oxide, NO, at its active site (Estevez et al., 1999).  The other proposed hypothesis is 
that the mutated Cu/ZnSOD enzyme may produce a highly reactive hydroxyl radical from 
its normal endproduct, hydrogen peroxide, leading to neuronal damage (Wiedau-Pazos et 
al., 1996).  
The presence of protein aggregates or inclusions has been detected in many 
neurodegenerative diseases: like amyloid plaques in Alzheimer’s (Selkoe, 1998) and α-
synuclein inclusions in Parkinson’s disease (Fahn and Sulzer, 2004). Prominent 
intracellular cytoplasmic inclusions in motor neurons have been reported in both SOD-1-
mutated transgenic mice (Bruijn et al., 1998) and in human ALS (Shibata et al., 1996; 
Seilhean et al., 2004). These cytoplasmic inclusions are highly immunoreactive to SOD-
1, but what is still unsolved is whether these aggregates damage neurons.  Neurofilament 
assembly in axons is essential for proper axonal diameters. Neurofilament accumulation 
and abnormal assembly is a common hallmark in many neurodegenerative diseases 
(Troulinaki and Tavernarakis, 2005), and is in ALS a commonly reported finding (Julien 
and Beaulieu, 2000). In both sporadic ALS and SOD-1-mutated mice the accumulation of 
neurofilaments affects the perikarya and proximal axons of the largest lower motor 
neurons (Brujin et al., 2004). Neurofilament knockout mice do not develop motor neuron 
disease (Julien and Beaulieu, 2000), and surprisingly, over-expression of either 
neurofilament-H (heavy) or neurofilament-L (light) subunits in the perikaya of neurons 
slows the onset of SOD-1-mediated disease (Couillard-Després et al., 1998; Kong and Xu 
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2000). The exact role of neurofilaments in ALS pathogenesis is unclear, but it seems that 
neurofilament content and organization are important contributors and probably risk 
factors for ALS. 
  
2.4.5. Laminins in Neuronal Degeneration 
Several studies have demonstrated ECM proteins in the Alzheimer’s brain. 
Immunocytochemical analysis reveals that fibronectin is located in crystal-like 
formations in gray matter, senile plaques, and in subset of neuronal perikarya in the AD 
brain (Howard and Pilkington, 1990). Various proteoglycans such as heparan sulfate 
(Snow et al., 1990; Perlmutter et al., 1991) and keratan sulfate associate with senile 
plaques of AD (Snow et al., 1996). Chondroitin sulfate (DeWitt et al., 1993) and 
dermatan sulfate are both found in senile plaques and in neurofibrillary tangles (Snow et 
al., 1992) in the AD brain. Perivascular cells with morphological characteristics of 
microglia express both laminin-1 and type IV collagen in the neocortex of the AD brain 
(Perlmutter et al., 1991). Both of these ECM proteins, laminin-1 and type IV collagen, 
are also localized in the senile plaques in the neocortical regions of the AD brain 
(Perlmutter et al., 1991). Laminin-1 is also detectable as large punctate deposits in both 
the plaques and pre-plaques in the brain tissue of both AD and Down’s syndrome 
(Murtomäki et al., 1992). Fine, not plaque-associated, punctate deposits of γ1 laminin as 
well as γ1 laminin-expressing reactive astrocytes are found in both AD and Down’s 
syndrome brain tissue (Murtomäki et al., 1992). More recent findings demonstrate 
punctate deposits of α1 and γ1 laminins in the senile plaques and in reactive astrocytes of 
the AD brain (Palu and Liesi, 2002). In addition, laminins α4, α5, and β1-β3 are 
selectively expressed by some astrocytes of the gray matter in the AD brain but not in 
normal human brain tissues (Palu and Liesi, 2002).  
The role of laminin-1 and additional laminins in the pathogenesis of AD needs to 
be clarified, but recent results indicate that laminin-1 and particularly α1 and γ1 laminins 
may interact with amyloid-β-peptides (Bronfman et al., 1996, Monji et al., 1998, Drouet 
et al., 1999; Palu and Liesi, 2002). Laminin-1 and α1 laminin-derived synthetic peptide 
prevent both toxicity and toxic fibrillogenesis of the amyloid-β-peptide in vitro 
(Bronfman et al., 1996, Monji et al., 1998, Drouet et al., 1999).  Laminin-1 also 
modulates the biogenesis and metabolism of β-amyloid precursor protein (APP) in 
cultivated microglial cells by down-regulating the APP secretion and increasing the 
amount of mature transmembrane APP (Mönning et al., 1995). In addition, APP binds 
laminin-1 with high affinity, and this interaction is mediated by the IKVAV-sequence in 
the C-terminus of α1 laminin (Narindraorasak et al., 1992; Kibbey et al., 1993).  
The possible role and the CNS distribution of laminins in amyotrophic lateral 
sclerosis (ALS) were unknown until we demonstrated (IV) that γ1 laminin is selectively 
over-expressed by the reactive astrocytes of the ALS spinal cord (IV).  Especially in the 
white matter of the ALS spinal cord, γ1 laminin-positive reactive astrocytes were found 
in large numbers. However, γ1 laminin-expressing reactive astrocytes were also present 
in the gray matter of ALS spinal cord. Astrocytes particularly in the ventrolateral 
columns and the ventral roots showed intense γ1 laminin exprssion (IV). The γ1 laminin 
expression was also more profound in the cervical regions of the spinal cord than 
elsewhere in the ALS spinal cord, indicating that γ1 laminin expression may correlate 
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with the severity of the disease (IV). Increased laminin-1 expression occurs also in the 
skin of ALS patients (Ono et al., 2000). Another known ALS-associated ECM protein is 
the platelet α-granule glycoprotein thrombospondin (TSP); its deposition has been 
increased in ALS patients’ muscles (Rao et al., 1992). 
In ALS, glutamate-induced excitotoxicity and increased intracellular Ca2+ are 
mediated mainly by AMPA receptors (Carriedo et al., 1996, 2000). Interestingly, we 
found that the KDI tripeptide almost completely inhibits AMPA receptor currents in a 
dose-dependent and non-competitive manner in human neocortical neurons (Möykkynen 
et al., 2005). Again, glutamate excitotoxicity may be at least partially involved in ALS, 
similar to pathogenesis of AD and PD. Thus, the common denominators for all 
neurodegenerative disorders may be glutamate excitotoxicity combined with the temporal 
and spatial γ1 laminin expression aimed at neutralizing the harmful effects of high 
glutamate levels by blocking the glutamate receptors. 
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AIMS OF THE STUDY 
The aim of this thesis project was to clarify the role of γ1 laminin and its biologically 
active KDI tripeptide in CNS development, injury, and neuronal degeneration.  
 
To achieve this goal we studied: 
 
- the distribution of γ1 laminin and additional laminins in correlation with axon 
guidance in the human embryonic spinal cord in vivo and the role of the KDI 
tripeptide in guiding the spinal cord axons in vitro (I) 
- the potential of the KDI tripeptide as a treatment for adult rat spinal cord injuries 
(II) 
- the ability of the KDI tripeptide to protect the CNS against neurotoxicity induced 
by kainic acid (III) 
- the distribution of γ1 laminin in postmortem spinal cord samples of patients with 
amyotrophic lateral sclerosis to understand whether expression of γ1 laminin and 
its neurite outgrowth domain correlates with ALS pathology (IV) 
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MATERIALS AND METHODS 
Human Embryonic Spinal Cord Tissues (I) 
Human embryonic spinal cord tissues were obtained from 7- to 11.5-week-old 
fetuses after legal abortion and a known consent from the mothers with the permission of 
both the Ethics Committee of the Maternity Hospital of the Central University Hospital 
and the national authority for medicolegal affairs (TEO). The fetal tissues were placed in 
sterile physiologic saline, and the spinal cord tissue was identified and freed of meninges 
under a stereomicroscope. Spinal cords for the Matrigel culture experiments were cut in 
the coronal plane, and the ventral floor plate area was dissected out, and placed on a 
sterile coverslip, and embedded in Matrigel (Becton-Dickinson, Bedford, MA, USA). 
Spinal cords intended for sectioning were either deep-frozen for immunocytochemistry or 
immersion fixed with 4% paraformaldehyde and embedded in paraffin for in situ 
hybridization. 
 
Antisera (I – IV) 
Highly specific polyclonal and monoclonal antibodies against various isoforms of 
laminins were used for immunocytochemistry. Rabbit polyclonal antibodies were used to 
identify α1-5, β1-3, and γ1-2 laminins (Murtomäki et al., 1992, Liesi et al., 2001a; 
Studies I-IV). Laminin-1 was detected by use of polyclonal antibodies against 
biochemically purified EHS-tumor laminin (Liesi et al., 1983). In addition, to detect γ1 
laminin and its neurite outgrowth-promoting domain, polyclonal rabbit antibody raised 
against a KLH-coupled (keyhole limpet hemocyanin) six amino-acid peptide (EIIKDI) 
was applied (Liesi et al., 2001b). Pre-immune sera or antibodies pre-absorbed with their 
respective peptide antigens served as controls (I-IV). A commercial rabbit polyclonal 
netrin-1 antibody (Oncogene Research, Boston, MA, USA) and mouse monoclonal α1, 
β1, and γ1 laminin antibodies (Chemicon, Harrow, UK) were also used in Study I. Rabbit 
polyclonal antibodies (Sigma, St. Louis, MO, USA) were used for detection of serotonin 
(5-HT)-expressing nerve fibers in regenerating rat spinal cord (II). In Study IV, 
degeneration-linked molecules were detected by commercially available antibodies: 
SOD-1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), α-synuclein (Chemicon), 
bNOS (Calbiochem; San Diego, CA, USA),  and bFGF=FGF-2 (Sigma). Neurons and 
their fibers were identified by use of a monoclonal mouse antibody against either 68-kDa 
or 160-kDa neurofilament (NF) proteins (Studies I, II, IV; Sigma). For detection of 
astrocytes and radial glial fibers, mouse monoclonal antibodies against the glial fibrillary 
acidic protein (GFAP) were used (Studies I, III, IV; Sigma).   
 
Immunocytochemistry in Mammalian Brain and Spinal Cord (I – IV) 
The deep frozen mammalian brain and spinal cord samples were sliced into 10-
µm cryostat sections and air-dried for 2 hours (Studies I – IV). Human embryonic spinal 
cords were cut into coronal sections (I) and spinal cords of the adult Sprague-Dawley rats 
into longitudinal sections (II). The brains of the adult Wistar rats were cut in the coronal 
plain (III) similar to the human post-mortem samples of ALS and age-matched control 
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spinal cords in Study IV. These samples were fixed in freshly prepared 0.4% p-
benzoquinone in phosphate-buffered saline (PBS) for 15 min at +4°C. The sections were 
briefly rinsed in PBS, dehydrated in a graded series of alcohols (50%, 70%, 96%, and 
100% ethanol for 10-15 min, and 5-10 min in xylene) and rehydrated through the same 
series to PBS (I-IV). Some sections in Study I were fixed in cold (-20°C) methanol for 15 
min at room temperature and washed in PBS (I). Both p-benzoquinone-fixed and 
methanol-fixed sections were incubated in normal goat serum (1:30 dilution in PBS; 
Sigma) at +4°C overnight. The following morning, the excess of the normal goat serum 
was tapped away, and the sections were incubated with a primary antiserum for 24 hrs at 
+4°C. Rabbit polyclonal antibodies against the various isoforms of laminins were used at 
1:1000 to 1:5000 dilutions (I-IV). After an overnight incubation at +4°C, the sections 
were briefly rinsed in PBS and incubated with fluorescein isothiocyanate-coupled goat 
antirabbit immunoglobulins (FITC; Cappel, Cochranville, PA, USA) for 1 hr at room 
temperature (RT). When double-stained, the sections were incubated further with mouse 
monoclonal antibodies overnight at +4°C (I, II, IV). After a brief rinsing in PBS, sections 
were exposed to goat anti-mouse immunoglobulins coupled to tetramethylrhodamine 
isothiocyanate (TRITC; Cappel) for 1 hr at RT. The sections were briefly rinsed in PBS 
and mounted in PBS:glycerol (1:1). For analysis and photography an Olympus Provis or 
Olympus BX51 microscope was used, both microscopes equipped with appropriate filter 
combinations. 
 
Laminin Probes for In Situ Hybrdization (I) 
The probe for γ1 laminin was a 141 bp RT-PCR (Reverse Transcriptase – PCR) –
fragment of the human embryonic spinal cord total RNA, isolated and purified from an 
agarose gel, bearing the neurite outgrowth domain of the γ1 laminin (Liesi et al., 1989). 
The primers HU-29 upper (5’ GGA AAG TGT CTG ACC TGG AGA ATG 3’) and HU-
29 lower (5’ TGT TGA AGC AGC CAG ATG GTA AG 3’) were used at a concentration 
of 10 µM. The γ1 laminin probe containing a 141-bp fragment was reamplified using a 
Gene Amp® PCR Reagent kit (Perkin Elmer, USA) according to manufacturer’s 
instructions.  
The polymerase chain reaction (PCR) was initiated by heating the DNA at +94°C 
for 5 minutes, followed by 35 cycles of PCR (+93°C for 1 min, +55°C for 1 min, +72°C 
for 2 min). This was followed by the final step at +72°C for 10 min for polymerase to 
complete all strands. The RoboCycler DNA amplifier (Stratagene, La Jolla, CA, USA) 
was used in all PCR reactions. The PCR product was loaded (10 µl) in 1% agarose gel for 
detection of the PCR fragments and for estimation for their size. Sephaglas™ Band Prep 
Kit (Pharmacia, Sweden) was used for extraction of DNA fragments by manufacturer’s 
instructions. 
In addition to the 141-bp RT-PCR fragment of the human embryonic spinal cord 
γ1 laminin, the following cloned mouse cDNA laminin probes were used: α1 laminin (1.2 
kb; Sasaki et al., 1988), β1 laminin (4.6 kb; Sasaki et al., 1987), and γ1 laminin (3.5 kb; 
Sasaki and Yamada, 1987). For oligolabeling, the DIG-DNA Genius Kit (Boehringer, 
Mannheim, Germany) was used according to manufacturer’s instructions. After 12 hours 
of labeling, the labeled DNA was run through Nick columns (Sephadex™ G-50 DNA 
Grade, Pharmacia, Sweden) in order to separate labeled PCR or cDNA fragments from 
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the free nucleotides. This was followed by plotting of the fractions on a Schleicer & 
Schuell nitrocellulose transfer membrane (Protran BA 83, pore size 0.2 µm, GmbH, 
Dassel, Germany), after which, fractions containing labeled DNA were detected with 
anti-digoxigenin-alkaline phosphates (1/1000) providing a purple-colored reaction. 
Ethanol (70%) precipitation was performed for the purple stained fractions. The 
precipitated DNA was centrifuged, and the DNA pellet formed was air dried before being 
dissolved in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0).  
 
In Situ Hybridization of Human Embryonic Spinal Cord (I) 
Human embryonic spinal cords were embedded in paraffin and cut into 4 µm 
sections on silanized slides. Paraffin was removed by placing the sections on a hot plate 
at +65°C, followed by rehydration in xylene for 20 minutes and ethanol incubations at 
100%, 96%, 70%, and 50% each for 15 minutes. These sections were fixed in 4% 
paraformaldehyde / TBS (1 M Tris, 5 M NaCl at pH 7.5) for 20 minutes. The fixed 
sections were washed quickly in TBS and incubated in 0.2 M HCl for 10 minutes, 
followed by a short incubation (1 minute) in 1% diethylpyrocarbonate (depec) water 
(Fluka, Switzerland). RNAase A (at 100 µg/ml) was applied to the sections and incubated 
for 30 minutes at RT. This was followed by incubation in Proteinase K at 20 µg/ml 
(Boehringer, Mannheim, Germany) in Tris-HCl pH 8.0 for 10 min at +37°C. Sections 
were then rinsed in TBS and incubated in 4% paraformaldehyde at +4°C for 15 minutes.  
After a brief TBS rinse, sections were incubated in 2x SSC in depec water (20xSSC BRL, 
Sigma) followed by hybridization with cDNA probes. Sections and digoxigenin (DIG)-
labeled cDNA probes were incubated at +37°C for 24 h in a Northern hybridization 
solution containing: 50% formamide, 50 mM tHEPES, 3× SSC, 5× Denhardt’s solution, 
0.2 mg/ml salmon sperm DNA, 1mM EDTA, and 0.2% SDS. The DIG-labeled probes 
were detected by means of goat anti-digoxigenin antibodies coupled to alkaline 
phosphatase (Boehringer), providing a visible blue/purple color reaction with a Naphthol 
AX (Sigma) substrate. The specificity of the labeling reaction was confirmed with 
unlabeled cDNA probes or a mixture of labeled/unlabeled cDNA probes instead of the 
labeled cDNA. 
 
Matrigel Cultures of the Human Embryonic Spinal Cord (I)  
Matrigel-embedded organotypic cultures of human embryonic spinal cord served 
as a three-dimensional environment for axon growth for study of the effect of KDI 
tripeptide in directional axon growth. Matrigel (Becton-Dickinson), rich in all basement 
membrane proteins, is soluble at +4°C, but solidifies at +37°C into a gel. Meningeal 
membranes were removed, and pieces of either dorsal or ventral human embryonic spinal 
cord (age 8–10 weeks) were dissected out from the lumbar region of the embryonic spinal 
cord. The spinal cords were cut in the coronal plane so that the ventral “zipper”-like floor 
plate region could be dissected out.  
Two different culture-configurations were designed, an “open-book” 
configuration and a configuration with a central palm-like area with three finger-like 
extensions. In order to create “open-book” cultures, the spinal cords were cut open along 
the dorsal midline, and the spinal cord was opened similar to a book so that the two 
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dorsal midline poles were in the opposite margins of the “book”, and the ventral midline 
and the floor plate region in the middle (I, Fig. 12, p. 350). The cultures were embedded 
in 20 µl of Matrigel and incubated at +37°C for 30 min. After the Matrigel had solidified, 
an additional 10 µl of Matrigel containing 1-10 µg/ml of KDI tripeptide (Multiple Peptide 
Systems, La Jolla, CA, USA) was added to form a Matrigel extension in a vertical line 
with the configuration. 
In the “palm-finger”configuration, pieces of either ventral or dorsal spinal cord 
were embedded in 10 µl of Matrigel. After the solidifying of the Matrigel, another 10 µl 
of Matrigel was added to form three finger-like extensions from the area containing the 
dorsal spinal cord explants. Two of the three Matrigel finger extensions contained 1 to 10 
µg/ml of KDI tripeptide (Multiple Peptide Systems, La Jolla, CA, USA), and the third, 
the middle extension had only a drop (3 µl) of plain Matrigel. After the Matrigel had 
solidified, a culture medium containing Neurobasal medium with a B27 supplement 
(Invitrogen, UK), 2 µM of L-glutamine, and penicillinstreptomycin was added, and the 
cultures were placed in a cell incubator at +37°C with 5% CO2/95% air. During the 
experiment, the live cultures were observed with a stereomicroscope, with images 
documented by a Leica DC 300F digital camera and the IM1000 Image Manager program 
(v1.20). At end of each experiment, cultures were fixed in 2% paraformaldehyde in PBS, 
and either mounted in PBS-glycerol or processed for immunocytochemistry. 
  
Animals (II, III) 
Adult male Sprague-Dawley rats (II, Harlan, Netherlands; 180–200 g, n=16) 
remained in individual cages after the surgery under a 12/12-hr light/dark cycle with food 
and water ad lib. The animals received regular rodent feed (2018 Global Rodent 
Breeding, Harlan Teklad, UK) and an additional fresh diet (for details, see Study II, p. 
404). Subcutaneous injections of morphine (Leiras Finland; 8–16 mg/kg) were the 
analgesic for all animals during the first post-operational week (II). Later, morphine and 
additional drugs were administered daily in the drinking water containing 10% glucose, 2 
to 3 ml of morphine (Leiras Finland; 20 mg/ml), 0.5 to 2 ml of orfenadrincitrate 
(Norflex™, 3M Pharma; 30 mg/ml) as a muscle relaxant, and 1 to 2 ml of ketoprofen 
(Orudis®, Sanofi-Aventis; 50 mg/ml) as an anti-inflammatory remedy in 200 ml of cold 
tap water. In order to prevent urinary tract infections, all animals initially received 
trimetoprim/sulfamethoxatsol (Cotrim, Ratiopharm; 16 mg/ml/80 mg/ml) in their 
drinking water (1–2 ml of Cotrim in 200 ml of water) and if any infection occurred, 1 to 3 
ml of levofloxacillin (Tavanic, Sanofi-Aventis) was used instead. The condition of the 
animals was evaluated twice a day to determine adequate drug dosage. 
 
Study III used 36 adult male (250–300 g) Wistar rats (Harlan) and animals were 
kept on 12/12h light/dark cycle with food and water ad lib. Animals were divided into six 
groups of six rats each. Ten days after surgery the animals were euthanized by 
decapitation with a guillotine, and the brains were carefully removed and processed for 
analysis. 
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Surgical Procedures (II, III) 
In Study II, spinal cord surgery was perfomed under deep pentobarbital (40–60 
mg/kg intraperitoneally) anesthesia, and rat lumbar spinal cord was transected at the Th12 
level (II). These transections were performed under a stereomicroscope with a 
microsurgery knife (#10055-12; Fine Science Tools, Heidelberg, Germany), and finished 
by a double cut with the fine needle-end of a spatula probe (#10090-13; Fine Science 
Tools). Osmotic mini-pumps (Alzet 2ML4; B&K Universal, Stockholm, Sweden) 
containing KDI tripeptide were placed subcutaneously, and the tip of the catheter was 
sutured at the lesion site for continuous application at rate of 2.5 µl/hr of tripeptide or 
placebo during a period of 28 days (II). The KDI tripeptide was 95% purified and 
synthesized as a C-terminal acid (Multiple Peptide Systems). The KDI tripeptide was 
applied at 100 µg/ml in 5% normal human serum in 0.9% NaCl. The control animals 
underwent the same surgical procedures as the KDI-treated but instead of the KDI 
tripeptide, received 5% normal human serum in 0.9% NaCl. 
 
In Study III, unilateral hippocampal injections were performed under 3.5% chloral 
hydrate anesthesia (350 mg/kg intraperitoneally; III). Stereotaxic coordinates for the right 
hippocampus were measured from Bregma (AP: -3.8 mm, Lat: +2.0 mm, DV: -2.7 mm 
and mouth bar at -3.5 mm; Paxinos and Watson, 1986). The KA-treated animals received 
unilateral injections of 0.9% NaCl (1 µl) and KA (1 µl at 1 µg/µl concentration). The KDI 
tripeptide was 95% purified and in a C-terminal acidic (-OH) form (Multiple Peptide 
Systems). KDI tripeptide was initially dissolved in deionized sterile water at a 10 mg/ml 
concentration and diluted further to 100 µg/ml or 500 µg/ml by 0.9% NaCl, and kainic 
acid (Sigma) was diluted to 1 mg/ml in sterile 0.9% NaCl. The KDI- and KA-treated 
animals received unilateral injections of the KDI tripeptide (1 µl at 100 or 500 µg/ml 
concentrations) and KA (1 µl at 1 µg/µl concentration). In control groups, the animals 
received unilateral injections either with 0.9% NaCl (1 µl) followed by another 0.9% 
NaCl (1 µl) or with KDI tripeptide (1 µl at 100 or 500 µg/ml) and 0.9% NaCl (1 µl). The 
injection velocity was steady: each 1 µl delivered in 5 minutes. After the first injection 
(KDI solution or NaCl), a 5-minute pause excluded any possible interaction with the 
second injection (1 µl of KA or NaCl). In order to avoid backflow of the injected 
solutions, an additional 5-minute pause followed. A thermal blanket and a heating lamp 
were used both during and after the injections to maintain normal body temperature of the 
animals (approximately +37°C).  
 
Motor Scoring and Behavioral Testing (II) 
Animals were weighed, and their behavior and motor functions were determined 
once a week (Wrathall, 1989; Wrathall et al., 1997). Investigators responsible for testing 
had no knowledge of the respective treatment of animals during the whole observation 
time. Motor scores of eight KDI-treated and eight placebo-treated rats had both hind 
limbs evaluated separately, and the values for both legs were added during the 14-week 
observation period. In this scoring system, the scale was from five to zero (Wrathall, 
1989; Wrathall et al., 1997). A score of 5 indicated normal movement of the limb, and a 
score of 0 indicated no hind limb movement and no weight-bearing. Initially after 
surgery, all animals were paralyzed and scored 0/0. Statistical analysis of both groups 
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was carried out with the Mann-Whitney nonparametric test (For more details, see Study 
II, pp: 404-405). 
Behavioral tests included several tasks (toe-spread, placing, extension, 
withdrawal, and inclined plane; Wrathall, 1989; Wrathall et al., 1997), and the final score 
was obtained by calculating the combined behavioral score (CBS) of the animals during 
the whole observation time. Behavioral scores for seven KDI-treated and seven placebo-
treated (n =7) rats were evaluated. The CBS scheme used was slightly modified from the 
original version by Wrathall (1989; Wrathall et al., 1997) and was presented as the 
percentage of deficit. In this presentation mode, a fully paralyzed animal scores the 
maximum CBS points, indicating a 100% deficit from normal behavioral function. A 
healthy animal with normal behavioral function receives zero CBS points and thus has a 
0% deficit. The CBS values were gathered from the weekly tests for the entire 14-week 
observation period. Analysis of variance (ANOVA) and the Student-Newman-Keuls 
multiple comparisons test were applied for statistical analysis of the CBS points. 
 
Evaluation of Brain Tissue Damage (III)  
Quantification of brain-tissue damage in six KA-injected, six KDI-500 + KA-
injected six, and six NaCl + NaCl-injected Wistar rats was done by evaluation of the 
injection site with low magnification light microscopy. Animals received 10 lesion points 
if the brain tissue was entirely destroyed with only an empty cavity at the lesion site (as 
for NaCl + KA).  If the lesion site appeared nearly normal at low magnification but 
abnormal at high magnification with atypical molecular marker expression, such as for γ1 
laminin, it earned 2 to 3 lesion points (as for KDI-500 + KA). Animals received zero 
lesion points if the brain tissue appeared normal apart from the injection track (as for 
NaCl + NaCl). One-way analysis of variance (ANOVA) was applied for statistical 
analysis of the lesion scores, and individual groups were compared with the Student-
Newman-Keuls multiple comparisons test. Animals were euthanized by decapitation 10 
days after the injections. 
 
Paraffin Sections (II, III) 
  Paraffin-embedded rat spinal cords were cut (4 µm) in longitudinal sections from 
the ventral to dorsal surface and stained with hematoxylin-eosin (Study II). 
Immunocytochemistry for paraffin sections were performed with antibodies against 
laminin-1 (Liesi and Silver, 1988) and serotonin (5-HT; Sigma). Mouse monoclonal 
antibodies were able to detect neuronal fibers also in paraffin-embedded neuronal tissue 
(68-kDa NF protein and 160-kDa NF protein; Sigma). 
 
Dissected rat brains were immersion-fixed in 4% paraformaldehyde in phosphate-
buffered saline (PBS; pH 7.4; Sigma) for 12 hr at +4°C (Study III). Fixed brain tissue was 
dehydrated and embedded in paraffin. Serial sections (4 µm) were cut in the coronal 
plane through the hippocampal area and stained with hematoxylin-eosin. 
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Human ALS and Age-Matched Normal Spinal Cord Tissues (IV)  
The tissue samples for ALS disorder and the normal controls came from the 
Human Brain and Spinal Fluid Resource Center (Los Angeles, CA, USA) or from the 
Brain and Tissue Bank (Baltimore, MD, USA). All the samples were neuropathologically 
verified and were from the cervical or thoracic level of the human spinal cord. 
 
Western Analysis (IV) 
The frozen samples of normal and ALS spinal cord tissue were homogenized in 
liquid nitrogen with a mortar and pestle. The powdered tissue was transferred into a 50-
ml Corning tube, and 2 ml of NET buffer (in mM: 400 NaCl, 50 Tris-HCl pH 8, 5 EDTA, 
pH 8) containing 1% NP40 and 2 mM PMSF was added to the tissue. The extracts were 
incubated on ice at +4°C for 30 min to facilitate dissolving of the proteins and passed 
several timers through G21 needle. The undissolved material was removed by 
centrifugation at 1,000 rpm for 10 min at room temperature, and aliquots of the protein 
extracts were stored at -70°C until used.  
Both normal and ALS spinal cord tissue extracts were denatured for 5 min at 
+100°C in Laemli buffer containing β-mercaptoethanol. Equal amounts of protein were 
loaded and subjected to analysis on 5% SDS polyacrylamide gels. In each gel, 25 µg of 
mouse EHS-tumor laminin-1 (Boehringer) was run parallel to the tissue extracts also 
under reducing conditions. The proteins were transferred to 0.2-µm nitrocellulose 
(Schleicher and Schuell) in 20% methanol, 20 mM Tris, 150 mM glycine, and 0.05% 
SDS for 24 hr at 350 mA. Non-specific binding of the primary antibody was blocked by 
incubation in 5% dried milk in buffer A (10 mM Tris, 150 mM NaCl, pH 7.4 containing 
0.05% Tween-20). The filters were subsequently incubated overnight at +4°C. Rabbit γ1 
laminin antibodies were used at 1:2,000 and, when re-used, stored in 5% milk containing 
0.01% sodium azide. The blots were washed with buffer A followed by a overnight 
incubation at +4°C with a peroxidase-conjugated goat-antirabbit IgG (Pharmacia, 
Sweden; Amersham, UK) diluted 1:2,000. The peroxidase-conjugated secondary 
antibody was diluted in buffer A containing 5% dried milk. Immunoreactive protein 
bands were visualized with an ECL Plus detection system and ECL Hyperfilm (both, 
Amersham). 
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RESULTS 
γ1 Laminin and Its KDI Tripeptide in Commissural Axon Guidence (I) 
Immunocytochemistry and three specific γ1 laminin antibodies (Murtomäki et al., 
1992; Liesi et al., 2001b), allowed detection of γ1 laminin at various locations in the 
human embryonic spinal cord (age 7-11 weeks). In the ventral midline of the lumbar 
spinal cord, γ1 laminin was expressed as punctate deposits in the floor plate region (I, 
Figs. 1 3, 5, pp. 340-343). Double immunocytochemistry for the 160-kDa neurofilament 
protein and γ1 laminin demonstrated that commissural nerve fibers crossing the ventral 
midline were in intimate contact with the punctate γ1 laminin deposits (I, Figs. 3, 5, pp. 
341-343). Immunoreactivity for γ1 laminin was generally weaker in the thoracic than in 
the lumbar spinal cord of the 10- to 11.5-week-old embryos (I, Figs. 5, p. 343). 
Expression of γ1 laminin was also detectedable in cells of the notochord inside the 
presumptive body of the forming vertebra (I, Fig. 4B’, p. 342) and in the cell bodies and 
fibers of immature neuroectodermal cells lining the central canal (I, Fig. 4B, p. 342). In 
methanol-fixed spinal cord, strong accumulation of γ1 laminin was evident in floor plate 
cells (I, Fig. 4A, p. 342) and in the cells lining the central canal. In addition, motor 
neurons of the ventral horn were γ1 laminin-positive (I, Fig. 4A, p. 342), and some of the 
GFAP-positive radial glial fibers near the surface of the spinal cord were immunoreactive 
for γ1 laminin (I, Fig. 4C, p. 342). 
To confirm that the γ1 laminin expression detected at the ventral midline was 
indeed produced by the floor plate cells, we used in situ hybridization. The DIG-labeled 
3.5-kb mouse γ1 laminin cDNA probe was used to investigate γ1 laminin mRNA 
expression in the developing human spinal cord. The γ1 laminin mRNA expression was 
intense in the floor plate cells and in the cells surrounding the central canal (I, Fig. 7D’, p. 
345). Another DIG-labeled 141-bp cDNA probe containing the primary sequence coding 
for the neurite outgrowth domain of γ1 laminin detected γ1 laminin mRNA in the floor 
plate of both the thoracic and lumbar spinal cord in the area where commissural fibers 
cross the ventral midline (I, Figs. 7G, H, p. 345). This localization was nearly identical to 
the immunocytochemical distribution of γ1 laminin punctate deposits in the immediate 
vicinity of 160-kDa neurofilament-positive fibers. Thus, the γ1 laminin protein is 
synthesized by the floor plate cells and can be deposited in the pathway of crossing 
commissural fibers.  
To test the hypothesis that the KDI tripeptide serves as a chemoattractant for 
growing commissural axons, we used the Matrigel culture system. Matrigel-embedded 
explants of the dorsal spinal cord selectively extended neurites toward the KDI peptide-
containing arms of Matrigel (I, Figs 10, 11, pp. 348-349). Few neurites extended toward 
the arm containing plain Matrigel, and some fibers initially growing in this direction 
turned towards the KDI-containing arm (I, Fig 11, p. 349). Interestingly, the KDI 
tripeptide had no effect on the directional growth of the neurites from the explants 
derived from ventral spinal cord. In the “open-book” culture system of the lumbar spinal 
cord, the KDI tripeptide overrode the chemoattraction of the floor plate, and the neurites 
from the dorsal spinal cord neurons extended toward the KDI-tripeptide and away from 
the floor plate cells (I, Fig 12, p. 350).       
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In addition to γ1 laminin, α1, α5, β1, and β3 laminins were detectable by 
immunocytochemistry in human embryonic spinal cord (7-11 weeks old). Laminins α1, 
β1, and β3 were distributed also as punctate deposits in the floor plate region of the 
lumbar spinal cord, in close contact with 160-kDa neurofilament-positive nerve fibers 
crossing the ventral midline (I, Figs. 1, 2, 6, 9, pp. 340-347), but no expression of α2-4, 
β2, or γ2 laminins was detectable in the floor plate region or elsewhere in the embryonic 
spinal cord (I, Fig. 1F, p. 340). Similar to γ1 laminin, expression of α1 and β3 laminins 
was generally weaker in the thoracic than in the lumbar embryonic spinal cord (10 to 11.5 
weeks old; I, Figs. 5, 6, pp. 343-344). However, in 7- to 8-week-old embryos no variation 
in the expression pattern of laminins (α1, β3, and γ1) between the thoracic and lumbar 
spinal cord was detectable. Interestingly, even though present in the lumbar spinal cord, 
β1 laminin was not detected in the thoracic spinal cord regardless of the age of spinal 
cord explants. Expression of α5 laminin was intense in the embryonic spinal cord, with 
α5 laminin specifically accumulating in motor neurons and in large neuron-like cells of 
the dorsal root ganglia (I, Fig. 8, p. 346). No specific accumulation of α5 laminin could, 
however, be detected in the floor plate region. Pre-immune serum of the same rabbit used 
to produce the specific α5 laminin antibody served as a control. All the control sections 
were negative (I, Fig. 8C, p. 346). Netrin-1 accumulated also in the floor plate region as 
punctate deposits (I, Fig. 1F, p. 340). 
In situ hybridization demonstrated that the punctate deposits of laminins were 
synthesized by the floor plate cells of the embryonic spinal cord. A DIG-labeled 1.2-kb 
mouse cDNA probe detected α1 laminin mRNA in the floor plate cells, in motor neurons, 
and in the cells surrounding the central canal of the embryonic spinal cord (I, Figs. 7A, B 
p. 345). Localization of the α1 laminin mRNA at the floor plate region correlates with the 
distribution of α1 laminin punctate deposits detected by using immunocytochemistry. 
Even subgroups of neuron like-cells of the dorsal root ganglia shared intense expression 
of α1 laminin mRNA (I, Figs. 7A, C, p. 345). The mRNA for β1 laminin, with DIG-
labeled 4.6-kb mouse cDNA as a probe, was localized in the floor plate as well as in the 
cells lining the central canal (I, Fig. 7G, p. 345). These in situ data correlate well with β1 
distribution detected by immunocytochemistry. The control sections hybridized with the 
unlabeled β1 probe were negative. 
 
Promotion of Spinal Cord Regeneration by Soluble KDI Tripeptide (II) 
To test the ability of the KDI tripeptide to promote functional recovery after SCI 
we used an animal model, in which the spinal cord of an adult rat was fully transected at 
Th12 level. An osmotic minipump was inserted subcutaneously to ensure continuous 
application of KDI into the lesion. The complete transection of the spinal cord was 
performed and verified during the surgery under a stereomicroscope and again verified in 
the microscopic analysis of the serially sectioned paraffin-embedded sections of the 
spinal cords of both KDI- and placebo-treated animals.   
During the first 2 weeks after the surgery, no significant differences emerged 
between the groups (II, Fig. 3, p. 405). After 14 weeks, however, the KDI-treated animals 
showed a marked improvement in their motor performance and in behavioral functions as 
compared to the placebo group (II, Figs. 2, 3, p. 405). All the KDI-treated rats (n=8) 
could bear their own weight and some even walk using their hind limbs; their motor 
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scores ranged from 2/3 to 5/5 (5/5 being equivalent to normal). The placebo group 
showed no significant improvement, and none of the animals had motor scores better than 
1/1. Statistical analyses of the motor scores indicate that the KDI treatment significantly 
(P = 0.0002) improved the recovery of motor function (II, Fig. 2, p. 405). Their 
behavioral functions (toe-spread, placing, withdrawal, and inclined plane positioning) 
were tested weekly, and the combined behavioral score (CBS) was presented as a 
percentage of deficit.  
The behavioral abilities between the KDI-treated and placebo-treated rats did not 
differ significantly during the first 2 post-operation weeks. However, during the 14-week 
observation period, the behavioral scores of the KDI-treated animals improved and were 
in line with the motor scores (II, Fig. 3, p. 405. The statistical analysis (ANOVA, 
F=13.250) of CBS indicated significant (P < 0.001) improvement in behavioral functions 
compared to the placebo group (II, Fig. 3, p. 405).  
The surgical procedures as well as the motor and behavioral testing were done 
blinded: Neither the surgeon nor the researchers testing the animals knew the treatments 
each animal received. In addition, the possibility of spinal shock interfering with the 
results could be ruled out, because in rats, spinal shock is known to ease at the latest 1 
week after the injury (Mimata et al., 1993; Shaker et al., 2003). Significant improvement 
in the KDI-treated was observed first after 3 weeks post-operation, and extremely long-
lasting spinal shock appearing selectively in KDI-treated rats is very unlikely.   
After 14 weeks of follow up, the animals were euthanized and spinal cord tissues 
processed for analysis. Evaluation of the hematoxylin-eosin-stained and longitudinally 
cut serial sections of the spinal cord indicated that the KDI-treated animals had a reduced 
injury area with improved healing (II, Fig. 5, p. 406). Both the cyst and scar formation 
was less in the KDI-treated group (II, Fig. 5, 6, pp. 406-407). Immunocytochemistry for 
neural markers revealed that the spinal cords of the KDI-treated rats had 68-kDa 
neurofilament-positive fibers extending through the injury site and co-localizing with an 
intense accumulation of KDI-immunoreactive material (II, Fig. 7, p. 408).  The 68-kDa-
positive neurofilaments distal from the injury site were also more abundant in KDI-
treated animals than in the placebo group (II, Figs. 8a, b, pp. 409). In placebo-treated 
animals, neurofilaments were unable to cross the injury site and accumulated in the 
proximal side of the large cysts. Serotonin (5-HT) immunoreactive fibers caudal to the 
transection serve as a positive regeneration marker in SCI studies (Faden et al., 1988a; 
Cheng and Olson, 1995; Saruhashi et al., 1996). No 5-HT is synthesized in the spinal 
cord but originates from specific nuclei located in the brainstem and is further transported 
distally along the efferent axons (Cheng and Olson, 1995). The KDI-treated animals had 
large bundles of 5-HT-immonoreactive nerve fibers distally, below the transection site 
(II, Fig. 9a, p. 409), whereas the placebo group had only a few 5-HT-positive fibers distal 
from the spinal cord transection (II, Fig. 9b, p. 409). Thus, the KDI-treated animals had 
clearly more regenerated 5-HT- and 68-kDa neurofilament-positive nerve fibers below 
the lesion site.  
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KDI Tripeptide Protection Against Excitotoxicity (III) 
To test the ability of the KDI tripeptide to protect the adult rat hippocampus (HC) 
against KA-induced excitotoxicity, we applied KA in to the rat HC by unilateral 
stereotaxic injections with and without the KDI.  
Ten days after the injections, the animals were euthanized and their brains 
processed for analysis. When applied alone, KA (NaCl + KA) induced massive tissue 
destruction at the site of the injection (III, Figs. 1, 2, pp. 412-413). Large areas of necrotic 
brain tissue was washed away during processing of the tissue in paraffin sections and 
during the immunostaining procedures (III, Figs. 1, 2, pp. 412-413). The neocortex and 
hippocampus on the ipsilateral side were largely destroyed by KA, but the tissue 
destruction spread also to the medial contralateral neocortex (III, Fig. 2a, p. 412). In 
addition, on the contralateral side, KA induced the death of CA1 hippocampal neurons, 
which appeared as γ1 laminin-negative yellow-brownish ghosts on immunostaining (III, 
Figs. 5a,b, p. 416). Normal hippocampal CA1 neurons express both laminin-1 and γ1 
laminin (Hager et al., 1998; Chen and Strickland, 1997; Nagai et al., 1999). At the 
injection site, large numbers of GFAP-positive reactive astrocytes were present in both 
neocortex and HC, surrounding the site that was most severly destroyed by KA.  
Importantly, our study showed that the KDI tripeptide provided dose-dependent 
protection against KA. An injection 1 µl of KDI at 100 µg/ml preceding KA protected the 
hippocampus against major destruction, but the tissue damage was clearly visible in both 
ipsilateral HC and neocortex (III, Fig. 1b, p. 412). An injection of 1µl of KDI tripeptide 
at 500 µg/ml (KDI-500) preceding KA provided efficient protection against KA-induced 
tissue destruction (III, Fig. 1c, 2b, pp. 412-413). In hematoxylin-eosin-stained paraffin 
sections, the HC appeared almost intact, but the neocortical structures surrounding the 
injection site were damaged (III, Fig. 1c, p. 412). In addition, immunocytochemistry 
revealed massive GFAP-positive gliosis surrounding the injection track in the ipsilateral 
neocortex and HC after KDI-500 + KA injection, and more GFAP-reactive astrocytes 
appeared on the ipsilateral side than after NaCl + NaCl or KDI-500 + NaCl injections 
(III, Figs. 2b, c, d, p. 413). These findings indicate that the protection provided by KDI 
was imcomplete (III, Fig. 2, p. 413). Evaluation of gliosis was done by low-magnification 
fluorescence microscopy and by comparison of the intensities of GFAP 
immunoreactivity, with lighter appearance of the tissue indicating more extensive gliosis. 
Immunocytochemical analysis of the ipsilateral side of the KDI-500 + KA-
injected hippocampus revealed a gap in γ1 laminin expression in the region of CA1 
neurons at the very site of injection (III, Fig. 4, p. 415). In fact, neurons were totally 
absent from the gap area. A similar reduction in laminin-1 expression was detectable in 
NaCl + KA-injected animals on the contralateral side; however, CA1-region neurons of 
the contralateral side still appeared as yellow-brownish ghosts (III, Fig. 6b, p. 417). In 
addition, KDI-500 + KA injections induced increased laminin-1 expression and an 
accumulation of laminin-1-positive fine punctate deposits in the neocortical regions (III, 
Fig. 6a, p. 417).  
The extent of the brain damage done by KA, and protection by KDI were 
quantified by low magnification light microscopy. Lesion score points were based on 
grade of the tissue destruction; 10 points indicated totally lysed tissue, 2 to 3 points 
indicated tissue appearing normal at low magnification but with abnormal expression of 
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molecular markers, and 0 points indicated tissue appearing normal also at high 
magnification. The NaCl + NaCl-injected hippocampus received 0 lesion score points and 
the only abnormality was related to the injection track. Statistical analysis (ANOVA and 
Student-Newman-Keuls multiple comparisons test) of the result indicated that the γ1 
laminin-derived KDI tripeptide at 500 µl/ml concentration provided significant protection 
(P < 0.001) against KA-induced glutamate excitotoxicity (III, Fig. 3, p. 414).  
 
Selective Over-Expression of γ1 Laminin in ALS Pathology (IV) 
We studied expression of laminins in human post-mortem samples of ALS spinal 
cord from both cervical and thoracic levels and compared these findings with expression 
of laminins in the normal human cervical and thoracic spinal cord. Immunocytochemistry 
indicated that the most striking difference between the ALS and normal human spinal 
cord tissue was the over-expression of γ1-laminin in the ALS spinal cord. 
Intense expression of γ1 laminin was present in reactive astrocytes in the white 
matter of the anterior columns in immediate association with the lateral ventral horns and 
ventral roots of the ALS spinal cord (IV, Figs. 2, 3,). The γ1 laminin-positive reactive 
astrocytes were present also in the white matter of the lateral columns in both thoracic 
and cervical ALS spinal cord. The anterior columns of the cervical spinal cord consist of 
nerve fibers which innervate muscles of the upper extremities, and the lateral columns are 
part of the corticospinal tract mediating the descending projections from the motor cortex. 
In the white matter of the normal spinal cord, no γ1 laminin-positive reactive astrocytes 
were detectable (IV, Fig. 2). In the cervical parts of the ALS spinal cord, not only the 
surroundings of the lateral ventral horns and ventral roots but also the posterior columns 
shared an invasion of reactive astrocytes and intense over-expression of γ1 laminin (IV, 
Figs. 3, 4A, 5). The posterior columns consist of the two parallel fiber tracts (cuneate and 
gracile) responsible for mediating mechanosensory information from all four extremities, 
the trunk, and the neck. ALS is known as a selective motor neuron disease, but some 
evidence indicates additional involvement of the somatosensory system (Theys et al., 
1999).  In the thoracic ALS spinal cord and the normal spinal cord, no γ1 laminin-
positive reactive astrocytes appeared in the posterior columns. In the gray matter of the 
ALS spinal cord, especially in the ventral horn and areas close to the central canal, γ1 
laminin-positive reactive astrocytes were present, but not in the same quantities as in the 
white matter (IV, Figs. 6A-B, 7C). The gray matter expression patterns of γ1 laminin in 
both the cervical and thoracic spinal cord were largely similar. None of the other screened 
laminins (α1-5, β1-3, and γ2 laminins) demonstrated over-expression or variation in 
distribution between the ALS and normal spinal cord.  
We also found that expression of 160-kDa neurofilament protein was drastically 
reduced in the ALS spinal cord compared to the normal. This reduction occurred in the 
part of the spinal cord containing the corticospinal tract (IV, Fig. 1); the lateral parts of 
the tract, meaning the dorsolateral column and the lateral column, had suffered the most 
prominent loss of motor neuron fibers (IV, Figs.1, 6A-B, 7A-B). In addition, the white 
matter surrounding the anterior ventral horns shared a similar reduction in 160-kDa-
positive nerve fibers (IV, Fig.1). In these same spinal cord regions with reduced 
neurofilament expression, a great number of GFAP-positive and γ1 laminin-expressing 
reactive astrocytes were detectable (IV, Figs. 6A-B, 7A-B). 
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Immunocytochemical analysis using antibodies against both intact γ1 laminin and 
the decapeptide containing the neurite outgrowth domain of γ1 laminin (Murtomäki et al., 
1992) revealed a large number of inclusions in the white matter of ALS spinal cord (IV, 
Figs. 6A, 7A-B). These inclusions were also detectable by antibodies against α1, α2, β1-
β3, and γ2 laminins and by antibodies against ALS-associated and degeneration-linked 
proteins, e.g., SOD-1, FGF-2, α-synuclein, and bNOS (IV, Table 1).  However, none of 
these additional antibodies detected the reactive astrocytes in the white matter of ALS 
spinal cord as did the antibodies against the γ1 laminin (IV, Table 1). The inclusions were 
also found in normal spinal cord but were more abundant in ALS spinal cord (IV, Fig. 8). 
Furthermore, a larger number of inclusions were present in the white matter than in the 
gray matter of ALS spinal cord (IV, Fig. 8).  
Western analysis with 5% SDS-PAGE confirmed the γ1 laminin expression 
revealed by the immunocytochemistry, showing that the ALS spinal cord-derived protein 
extracts contained γ1 laminin (200-kDa), as expected (IV, Fig. 9). The analysis revealed 
also that the γ1 laminin was fragmented (IV, Fig. 9). This fragmentation of γ1 laminin 
was evident in protein extracts obtained from both the cervical and thoracic ALS spinal 
cord, whereas γ1 laminin from normal spinal cord extracts was intact. The sizes of 
fragments were approximately 85-kDa and 100-kDa compared to the original size of 
intact γ1 laminin: around 200-kDa (IV, Fig. 9). More intensive fragmentation of γ1 
laminin was detectable in the cervical ALS spinal cord and in some thoracic spinal cord 
samples, resulting in a total absence of the intact 200-kDa γ1 laminin (IV, Fig. 9). The γ1 
laminin fragments contained the neurite outgrowth-promoting domain of γ1 laminin, 
detected by the polyclonal antibody against the decapeptide (RDIAEIIKDI). The 
mechanism or the enzymes responsible for γ1 laminin cleavage remains unknown, but 
both proteolysis and oxidation may be involved. 
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DISCUSSION 
DISTRIBUTION AND POSSIBLE ROLES OF LAMININS IN 
DEVELOPMENT OF HUMAN SPINAL CORD 
The expression of laminins (α1, β1, β3, and γ1) as punctate deposits in the floor 
plate region in the human embryonic spinal cord indicates a significant role for laminins 
in its development (I). Due to the rostrocaudal development of the human spinal cord, 
caudal regions mature later than its cervical and thoracic regions. According to our data, 
expression of laminins (α1, β1, and γ1) was generally weaker in the thoracic spinal cord 
and β3 laminin was non-existent, but was present in lumbar regions (I). Thus, the 
expression of laminins in the spinal cord floor plate follows a spatial and temporal pattern 
and correlates with human spinal cord development. The punctate deposits of laminins 
(α1, β1, and γ1) in the floor plate were also in immediate contact with the neurofilament 
160-kDa-positive neuronal fibers crossing the ventral midline, indicating that laminins 
may participate in commissural axon guidance during embryonic spinal cord 
development (I). The distribution patterns of different laminins in the floor plate were all 
punctate, but differed from each other in a manner that is not currently understood (I). 
This may indicate that different laminins have different functions and perhaps guide 
different groups of axons during the midline crossing, or they may participate in guidance 
only during a specific time-point. For instance, the β3 laminin expression was found to a 
great extent in the floor plates of 7- to 8-week-old embryos both in the thoracic and 
lumbar region, but was nearly undetectable in the spinal cord of 10- to 11.5-week-old 
human embryos (I). These findings indicate that the β3 laminin is essential earlier, 
participating perhaps in the guidance of the pioneer axons, but becomes useless after the 
first crossings have occurred.  
Laminins were expressed differently also outside the floor plate area, e.g., cells of 
notochord and neuroechtodermal cells lining the central canal expressed γ1 laminin, and 
the motor neurons of the ventral horn were immunoreactive to α1, α5, and γ1 laminin. 
Laminin α5 is known to be important for the development of striated muscles (Sorokin et 
al., 1997). Thus, expression of α5 laminin both in developing motor neurons and in 
striated muscle indicates synergistic development of motor units (a motor neuron and the 
skeletal muscle fibers it innervates) with a similar laminin expression pattern. 
Results from in situ hybridization indicate that the laminins α1, β1, and γ1 are 
synthesized by the floor plate cells of the human embryonic spinal cord (I). The mRNA 
distribution of these three laminins was similar to the punctate deposits of laminins 
detected by immunocytochemistry (I). Laminin mRNA expression was, however, not 
uniform at the floor plate, and some cells showed more intense labeling than others, for 
instance γ1 laminin mRNA expression (I, Fig. 7G, p. 345), verifying the variation in 
laminin distribution pattern detected by immunocytochemistry. The synthesis of different 
laminin mRNAs thus seems to vary in intensity and to be dependent on the 
developmental stage of the spinal cord and the location of the synthesizing cell in the 
floor plate. This may be important for the accurate guidance of specific groups of 
commissural axons crossing the ventral midline at a certain level of the spinal cord during 
a specific time-point. 
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We were the first to demonstrate that laminins are synthesized and expressed by 
the floor plate cells in the human embryonic spinal cord (I). It had already been shown 
that laminin-1 is expressed by the cells lining the central canal and in vascular walls of 
the mouse embryonic spinal cord (Ohyama et al., 1997) and that various laminins are 
expressed by neurons derived from human embryonic CNS in vitro (Liesi et al., 2001). 
Netrin-1 and netrin-2 share a structural homology with N-terminal domains of both β1 
and γ1 laminins (Yurchenco and Wadsworth, 2004) and are thought to act as 
chemoattractants for commissural axons. Netrin-1 is synthesized and secreted by floor 
plate cells, and netrin-2 is synthesized by cells of the ventral spinal cord (Kennedy et al., 
1994; Serafini et al., 1994, 1996). We also detected netrin-1 as punctate deposits similar 
to γ1 laminin within the floor plate region (I). Thus, similarities in structure and 
localization indicate synergistic functions of γ1 laminin and netrins during the embryonic 
development of the mammalian spinal cord.  
No laminins have been demonstrated to participate in commissural axon guidance. 
However, laminin-1 expression in the embryonic CNS is known to be transient and 
declines as the CNS matures (Liesi, 1985a; Cohen et al., 1987; Liesi and Silver, 1988; 
Letourneau et al., 1988). During the development of the avian and rodent CNS, laminin-1 
localizes in spatial temporal correlation with the pioneer axon growth along the both optic 
and ventral pathways (Cohen et al., 1987; McLoon et al., 1988; Liesi and Silver, 1988; 
Letourneau et al., 1988). Thus, the participation of laminin-1 in axon guidance elsewhere 
in the developing CNS is well documented, and it is therefore likely that laminins play a 
role also in commissural axon guidance.  
 
KDI Tripeptide of γ1 Laminin as a Chemotrophic Guidance Cue 
Laminin-1 is an efficient neurite outgrowth-promoting protein (Manthorpe et al., 
1983; Liesi et al., 1984a), and this function has been mapped in the C-terminus of γ1 
laminin containing the RDIAEIIKDI peptide (Liesi et al., 1989, 2001b). Previous 
experiments from our laboratory indicate that both the decapeptide (RDIAEIIKDI) and 
the KDI tripeptide promote neurite outgrowth of human CNS neurons in both soluble and 
substrate-bound forms (Liesi et al., 1989; Liesi et al., 2001b). The decapeptide also 
participates in axonal differentiation and in directional growth of rat hippocampal 
neurons (Matsuzawa et al., 1996, 1998). Results from our study using the Matrigel 
culture system, allowing the diffusion of the small KDI tripeptide, demonstrate that axons 
from the dorsal embryonic spinal cord grew selectively towards the KDI-containing zone 
(I). These results indicate that the KDI tripeptide, similar to netrin-1, provides both 
chemoattractive cues for dorsal spinal cord neurons (I) and contact guidance for human 
embryonic brain neurons (Liesi et al., 2001b). Neurons of the ventral spinal cord failed to 
respond to the KDI tripeptide and showed no specific axon guidance towards the peptide 
(I). Similarly, the ventral midline neurons fail to respond to netrin-1 chemoattraction 
(Varela-Echavarria et al., 1997). The KDI tripeptide mediates its function via a G-
protein-coupled mechanism (Liesi et al., 2001b), and interestingly, netrin-1 is also known 
to interact with a G-protein-coupled receptor which induces the production and 
intracellular accumulation of cAMP (Corset et al., 2000). These findings indicate a high 
functional similarity between these two guidance molecules. The spatial and temporal 
colocalization of γ1 laminin with commissural axons at the floor plate region of human 
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embryonic spinal cord and the ability of the KDI tripeptide to provide chemotrophic 
guidance cue for neurites indicate involvement of γ1 laminin in commissural axon 
guidance and in proper development of the embryonic CNS. 
 
KDI-MEDIATED REGENERATION AFTER ADULT MAMMALIAN SCI 
Based on our previous findings, we hypothesized that use of soluble KDI 
tripeptide will enhance regeneration in mammalian CNS trauma. This indicates that the 
KDI-treated neurons are able to overcome environmental inhibition in vitro and elongate 
their axons on hostile surfaces such as the injured glial monolayer and white matter of the 
adult human spinal cord (Liebkind et al., 2003). The exact mechanism of action 
mediating the neurite outgrowth-promoting property of the KDI tripeptide remains, 
however, unknown (Liesi et al., 2001b; I). Despite the lack of comprehensive 
understanding of activation pathways involved in KDI-promoted regeneration, the 
potential of the tripeptide is convincing. After complete transection of the adult rat spinal 
cord, the KDI-treated animals improved significantly in motor and behavioral functions 
compared to placebo-treated animals with their persistent paralysis (II). The KDI-treated 
rats were able to support their own body weight and some even to walk using their hind 
limbs (II). Results from immunocytochemistry confirmed that KDI enhances the 
regeneration of damaged fiber tracts. In KDI-treated animals, but not in the placebo-
treated, serotonin (5-HT)-positive fibers appeared below the injury site (II). Serotonin-
positive fibers originate from medullary raphe nuclei located in the brainstem, which is 
unique for 5-HT-expressing neurons; 5-HT positive fibers are therefore considered a 
regeneration indicator in SCI research (Faden et al., 1988a; Cheng and Olson, 1995; 
Saruhashi et al., 1996). After SCI, 5-HT fibers degenerate in a rostrocaudal fashion, and 
according to Cheng and Olson (1995), all 5-HT fibers had degenerated 1 month after the 
total transection of the rat spinal cord. Thus, serotonin-positive fibers found 14 weeks 
after the SCI must be considered regenerated, indicating that KDI promotes regeneration 
and neurite outgrowth over the transection site (II). Laminin-1 is induced in reactive 
astrocytes after CNS trauma (Liesi et al., 1984b) and in both mammalians and lower 
vertebrates continued laminin-1 expression correlates with the regeneration capacity of 
the CNS (Liesi, 1985b). In addition, γ1 laminin is linked to CNS regeneration. Expression 
of γ1 laminin is induced in reactive astrocytes after rodent SCI (Liesi and Kauppila, 2002; 
II) and in reactive glial cells surrounding the necrotic area after cerebral ischemia 
(Liebkind, unpublished results). Recently it was demonstrated that inhibition of γ1 
laminin mRNA translation leads to impaired regeneration of lesioned postnatal rat 
hippocampal mossy fibers (Grimpe et al., 2002). The regeneration ability of the mossy 
fibers resumed after selective inhibition of γ1 laminin mRNA synthesis ceased (Grimpe 
et al., 2002).  
The KDI tripeptide may enhance the regeneration also by affecting the harmful 
environmental factors at the injury site. The scar- and cyst-formation was reduced at the 
lesion site in KDI-treated animals compared to those placebo-treated (II). The glial scar 
and the myelin-derived inhibitory signals are the major obstacles hampering the 
regenerating neurites (see, 2.2.2 and 2.2.3). Our previous findings indicate that KDI 
seems to override both the myelin- and glial-derived inhibition (Liebkind et al., 2003). 
Thus, the regenerating axons of the KDI-treated animals had a less regeneration-hostile 
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environment and a shorter distance to regenerate across the lesion site (II). These data 
strongly imply that KDI tripeptide treatment enhances healing and functional 
regeneration of damaged nerve fiber tracts, thus providing a clinically applicable and 
effective method to enhance regeneration and recovery of SCI patients.  
 
THE ROLE OF γ1 LAMININ AND ITS KDI TRIPEPTIDE AS A 
NEURONAL PROTECTOR 
Glutamate Induced Excitotoxicity 
Results from my thesis studies indicate that the KDI tripeptide of γ1 laminin 
provides efficient protection against KA-induced neuronal death (III). Because 
neurotoxicity of KA is mediated via ionotropic glutamate receptors, KA provides an 
excellent research model for glutamate excitotoxicity (Wang et al., 2005). Glutamate 
excitotoxicity-mediated neuronal death has been associated with various 
neurodegenerative disorders (Heath and Shaw, 2002; Hynd et al., 2004; Fahn and Sulzer, 
2004) and CNS trauma (Arundine and Tymianski, 2004). Hippocampal CA1-CA3 
neurons are especially vulnerable to KA-induced excitotoxicity due to their high 
concentration of ionotropic glutamate receptors (Ben-Ari, 1985). We demonstrated that 
stereotaxic injection of KDI tripeptide at 500 µg/ml provided effective protection against 
KA-induced neuronal death and tissue destruction in the adult rat hippocampus (III). This 
protection was incomplete: at the actual injection site, no viable neurons were visible, and 
the reactive gliosis was more extensive than in NaCl + NaCl-injected controls (III). The 
hippocampal tissue was, however, neither fully destroyed and nor replaced by large 
vacuoles, as in animals receiving only NaCl before toxic intra-hippocampal KA injection 
(III).  
These results demonstrate for the first time a clear link between the glutamate 
system and laminins (III). Previous reports have, however, predicted this linkage, and it is 
known that normal adult rodent hippocampal neurons express γ1 laminin (Hager et al., 
1998; Indyk et al., 2003), and that kainic acid down-regulates this expression (Chen and 
Strickland, 1997; Nagai et al., 1999). KA-mediated hippocampal neuronal death is 
associated with serine protease-cascade activation involving tissue plasminogen activator 
(tPA) and plasmin(ogen) (Chen and Strickland, 1997;  Nagai et al., 1999; Indyk et al., 
2003). These proteases degrade hippocampal laminin and ECM due to the high-
magnitude depolarization caused by KA. Interestingly, KA-mediated hippocampal 
neuronal death is prevented by pharmacological inhibition of the proteases tPA and 
plasmin(ogen) (Tsirka et al., 1997). In addition, tPA-deficient mice are resistant to KA-
induced neuronal death after intrahippocampal injections of KA and show no changes in 
hippocampal laminin expression (Chen et al., 2003; Indyk et al., 2003). Proteolytic 
degradation due to the KA administration may liberate biologically active peptide 
sequences such as KDI, which are neither exposed nor fully active in the intact laminin-1 
trimer. This proteolytic pathway is, however, unable to protect hippocampal neurons 
against KA-induced neuronal death, indicating either that the KDI tripeptide is 
completely degraded with the rest of the trimer or that the amount of liberated KDI is 
insufficient to promote any overall neuronal survival. 
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Oxidative Stress 
Recent studies in our laboratory indicate that a stereotaxic injection of KDI 
tripeptide protects dopaminergic neurons in the substantia nigra against the neurotoxin 6-
hydroxy-dopamine (6-OHDA; Väänänen et al., 2006). The 6-OHDA is an analogue of 
neurotransmitter dopamine and mediates its toxicity via formation of reactive oxygen 
species which inhibit the mitochondrial electron transfer chain (Schober et al., 2004). 
Thus, stereotaxic injection of 6-OHDA into the substantia nigra leads to neuronal tissue 
destruction and selective death of dopaminergic neurons, if applied without preceding 
KDI (Väänänen et al., 2006). These results should not only further support the role of 
KDI as a universal protector against neurotoxins but also link the KDI to a new cause of 
neuronal death, namely oxidative stress. Possible molecular pathways mediating the 
protective property of KDI against oxidative stress remain to be revealed. However, 
neurotrophic factors such as NGF and glial cell line-derived neurotrophic factor (GDNF) 
have been able to protect dopaminergic neurons against 6-OHDA-mediated neuronal 
death even though the exact mechanism of action remains unclear (Sullivan et al., 1998; 
Kumar et al., 2006). Another possible pathway may be the KDI-induced cessation of 
simultaneous glutamate transmission (Möykkynen et al., 2005), sparing the neurons from 
a harmful combination of glutamate excitation and 6-OHDA-induced excessive dopamine 
receptor activation. Glutamate receptor blockers such as the NMDA-receptor inhibitor 
MK-801 are known to attenuate dopamine receptor activation and reduce the firing rate 
of dopaminergic neurons (Huang et al., 1998). 
 
KDI TRIPEPTIDE AND ITS MECHANISMS OF ACTION  
The exact mechanisms by which the KDI tripeptide mediates its various actions 
remain unknown. It has, however, become evident that this involves more than one 
mechanism of action. Its promotion of neurite outgrowth, proliferation, and neuronal 
survival, together with its regeneration-enhancing function (Liebkind et al., 2003; II) and 
protection against neurotoxins (III; Väänänen, et al., 2006) are unlikely to be mediated 
via only one receptor pathway. Nevertheless, some functionally important mechanisms 
behind this multifunctional peptide have been revealed: Recent findings from our 
laboratory elucidate the mechanism behind the effective neuronal protection of the KDI 
tripeptide against KA-induced glutamate excitotoxicity (III). According to patch-clamp 
recording data, the KDI acts as a universal ionotropic glutamate-receptor inhibitor, 
capable of inhibiting NMDA, AMPA, and kainate receptors (Möykkynen et al., 2005), 
the same receptors responsible for mediating glutamate excitotoxicity. The KDI inhibited 
all three ionotropic glutamate-receptor types in a dose-dependent and non-competitive 
manner. The tripeptide produces almost complete inhibition of AMPA and kainate 
receptors and a 50% inhibition of the NMDA receptors (Möykkynen et al., 2005). 
 Previous results further indicate that KDI induces outward-rectifying potassium 
currents causing hyperpolarization of the neuron (Liesi et al., 2001b), which enhances 
survival by inhibiting the repeated depolarizations, thus reducing the massive Ca2+ influx 
into the affected neuron. Interestingly, activation of the ECM protein receptor β1 integrin 
also protects embryonic rat hippocampal neurons against glutamate excitotoxicity (Gary 
and Mattson, 2001; Gary et al., 2003). Receptor activation can be performed by use of a 
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seven-amino-acid peptide derived from the α1 laminin (EIKLLIS; Tashiro et al., 1999), 
leading to activation of an integrin-linked kinase and an Akt kinase-dependent anti-
apoptotic pathway (Gary et al., 2003). Laminins are known to bind various integrins, but 
these connections are often mediated via globular G domains of α laminins (Aumailley et 
al., 1990a,b; Sonnenberg et al., 1991) or via various N-terminal domains of laminin-1 
(Pfaff et al., 1994; Colognato-Pyke et al., 1995) but not via the C terminus of γ1 laminin. 
Because the KDI tripeptide gains laminin-like neurotrophic properties and 
promotes neurite outgrowth and axonal regeneration, it is therefore probable that the KDI 
mechanism of action also involves classical laminin receptors. Laminin receptors such as 
integrins, the 67/68-kDa laminin receptor, and α-dystroglycan mediate their functions via 
secondary messenger-mediated cascades and ultimately affect gene transcription. 
Activation of gene transcription as well as recruitment of filamentous actin and the 
microtubule cytoskeleton is necessary for any significant neurite outgrowth and axonal 
regeneration. The KDI tripeptide also activates second messenger-dependent pathways, 
indicating that a G-protein-coupled mechanism may be involved (Liesi et al., 2001b). The 
KDI is able to hyperpolarize neurons by activation of outwardly rectifying potassium 
currents via a G-protein-coupled pathway (Liesi et al., 2001b).  
Cellular prion protein (PrP), a normal component of cell membrane, has been 
shown to form a high affinity interaction with laminin-1 (Graner et al., 2000). This 
interaction is mediated by the C-terminal neurite outgrowth domain (RDIAEIIKDI) of γ1 
laminin, and it has been proposed that the cellular PrP may even act as a laminin-1 
receptor (Graner et al., 2000). However, what is still unknown is whether the three 
amino-acid-long KDI peptide is able to interact in similar manner with the cellular PrP. 
The unique and specific functions of short laminin-derived peptides should not be 
considered identical to the biological functions of the large heterotrimeric laminin-1. It is 
obvious that the complex three-dimensional structure of the whole laminin-1 protein 
affects and alters the function of these active sites in vivo. However, short peptides 
derived from the active sites are important in investigation of the mechanisms of the 
actions and receptor binding of extracellular matrix proteins. Thus, the focus of future 
studies should be on resolving the exact mechanisms of action and signaling pathways for 
γ1 laminin and KDI tripeptide. 
 
ROLE OF LAMININS IN DEGENERATIVE CONDITIONS OF CNS  
The selective over-expression of γ1 laminin in reactive astrocytes of ALS spinal 
cord was the first-ever finding linking the laminins to the CNS pathology of ALS (IV). 
Previously, elevated expression of laminin-1 was found only in the skin of ALS patients 
(Ono et al., 2000), with involvement of laminins in the ALS-affected CNS undiscovered. 
This is not, however, the first time that laminins have been associated with 
neurodegeneration. Selective expression of laminin-1 appeared in both plaques and pre-
plaques of the Alzheimer’s (AD) brain and in plaques of the Down’s syndrome brain 
(Murtomäki et al., 1992). Perivascular microglia of the AD brain express laminin-1 
(Perlmutter et al., 1991). In addition, γ1 laminin is over-expressed by the reactive 
astrocytes of the AD brain (Murtomäki et al., 1992; Palu and Liesi, 2002), and antibodies 
against the N-terminal domains of γ1 laminin detect γ1 laminin in senile plaques (Palu 
and Liesi, 2002). Deposition of amyloid β-peptides in the form of amyloid firbrils leads 
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to formation of the senile plaques characteristic of the AD brain (Selkoe, 1998). Laminin-
1 is known to interact with the amyloid β-peptides, and these interactions are mediated by 
two separate binding sites on α1 laminin, one in domain III of α1 laminin containing the 
YFQRYLI peptide sequence (Monji et al., 1998) and another in the globular G-domain 
region of α1 laminin (Castillo et al., 2000). Laminin-1 inhibits fibrilogenesis (Bronfmnan 
et al., 1996) and neurotoxicity (Druet et al., 1999) of the amyloid β-peptide, and these 
functions are believed to be mediated by the amyloid β-peptide-specific binding sites on 
α1 laminin (Monji et al., 1998; Castillo et al., 2000). Thus, laminin-1 may prevent or 
slow down the progression of amyloidogenesis in AD. These findings imply a clear 
association between the laminin system and CNS degeneration. 
 
Selective Over-Expression of γ1 Laminin in ALS   
Studies on human ALS demonstrate that γ1 laminin is expressed by reactive 
astrocytes in the white matter of the ALS spinal cord, distinguishing the diseased spinal 
cord from the normal (IV). The selective and spatial expression of γ1 laminin-positive 
reactive astrocytes correlates well with our other ALS-related findings. The γ1 laminin 
expression is more intensive in the worst affected parts of the ALS spinal cord, namely in 
the cervical spinal cord compared to the thoracic spinal cord and in areas suffering from 
massive neurofilament reduction, e.g., in the lateral corticospinal tract containing the 
descending motor fibers (IV). Such a decrease in descending motor fibers in the ALS 
spinal cord is reasonable, based on the fact that ALS more prominently affects upper and 
lower motorneurons; motor fibers thus also degenerate (Bruijn et al., 2004).  In addition, 
ALS pathology affects the cervical more severely than the thoracic spinal cord (Kuncl et 
al., 1992). Thus, γ1 laminin over-expression in ALS spinal cord correlates with severity 
of disease.  
In the cervical ALS spinal cord, γ1 laminin-positive reactive astrocytes also 
occurred in the dorsal columns containing the ascending sensory pathways (IV). The 
localization of γ1 laminin-positive reactive astrocytes and the normal number of 
somatosensory neuronal fibers in the dorsal columns of the ALS spinal cord rules out the 
involvement of γ1 laminin in the reduction of neurofilaments detected in dorsolateral 
columns (IV). Although ALS is a degenerative motor-neuron disease, several studies 
have demonstrated that even the somatosensory system may be affected (Tandan and 
Bradley, 1985; Mondelli et al., 1993; Gregory et al., 1993). Electrophysiological studies 
of sensory fibers have revealed a decrease in the conduction velocity of central and 
peripheral sensory pathways (Mondelli et al., 1993; Theys et al., 1999). In addition, 
Lewy body-like hyaline inclusions have been found in the dorsal columns of both familial 
(Kato et al., 1999) and sporadic ALS (Hays et al., 2006). 
In the ALS spinal cord, γ1 laminin-positive Lewy body-like inclusions appeared 
in larger numbers in both the white and gray matter than in normal spinal cord (IV). The 
γ1 laminin-positive inclusions shared an immunoreactivity to degeneration-linked 
molecules such as α-synuclein, SOD-1, and bNOS, but stained positive also for various 
laminins (IV). Inclusions are often considered a characteristic feature of 
neurodegenerative disorders (Kato et al., 1999; Doherty et al., 2004; Kawamoto et al., 
2004). Although a few inclusions were found in normal spinal cord, these were 
significantly less abundant than in the ALS spinal cord (IV). Thus, inclusion may be an 
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early indicator for neuronal death, occurring to some extent even under physiological 
conditions; it is therefore feasible that some inclusions will be evident even in normal 
spinal cord tissue. 
Western analysis demonstrated that the γ1 laminin derived from ALS spinal cord 
protein extracts was fragmented compared to intact γ1 laminin from normal spinal cord, 
and that the fragments contained the biologically active KDI tripeptide (IV). This 
degradation may be due to the proteolytic or oxidative cleavage of γ1 laminin in the ALS 
spinal cord. Matrix metalopreoteinases (MMP) are upregulated after various CNS insults 
including ALS (Lim et al., 1996; Ludolph, 2006), and according to the latest results, 
increased MMP-9 activity is associated with laminin-1 degradation and induction of 
apoptosis after cerebral ischemia (Gu et al., 2005). Interestingly, both laminin-1 
degradation and neuronal death can be reduced by use of a specific thiirane gelatinase 
inhibitor SB-3CT to block the MPP-9 activity (Gu et al., 2005). As oxidative stress is 
known to alter and degrade proteins in ALS, it is another possible mediator for ALS-
related γ1 laminin fragmentation. The reported selective over-expression of γ1 laminin 
and its degradation into smaller KDI tripeptide-containing fragments, together with our 
earlier results on the neurotrophic role of γ1 laminin and KDI, suggest that γ1 laminin 
may play a neutralizing role against ALS-related pathogens, providing protection and 
enhancing the viability of the affected neurons. 
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SUMMARY AND CONCLUSIONS 
In these thesis studies we demonstrated that γ1 laminin together with α1, β1, and 
β3 laminins localize at the floor plate region in human embryonic spinal cord. This 
localization of γ1 laminin is in spatial and temporal correlation with development of the 
spinal cord and indicates that γ1 laminin may participate in commissural axon guidance 
during the embryonic development of the human CNS (I). With in vitro studies using the 
Matrigel culture system, we demonstrated that the KDI tripeptide of γ1 laminin provides 
a chemotrophic guidance cue for neurites of the human embryonic dorsal spinal cord (I), 
verifying the functional ability of γ1 laminin to guide commissural axons. Results from 
our experimental SCI model demonstrate that the KDI tripeptide enhanced functional 
recovery and promoted neurite outgrowth across the mechanically injured area in the 
adult rat spinal cord (II). Furthermore, our findings indicate that the KDI tripeptide as a 
non-competitive inhibitor of the ionotropic glutamate receptors can provide–when 
administered in adequate concentrations–an effective method to protect neurons against 
glutamate-induced excitotoxic cell death (III). Human postmortem samples were used to 
study motor neuron disease, ALS (IV), and the study revealed that in human ALS spinal 
cord, γ1 laminin was selectively over-expressed by reactive astrocytes, and that this over-
expression may correlate with disease severity (IV). The multiple ways by which γ1 
laminin and its KDI tripeptide provide neurotrophic protection and enhance neuronal 
viability suggest that the over-expression of γ1 laminin may be a glial attempt to provide 
protection for neurons against ALS pathology (IV).   
The KDI tripeptide is effective therapeutically thus far in animal models only. 
However, because KDI containing γ1 laminin exists naturally in the human CNS, KDI 
therapies are unlikely to be toxic or allergenic. Results from our animal models are 
encouraging, with no toxic side-effects detected even at high concentrations, but the 
ultimate confirmation can be achieved only after clinical trials. More research is still 
needed until the KDI tripeptide is refined into a clinically applicable method to treat 
various neurological disorders. 
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